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Abstract
Pathogenic theories of Restless Legs Syndrome (RLS) 
and Periodic Limb Movements in Sleep (PLMS) were reviewed 
and critiqued, and a new theory for the pathogenesis of 
RLS and PLMS was presented. It was proposed that both 
disorders are caused by sleep-related hypoperfusion in the 
area of the cerebral cortex that mediates sensation and 
movement in the legs. The hypoperfusion was proposed to 
be caused by high amplitude oscillations in total cerebral 
blood flow known as B-waves and by flow-reducing 
turbulence at several of the bifurcations in the anterior 
cerebral artery. This theory was tested by using near 
infra-red spectroscopy (NIRS) to measure cerebral 
hemoglobin oxygen saturation and total blood flow in three 
groups of subjects: nine patients with RLS, six patients
with PLMS, and eleven age-matched control subjects. 
Cerebral oximetry was performed during both wakefulness 
and sleep. Polysomnography was used to assess sleep. It 
was predicted that high amplitude B-waves would occur in 
the RLS subjects during wakefulness, and in both RLS and 
PLMS subjects during sleep. In addition, it was predicted 
that the abnormal sensations and movement in RLS patients 
and the PLMS in both RLS and PLMS patients would occur 
during the B-wave troughs in cerebral hemoglobin
vii
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oxygen saturation. As expected, significant differences 
among the groups in abnormal leg sensations and leg 
movements while awake, and periodic leg movements while 
asleep were found. However, the results did not support 
the proposed theory. Although there was a statistically 
significant non-random occurrence of abnormal sensations 
and movements (both waking RLS movements and PLMS) in the 
B-wave cycle, the tendency was for these events to occur 
at both B-wave peaks and troughs. B-wave amplitudes and 
cerebral hemoglobin oxygen saturation levels were not 
significantly different among the three groups. There 
were also no significant differences within the RLS and 
PLMS groups in hemoglobin oxygen saturation levels at 
event onset as compared to periods when no events were 
present. Future studies should attempt to replicate the 
previous research that has implicated circulatory 
insufficiency in the pathogenesis of both disorders.
viii
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Introduction
Restless legs syndrome (RLS) is a neurological 
disorder characterized by the appearance of lower leg 
paresthesias during periods of prolonged motor inactivity. 
The symptoms appear most commonly in the evening, and are 
relieved by movement of the legs. Because the 
paresthesias (and subsequent motor hyperactivity) are most 
prominent as the patient attempts to fall asleep, chronic 
insomnia and sleep deprivation often occur in more 
severely affected patients.
Almost all patients who have RLS also have periodic 
limb movements in sleep (PLMS), which are stereotypic 
movements of the feet and lower legs that occur at semi- 
periodic intervals of between 20 and 40 seconds. The 
movements are generally restricted to non-rapid eye 
movement (NREM) sleep. Videotaped analyses of these 
movements have shown that they appear similar to the 
abnormal plantar reflex or Babinski response (Smith,
1985). The movements may cause brief arousals from sleep, 
and thus impair sleep quality, although it is also common 
for affected patients to have no sleep complaints. For 
example, Kales et al. (1982) studied 200 patients with 
complaints of insomnia and 100 control subjects without 
any sleep complaints. The prevalence of PLMS was exactly
1
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2the same (11%) in both groups, suggesting that 
approximately half of all subjects who have PLMS do not 
have a sleep complaint. Although about 90% of RLS 
patients have PLMS (Montplaisir, Godbout, Pelletier, and 
Warnes, 1994), many persons who have PLMS do not have RLS. 
For example, Guilleminault, Raynal, Weitzman, and Dement 
(1975) found that only two of sixteen insomniacs (12.5%) 
who had PLMS also had RLS. Despite this, because most RLS 
patients also have PLMS, and because many treatments which 
are effective for RLS are also effective for PLMS (e.g. 
dopamine and opioid agonists) , it is generally accepted 
that the pathogenic mechanisms of the two disorders are 
closely related.
The pathogenesis of these two disorders remains 
unknown (Montplaisir, Godbout, Pelletier, and Warnes 1994; 
O'Keeffe, 1996), although four pathogenic theories of RLS, 
and two pathogenic theories of PLMS have been discussed 
with somewhat greater frequency. The pathogenic theories 
of RLS include reduced peripheral blood flow, peripheral 
neuropathy, central dopaminergic dysfunction, and central 
opioid neurotransmitter dysfunction. Reduced peripheral 
blood flow has also been proposed as a pathogenic 
mechanism for PLMS. Other pathogenic theories of PLMS 
include oscillations of reticular system excitability and
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
3spontaneously occurring Babinski responses. In general, 
these theories are vague and poorly developed. A critical 
review shows that there is very little direct evidence to 
support any of them. Furthermore, none of these theories 
seem to be able to account for all of the well-established 
features of either disorder.
Even though the pathogenic mechanisms of RLS and PLMS 
remain unknown, effective treatments for both disorders 
are available. These include correction of anemia, opioid 
agonists, dopamine agonists, benzodiazepines (especially 
clonazepam), clonidine, and the anti-convulsants 
carbamezapine and gabapentin. The discovery of the 
effectiveness of these drugs has often come about through 
chance observation or through empirical trial and error 
investigation in single patients. Because the 
pathogenesis of RLS and PLMS remains unknown, the 
mechanisms by which these drugs exert their therapeutic 
effect is also unknown (correction of anemia being the 
apparent exception to this). This is problematical 
because many of these drugs can have serious side effects, 
and because it is possible that the therapeutic effect of 
these drugs arises from a secondary or non-specific 
effect, such as their sedative effects or their effects on 
cerebral blood flow, rather than their primary effect
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
4(e.g. increasing dopamine levels in the case of dopamine 
agonists).
In this paper a new theory for the pathogenesis of 
RLS and PLMS will be presented. Briefly, it is proposed 
that both disorders are caused by sleep-related changes in 
cerebral blood flow which lead to periodic cerebral 
ischemia and hypercapnia that are most prominent in the 
distal territory perfused by the callosomarginal branches 
of the anterior cerebral arteries. This territory 
includes the somatosensory cortex for the feet and lower 
legs. It is further suggested (in agreement with Smith's 
spontaneous Babinski response theory of PLMS) that this 
cortical ischemia causes the normal descending pyramidal 
tract inhibition of the Babinski response to be 
periodically released, resulting in the spontaneous and 
periodic occurrence of the reflex. The ability of this 
periodic cerebral ischemia theory (the PCI theory) to 
account for all of the well-established features of both 
RLS and PLMS will be briefly discussed.
One important implication of the PCI theory that will 
also be discussed concerns the treatment of RLS and PLMS. 
The proposed PCI theory suggests that cerebral 
vasodilators should be the most effective means of 
treatment for both disorders, and further that the drugs
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
which have been found to be beneficial (e.g. L-dopa, 
clonazepam) exert their therapeutic effect by either 
increasing cerebral blood flow or by reducing the 
amplitude of the oscillations in cerebral blood flow (B- 
waves) that are proposed to be one of the physiological 
bases of both disorders. Thus, vasodilators have the 
potential for offering a more effective means of treating 
RLS and PLMS.
The present study was an attempt to test this new 
theory of RLS and PLMS by recording cerebral hemoglobin 
oxygen saturation levels during wakefulness and sleep in 
three groups of subjects: RLS patients, PLMS patients,
and control subjects without any sleep complaints. It was 
predicted that both RLS and PLMS patients would have 
oscillations of total cerebral blood flow and cerebral 
oxyhemoglobin levels (i.e. B-waves) when symptoms were 
present. It was further predicted that the waking sensory 
and motor symptoms in RLS patients, and the PLMs during 
sleep in RLS and PLMS patients, would occur at the troughs 
of the cyclic oscillations of cerebral oxyhemoglobin 
levels (i.e. when cerebral oxyhemoglobin levels were at 
their lowest).
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Restless Legs Syndrome (RLS) and Periodic Limb Movements 
in Sleep (PLMS): A Brief Review
Clinical Features 
Restless legs syndrome was first described by Willis 
(1685), but was almost unknown to the modern medical 
community until 1944 when Karl Ekbom described a series o 
eight cases (K. A. Ekbom, 1944). Ekbom later described 
several larger case study series in extensive detail (K. 
A. Ekbom, 1945, 1960, 1970) . Other excellent reviews of 
the clinical features of RLS have been presented by 
several authors (Gorman, Dyck, and Pearson, 1965; Morgan, 
1967; Walters, 1995; Young, Humphries, and DeWolfe, 1969) 
and the following description of the clinical features of 
RLS is based on these reviews.
Although the name "Restless Legs Syndrome" is 
suggestive of a motor disorder, RLS is characterized by 
both sensory and motor symptoms. The sensory symptoms 
consist primarily of a difficult-to-describe lower leg 
paresthesia. Terms used most often to describe the 
sensations include "creeping," "crawling," "pulling," 
"prickling," etc.. These sensations are usually reported 
to occur deep within the leg muscles rather than on the 
surface of the skin. A review of the symptomatology of 
112 RLS patients by K. A. Ekbom (1945) found that 98% of
6
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patients had paresthesias in the lower legs (between the 
ankle and knees), 27% had paresthesias in the thighs, 15% 
had paresthesias in the feet, and 6% had paresthesias in 
the arms. Patients who had paresthesias in the arms often 
did not have them in the hands. The paresthesias are 
usually bilateral, but may be worse or appear exclusively 
on one side. Some patients do report having pain in 
addition to the paresthesias, usually of a dull aching 
quality (K. A. Ekbom, 1944, 1945; Young et al., 1969). In 
fact, in his 1945 monograph, K. A. Ekbom initially divided 
RLS into separate painful and paresthetic forms. However, 
he did not maintain this distinction in his later reviews 
(K. A. Ekbom, 1960, 1970). Finally, some RLS patients 
also complain of cold legs and feet (Ancoli-Israel,
Seifert, and Lemon, 1986; K. A. Ekbom, 1945; Ware,
Blumoff, and Pittard, 1988).
One of the most characteristic features of RLS is 
that the sensory symptoms appear almost exclusively during 
periods of prolonged motor inactivity. Another 
characteristic feature is that movement of the legs 
provides temporary relief from the paresthesias. This 
relief may be partial or complete, and is usually 
effective only when the patient is actually engaging in 
movement and for a relatively short time after the
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9movement has been stopped. Although it is generally 
accepted that RLS patients move their legs to gain relief 
from their paresthesias, a study by Pelletier, Lorrain, 
and Montplaisir (1992) found that only about half of the 
recorded waking leg movements in RLS patients were 
associated with sensory events, while almost all sensory 
events were associated with leg movements. Thus, waking 
movements in RLS patients may occur in the absence of any 
sensory event. Pelletier et al. concluded that the sensory 
and motor events in RLS were independent manifestations of 
a common underlying pathogenic mechanism. Finally, there 
is a definite circadian periodicity to the appearance of 
RLS symptoms; regardless of whether they occur in the 
waking or sleep state, they are most common in the late 
evening and during the night (Becker, Jamieson, and 
DeLaCueva, 1993; Walters, Trenkwalder, Hening,
Chokroverty, and Rahman, 1995) .
The motor symptoms in RLS consist primarily of 
excessive voluntary motor activity such as rubbing or 
massaging the legs, rubbing the legs together while in 
bed, and (eventually) getting out of bed and walking 
around. The motor activity usually has an agitated or 
restless quality. In older and more severely affected 
patients, waking myoclonic twitches of both upper and
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
lower extremities may be present (Walters, Hening, and 
Chokroverty, 1988). Some studies have also found that RLS 
patients may have periodic movements of the feet and lower 
legs while awake (Pollmacher and Schulz, 1993; Walters et 
al, 1988), although it is unclear from these reports if 
these movements are similar to the PLMs that occur during 
sleep. Finally, about 80 to 90 percent of RLS patients 
have PLMS during sleep (Coccagna and Lugaresi, 1981; 
Montplaisir, Lapierre, Warnes, and Pelletier, 1992).
Although many authors have emphasized that RLS can 
produce severe and chronic insomnia (e.g. K. A. Ekbom, 
1945; 1960; Gorman et al., 1965; Morgan, 1967; Walters, 
1995), there is surprisingly little quantitative data 
available on this subject. For example, no studies have 
been published in which the nocturnal sleep parameters of 
RLS patients have been compared to those of normal 
subjects. In an attempt to address this issue, one must 
turn to the RLS treatment studies in which polysomnography 
was performed under either baseline or placebo conditions. 
Three such studies (Trenkwalder et al., 1995; Wagner et 
al., 1996; and Zucconi et al., 1989) will be briefly 
mentioned here. Trenkwalder et al. studied 28 RLS 
subjects under placebo and treatment conditions, and 
reported a mean sleep latency of 70 minutes for the
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 0
placebo condition. Wagner et al. studied ten RLS patients 
under baseline, placebo, and treatment conditions, and 
reported a mean sleep latency of 4 7.4 minutes and a mean 
sleep efficiency (defined as the percentage of time in bed 
spent in sleep) of 72.0% for the baseline condition. 
Zucconi et al. studied nine RLS patients and reported a 
mean sleep latency of 37.5 minutes and a mean sleep 
efficiency of 57.0% under baseline conditions. When 
compared to normative values published by Bixler, Kales, 
Jacoby, Soldatos, and Vela-Bueno (1984) (sleep latency - 
22.1 minutes, sleep efficiency - 88.1%), the values in the 
three studies above are clearly indicative of insomnia.
The first description of periodic limb movements in 
sleep (PLMS) is generally attributed to Symonds (1953) who 
described five patients with a variety of motor 
abnormalities in sleep. Although Symonds noted that his 
patients had nocturnal leg movements, he did not record 
these movements polygraphically or observe them visually, 
and he was apparently unaware of their periodic nature.
At least two of his patients also apparently had either 
waking or nocturnal epileptic seizures, a finding which 
led Symonds to conclude that PLMS was caused by epileptic 
activity. Symonds used the term "nocturnal myoclonus" to 
describe his patients' abnormal motor activity. This term
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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persisted until the early 1980s, and was replaced with the 
term "periodic limb movements in sleep" after the periodic 
nature of the movements had become well established, and 
after it had been shown that the movements were neither 
myoclonic seizure activity nor exclusively nocturnal in 
occurrence (Coleman et al., 1980; Guilleminault, Raynal, 
Weitzman, and Dement, 1975; Lugaresi, Coccagna, Ceroni, 
and Ambrosetto, 1968). The studies by Guilleminault et 
al. and Lugaresi et al. failed to support Symonds' 
hypothesis that the movements were associated with 
epileptic activity.
Lugaresi et al. (1968) were the first to record PLMs 
polygraphically, and to emphasize their periodic nature. 
Their initial recordings of PLMS were in patients with 
RLS, but they soon found that PLMS could occur in patients 
without RLS or sleep complaints. Their recordings showed 
that the movements occurred at semi-periodic intervals of 
between 20 and 40 seconds, and that they were generally 
bilateral, simultaneous, and occurred primarily in the 
legs. They also noted that the movements were most common 
in light NREM sleep (Stages 1 and 2), and were often 
accompanied by brief electroencephalographic (EEG) 
arousals from sleep. A recent study by Pollmacher and 
Schulz (1993) found that PLMs were most frequent during
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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wakefulness and sleep Stages 1 and 2, less frequent in 
Stages 3 and 4 (slow wave sleep), and relatively uncommon 
in rapid eye movement (REM) sleep. They also found that 
the inter-movement-interval (IMI) was shortest during 
wakefulness and Stage 1 (mean IMIs of 33.3 and 34.4 
seconds respectively), got longer during NREM stages 2, 3, 
and 4 (combined IMI of 41.0 seconds), and was longest 
during REM sleep (mean IMI 53.2 seconds). The movement 
duration was longest during wakefulness (2.9 seconds) and 
Stage 1 (2.6 seconds), got progressively shorter during 
NREM stages 2, 3, and 4 (2.3 seconds), and was shortest in 
REM sleep (1.8 seconds). Thus, the movements were clearly 
too long to be considered myoclonic. An examination of 
IMI distributions for both groups of PLMS patients (Kayed, 
Roberts, and Davies, 1990) and individual patients 
(Montplaisir et al., 1985) shows that the modal IMI is 
often in the 20 to 30 second range, and that the mean IMI 
is usually higher than this because of outliers at the 
upper end of the distribution.
Two studies have provided detailed descriptions of 
PLMs based on videotaped analyses of the movements 
(Guilleminault et al., 1975; Smith, 1985). Guilleminault 
et al. reported that the movements consisted of "a rapid 
partial flexion of the foot at the ankle, extension of the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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big toe, and partial flexion at the knee and hip..." 
(Guilleminault et al., 1975, p. 19). Smith (1985) found 
results that were very similar to those obtained by 
Guilleminault et al.. Smith reported that 91% of the PLMs 
he recorded were characterized by dorsiflexion of the foot 
at the ankle, 82% showed dorsiflexion and fanning of the 
small toes, 72% showed dorsiflexion of the big toe, and 
28% showed partial flexion of the leg at the knee and hip. 
Smith pointed out that this pattern of movements was 
similar in appearance to the abnormal plantar reflex 
(Babinski's response), and he proposed that PLMs were in 
fact spontaneously occurring Babinski responses which 
occurred because of a reduction in supraspinal inhibition 
of lower motor neurons during NREM sleep.
Several different sets of scoring criteria have been 
used to score PLMs over the years, and unfortunately, none 
of them have been empirically derived. Guilleminault et 
al. (1975) scored any movement as a PLM if it had a
duration of between 0.5 and 15 seconds and an IMI of less 
than 120 seconds. In addition, each movement had to part 
of a series of at least three such movements. Coleman, 
Poliak, and Weitzman (1980) scored movements as PLMs if 
they were between 0.5 and 4.5 seconds in duration, had an 
IMI of between 20 and 40 seconds, and were part of series
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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of at least five such movements. Coleman (1982) later 
modified his criteria such that any movement which was 0.5 
to 5.0 seconds in duration with an IMI of between 5 and 90 
seconds, and part of a series of four such movements was 
scored as a PLM. Several years earlier, the Association 
of Sleep Disorders Centers (ASDC, 1979) used movement 
duration criteria of 0.5 to 10 seconds, and IMI criteria 
of 5 to 120 seconds in its diagnostic criteria for 
nocturnal myoclonus. In addition, three separate series 
of at least 30 PLMs each had to be present for a diagnosis 
of nocturnal myoclonus to be given. Finally, the American 
Sleep Disorders Association (ASDA, 1993) has recently 
published a set of guidelines and scoring criteria for 
recording and scoring PLMs. These criteria are recognized 
as the current standard, and are a revision of those 
presented earlier by Coleman (1982). Briefly, PLMs are 
recorded polygraphically by placing two small surface 
electrodes over the anterior tibialis muscle (the primary 
muscle involved in flexion of foot). The scoring criteria 
can be summarized as follows: 1) each movement must be
part of a series of at least four PLMs, 2) the movement 
duration must be between 0.5 and 5.0 seconds, and 3) the 
IMI must be between 5 and 90 seconds. Movements which 
occur at the end of respiratory events (i.e. apneas and
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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hypopneas) are not counted as PLMs. The number of PLMs 
per hour of sleep (the PLM index or PLMi) is tabulated, 
and five or more movements per hour of sleep is considered 
abnormal.
As noted above, these criteria have not been derived 
from an empirical analysis of the temporal characteristics 
of PLMs, but instead reflect the consensus of various 
researchers familiar with this disorder. The current ASDA 
criteria can be criticized for being somewhat liberal in 
both the IMI and number of movements in a series criteria. 
For example, according to these criteria, four movements 
with IMIs of 7, 90, and 30 seconds would be scored as 
PLMs, despite the obvious lack of any consistent 
periodicity in their IMIs. Given this somewhat liberal 
definition of PLMs, the diagnostic criterion for the PLMi 
of five or more events per hour of sleep also seems 
liberal, and it is possible that it may be resulting in a 
significant number of false positive PLMS diagnoses.
The issue of whether or not PLMS leads to daytime 
sleepiness or to nocturnal sleep disruption has received 
much attention over the years. The early descriptive 
study by Guilleminault et al. (197 5) was based on PLM data 
from 16 patients who were part of a total sample of 140 
patients who were referred for evaluation of insomnia.
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These 16 patients thus represented 11.4% of the total 
sample, a finding which led Guilleminault to conclude that 
PLMS could be an important cause of insomnia [122]. The 
association of PLMS with insomnia in some patients, and 
its well known association with RLS seemed to indicate 
that it might always represent a pathological (or sleep 
disrupting) finding. However, it was soon shown that PLMS 
could occur in a variety of sleep disorders (such as 
narcolepsy and sleep apnea), and that its prevalence in 
these disorders was not significantly different from its 
prevalence in insomnia (Coleman et al., 1980). Moreover, 
a study by Kales et al. (1982) also showed that the 
prevalence of PLMS in insomnia was not significantly 
different from its prevalence in normal subjects. Other 
work has shown that the PLM arousal index (PLMAi) is 
poorly correlated with subjective sleep complaints 
(Ancoli-Israel et al., 1991; Dickel and Mosko, 1990), and 
has either low correlations (Coleman, Bliwise, et al.,
1982) or is not correlated (Mendelson, 1996) with the 
average sleep latency on the Multiple Sleep Latency Test 
(MSLT), an objective test of sleepiness.
It is clear from these studies that PLMS is often not 
associated with subjective sleep complaints or with 
objective evidence of abnormal sleep or excessive daytime
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sleepiness. Because of this, a distinction is usually 
made between periodic limb movements in sleep (PLMS) and 
periodic limb movement disorder (PLMD) . Periodic limb 
movement disorder (PLMD) is a clinical diagnosis in which 
PLMS are present and have been determined to lead to 
either a complaint of insomnia or excessive sleepiness or 
to cause sleep disruption (i.e. excessive arousals) as 
determined by polysomnography, even though a subjective 
complaint may not be present (Diagnostic Classification 
Steering Committee [DCSC], 1990, pp. 65-68). The 
diagnostic criteria for PLMD (DCSC, 1990) can be briefly 
summarized as follows: 1) a complaint of insomnia or
excessive sleepiness is present, 2) the leg movements are 
stereotyped and repetitive, and 3) polysomnographic 
monitoring shows five or more PLMs (which often cause 
arousals or awakenings) per hour sleep. If PLMS are 
present, but there is no subjective sleep complaint or 
objective evidence of abnormal sleep or excessive 
sleepiness, then the movements are generally not 
considered to be clinically significant and/or worthy of 
treatment. Finally, it is generally agreed that PLMs 
exert their pathological influence by causing EEG arousals 
and awakenings during sleep (Rosenthal et al., 1984); 
however, as noted earlier, the PLM arousal index may be
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poorly correlated or not correlated with the average sleep 
latency on the MSLT (Coleman, Bliwise, et al., 1982; 
Mendelson, 1996).
Prevalence
Ekbom was the first to attempt to determine the 
prevalence of RLS in the general population (K.A. Ekbom, 
1945). He questioned 503 normal individuals and 503 
neurological outpatients, and found prevalence rates of 
5.2 and 7.8 percent respectively. Ekbom noted that most 
of these were mild cases, but he did not provide any clear 
definition of "mild" in terms of the frequency and 
severity of symptoms. The value of 5.2 percent in normals 
is in good agreement with a recent study by O'Keeffe,
Noel, and Lavan (1993) which found a prevalence rate of 
4.9 percent in 307 older subjects seen at an outpatient 
medical clinic. In addition to these two studies, Hurry 
(1997) reviewed eleven additional studies which examined 
the prevalence of RLS in various normal or outpatient 
samples. The large majority of these studies found 
prevalence rates in the two to six percent range, although 
three studies found prevalences of over ten percent. When 
those three studies were excluded and the results were 
averaged across studies, the mean prevalence was found to 
be 4.1 percent. One general problem with these studies
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was that RLS was often assessed by questionnaires (usually 
with only one or two items), rather than by clinical 
interviews. Despite this, there was general agreement 
across studies that the prevalence of RLS in the general 
population was about five percent, with most of these 
being mild cases.
Several prevalence studies and large case study 
series have found that the prevalence of RLS appears to be 
higher in women. For example, O'Keeffe et al. (1993) 
found prevalence rates of 6.3% for females and 3.0% for 
males. Of 237 RLS cases studied by Ekbom, 58% of the 
patients were women (K. A. Ekbom, 1970).
There is general agreement across a number of studies 
that about one-third to one-half of RLS patients report a 
positive family history of RLS (K. A. Ekbom, 1945;
Walters, 1995; Walters et al., 1996). Several authors 
have presented family pedigrees that are consistent with 
an autosomal dominant mode of inheritance (Boghen and 
Peyronnard, 1976; Montagna, Coccagna, Cirignotta, and 
Lugaresi, 1983; Walters, Picchietti, Hening, and 
Lazzarini, 1990).
The age of onset appears to be variable. Ekbom found 
that 15% of the cases he studied first experienced 
symptoms before the age of 20, while the remaining cases
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had their ages of onset fairly evenly distributed across 
the next four decades (K. A. Ekbom, 1945). Walters et al. 
(1996) found that 43% of 138 RLS patients they interviewed 
first had symptoms before the age of 20, while the 
remaining patients had their ages of onset fairly evenly 
distributed across the next four decades. Both Ekbom and 
Walters et a l . found that periods of remission were 
common, and that there was a general tendency for symptoms 
to worsen with increasing age.
A higher than normal prevalence of RLS has been 
reported in a fairly large number of medical conditions 
and disorders. These include the following: iron
deficiency (K. A. Ekbom, 1945; O'Keeffe, Noel, and Lavan, 
1993), uremia (Banerji and Hurwitz, 1970; Nielsen, 1971a; 
Winkelman and Lazarus, 1994), rheumatoid arthritis 
(Reynolds, Blake, Pall, and Williams, 1986; Salih, Gray, 
Mills, and Webley, 1994), pregnancy (K. A. Ekbom, 1945; 
Goodman, Brodie, and Ayida, 1988), diabetes (Banerji and 
Hurwitz, 1970; Schiavi, Stimmel, Mandeli, and Rayfield, 
1993), varicose veins and venous insufficiency (Kanter, 
1995; Popkin, 1963), folate deficiency (Botez, 1976;
Botez, Cadote, Beaulieu, Pichette, and Pison, 1976), 
Sjogren's syndrome (Gudbjornsson, Broman, Hetta, and 
Hallgreen, 1993), and as a complication following
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gastrectomy (Banerji and Hurwitz, 1970; K. Ekbom, 1966). 
There are also case reports of individuals who developed 
RLS in association with various forms of peripheral 
neuropathy or radiculopathy (Ambrosetto and Lugaresi,
1968; Salvi et al., 1990; Walters, Hening, Wagner, and 
Chokroverty, 1996); however, a recent study by Rutkove, 
Matheson, and Logigian (1996) found that only 5.2% of 154 
patients with polyneuropathy had RLS. Thus, it does not 
appear that patients with peripheral neuropathy have a 
higher than normal prevalence of RLS. Spillane (1970) 
reported that he had seen eight consecutive cases of RLS 
in a period of four years, all of whom suffered from 
chronic lung disease. Because this was not an unselected 
sample of lung disease patients, it remains unclear if 
patients with lung disease have a higher than normal 
prevalence of RLS. It is worth noting; however, that a 
recent prevalence study of PLMS by Ancoli-Israel et al., 
(1991) did find that persons with lung disease had a 
higher than normal prevalence of PLMS. Hurry (1997) 
reviewed the RLS prevalence literature in detail, and when 
the results were summarized across studies, the prevalence 
rates for RLS in the various disorders listed above were 
found to be as follows; iron deficiency (38%), uremia 
(31%), Sjogren's syndrome (24%), rheumatoid arthritis
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(23%), venous insufficiency (22%), diabetes (20%), 
pregnancy (16%), and following gastrectomy (14%). A 
prevalence estimate for folate deficiency could not be 
derived because it was unclear if the subjects in the 
studies reported were unselected with respect to the 
presence or absence of RLS. It should also be noted that 
the estimates for diabetes and Sjogren's syndrome were 
based on data from less than 100 patients across studies, 
and as such, could be expected to be less reliable than 
the estimates of RLS prevalence in the other disorders.
In recent years it has become an accepted practice to 
refer to the RLS that occurs in the conditions above as 
secondary RLS, while the terms primary or idiopathic RLS 
are reserved for RLS patients who do not have any of the 
above conditions (Walters, 1995). It should be noted that 
there do not appear to be any differences in symptom 
presentation between the primary and secondary forms 
(Walters, 1995).
An obvious question that arises from a review of this 
literature is what one factor, if any, is common to all of 
these conditions. Although a number of authors have 
pointed out that iron deficiency and/or anemia are common 
in several of these conditions (Pall, Williams, Fonseca, 
and Blake, 1987; Reynolds et al., 1986; Roger, Harris, and
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 3
Stewart, 1991), it has not been emphasized that anemia 
and/or circulatory problems are common in all of them.
Iron deficiency is common in pregnancy (Chanarin and 
Rothman, 1971), in uremia patients on hemodialysis 
(Eschbach, Cook, Scribner, and Finch, 1977), and as a 
complication following gastrectomy (Lloyd and Valberg, 
1977). Anemia is a well-known complication of iron 
deficiency (Beck, 1991a), and is also common in uremia 
(Beck, 1991b), rheumatoid arthritis (Cash and Sears,
1989), diabetes (Bern and Busick, 1985; Jones and 
Peterson, 1981), Sjogren's syndrome (Bloch, Buchanan,
Wohl, and Bunim, 1965), and folate deficiency (Beck,
1991c). Circulatory problems are common in varicose veins 
and venous insufficiency (Goldman, Weiss, and Bergan,
1994; Ibrahim, MacPherson, and Goldhaber, 1996) and in 
diabetes (Colwell, 1986).
Peripheral neuropathy is also common in several of 
these conditions including uremia (Nielson, 1971), 
rheumatoid arthritis (Good, Christopher, Koepke, Bender, 
and Tarter, 1965), diabetes (Walker, 1986), Sjogren's 
syndrome (Alexander, Provost, Stevens, and Alexander, 
1982), and folate deficiency (Botez et al., 1976).
The high rates of iron deficiency, anemia, and 
peripheral neuropathy in many of the conditions above is
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important because these data are supportive of three of 
the four major theories of the pathogenesis of RLS. 
Experimentally produced iron deficiency has been shown to 
lead to reductions in dopamine receptor density in rats 
(Ashkenazi, Ben-Shachar, and Youdim, 1982). Thus, the 
theory that RLS is caused by dopaminergic dysfunction 
could account for the higher than normal prevalence of RLS 
seen in iron deficiency, pregnancy, hemodialysis patients, 
and in post-gastrectomy patients. The theory that RLS is 
caused by peripheral neuropathy could explain the higher 
than normal prevalence of RLS in uremia, rheumatoid 
arthritis, diabetes, Sjogren's syndrome, and folate 
deficiency. Finally, the theory that RLS is caused by 
impaired peripheral circulation (or by reduced oxygen 
delivery secondary to impaired peripheral circulation) 
could potentially account the higher than normal 
prevalence of RLS in all of the conditions listed above, 
since all of them are associated with either impaired 
circulation or high rates of anemia.
Unlike RLS, there are relatively few prevalence 
studies of PLMS in normal subjects. Only three studies 
with a combined total of 620 subjects have investigated 
this issue, and the largest of these (which included 420 
subjects) used portable home recordings to assess PLMS
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rather than laboratory polysomnography (Ancoli-Israel et 
al., 1991). These home recordings did not include 
measurements of EEG or other physiologic variables 
normally used to measure sleep; sleep was assessed using a 
wrist-worn actigraph. The other two large studies used
laboratory polysomnography to assess PLMS. In addition to
these three large studies, there are three additional
studies of PLMS prevalence in various patient groups which
have included small control groups of normal subjects 
(i.e. those either unselected for the presence or absence 
of sleep complaints or without any sleep complaint).
Bixler et al. (1982) were the first to investigate 
the prevalence of PLMS in normal subjects, and they 
reported a total PLMS prevalence of 11% in a sample of 100 
subjects who did not have any sleep complaints. They 
found that the prevalence of PLMS was strongly age- 
related. In their sample, none of the subjects aged 18 to 
29 had PLMS, only five percent of subjects aged 30 to 49 
had PLMS, and 29% of subjects aged 50 to 74 had PLMS.
They also found that more men (14.6%) than women (8.5%) 
had PLMS. Dickel and Mosko (1990) performed three 
consecutive nights of polysomnography on 100 subjects who 
were over the age of 60. These subjects were selected 
without any regard to the presence or absence of sleep
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complaints. Using the average PLMi from all three nights 
for each subject, they found a total prevalence for the 
sample of 58%. The PLMi was significantly correlated with 
age, but not with sex. Ancoli-Israel et al. (1991) used 
portable home recordings to assess PLMS prevalence in 420 
subjects over the age of 65. These subjects were also 
selected without any regard to the presence or absence of 
sleep complaints. Using a PLMi criterion of five or more, 
45% of the sample had PLMS. When PLMi criteria of 10 or 
more and 20 or more were used, 34% and 20% (respectively) 
of the sample had PLMS. In the three studies with small 
control groups of normal subjects, Schiavi et al. (1993) 
found that 18% of 40 male subjects with a mean age of 52.8 
years had a PLMi of 10 or greater; Ferini-Strambi et al.
(1994) found that eight percent of 25 subjects (who were 
age-matched to a patient group with a mean age of 39.9 
years) had PLMS; and Hanly and Zuberi-Khokhar (1996) found 
that one of nine subjects with a mean age of 65 had PLMS. 
Although there have been relatively few younger subjects 
in these six studies, there is general agreement among 
them that the prevalence of PLMS increases sharply in 
older age groups. However, studies of PLMS prevalence in 
patients with insomnia (in which higher than normal rates 
of PLMS have not been documented) have found a much more
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linear increase in PLMS prevalence with increasing age, so 
the age of onset issue remains unresolved. Despite this, 
it is clear that the prevalence of PLMS is very high in 
older subjects.
A large number of studies have investigated the 
prevalence of PLMS in various medical disorders and/or 
patient groups. Unfortunately, only a few of these 
studies have included age matched control groups of normal 
subjects. This represents a serious shortcoming given the 
apparent sharp increase in PLMS prevalence in older 
subjects, and the small amounts of data that are actually 
available on PLMS prevalence in normal subjects. In 
addition to the lack of control groups, many of the 
studies discussed below arbitrarily used PLMi criteria 
that were different from the standard of five or more leg 
movements per hour. Another point worth noting is that 
only a few of the disorders in which a higher than normal 
prevalence of RLS has been documented have been 
investigated with respect to the prevalence of PLMS. This 
probably reflects the time, expense, and inconvenience 
involved in conducting the large scale polysomnography 
studies which are needed to investigate PLMS (but not RLS 
since RLS is not defined by polysomnographic measures).
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As reviewed by Hurry (1997), there are four medical 
disorders in which a higher than normal prevalence of PLMS 
has been well established. The term "well established" 
was arbitrarily defined as indicating that a higher than 
normal PLMS prevalence (than would be expected based on 
the age of subjects) was found when the results were 
averaged across studies. An additional stipulation was 
that the total number of subjects included across all 
studies for a given disorder had to be 100 or greater. 
These disorders include the following: RLS (Coccagna and
Lugaresi, 1981; Montplaisir et al., 1992), narcolepsy 
(Baker, Guilleminault, Nino-Murcia, and Dement, 1986; 
Mosko, Shampin, and Sassin, 1984), organic impotence 
(Hirshkowitz, Karacan, Arcasoy, Acik, and Williams, 1989; 
Schmidt, Wise, and Jackson, 1981), and uremia (Kimmel, 
Miller, and Mendelson, 1989; Pressman, Benz, and Peterson, 
1995).
The prevalence of PLMS has been investigated in two 
other disorders in which the total number of subjects 
included across studies was greater than 100. These two 
disorders are insomnia and obstructive sleep apnea. As 
mentioned earlier, Kales et al. (1982) found the same 
prevalence rate of PLMS (11%) in 100 normal subjects and 
200 insomnia patients. Guilleminault et al. (1975) also
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reported an 11% prevalence of FLMS in 140 insomnia 
patients. Coleman et al. (1980) found an 18% prevalence 
of PLMS in 140 insomnia patients. In a large multi-center 
collaborative study, Coleman, Roffwarg, et al. (1982) 
found that 12.2% of 1,214 patients with disorders of 
initiating and maintaining sleep (insomnias) had either 
nocturnal myoclonus or RLS (the percentage of subjects 
with both disorders was not mentioned). Bliwise, Petta, 
Seidel, and Dement (1985) reported that 37% of 63 older 
subjects (mean age of 66 years) had PLMS. Roehrs, Zorick, 
Sicklesteel, Wittig, and Roth (1983) reported that 10.5% 
of 562 patients with sleep complaints (but without 
polysomnographic evidence of sleep apnea or narcolepsy) 
had either RLS or PLMS. The prevalence of PLMS in these 
patients showed a positive relationship with age: only
4.0% of patients between the ages of 20 and 40 had PLMS, 
while 11.4% and 21.6% of patients in the 41 to 60 and 61 
and older age groups had PLMS, respectively. Coleman 
(1982, Figure 12.2, p. 270) presented a figure of 
previously published data showing the PLMS prevalence for 
two groups of patients (with sample sizes of 441 and 506 
patients) referred for polysomnography. The data showed 
that PLMS prevalence increased linearly with increasing 
age. For example, in both groups of patients about eight
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percent of the subjects in the 20 to 29 age group had 
PLMS, while about 20% of subjects in the 50 to 59 age 
group of both samples had PLMS. Overall, the results from 
these studies do not indicate that insomnia patients have 
a higher than normal prevalence of PLMS than would be 
expected given their age. In addition, the Roehrs et al. 
(1983) and Coleman (1982) data suggest that the prevalence 
of PLMS increases in a relatively linear fashion with 
increasing age, rather than showing a sharp increase in 
older age groups.
Several studies have reported on the prevalence of 
PLMS in patients with sleep apnea. Coleman et al. (1980) 
reported that 14% of 63 apnea patients had PLMS. In their 
study of PLMS prevalence in 100 older subjects who were 
selected without regard for the presence or absence of 
sleep complaints, Dickel and Mosko (1990) found that 56% 
of the subjects who had sleep apnea also had PLMS (defined 
as a PLMi of 5 or greater). This value of 56% was very 
similar to the 58% prevalence of PLMS for the entire 
sample of 100 subjects. Similarly, Ancoli-Israel et al. 
(1991) found that 42% of their subjects with sleep apnea 
had PLMS, a value that was very similar to 45% prevalence 
of PLMS for the entire sample of 420 subjects (subjects 
were selected without regard for the presence or absence
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(1995) recently reported that 27% of 636 apnea patients 
with a mean age of 51.4 years had a PLMi of 10 or more.
By comparison, Ancoli-Israel et al. found that 34% of 
their sample of 420 subjects with a mean age of 72.5 years 
had a PLMi of 10 or more. Overall, these studies indicate 
that the prevalence of PLMS in persons with sleep apnea is 
either very similar to or only slightly higher than its 
prevalence in normal individuals. One point worth 
repeating is that leg movements that occur at end of 
respiratory events in patients with sleep apnea are not 
counted as PLMs according to the current scoring criteria 
(ASDA Atlas Task Force, 1993). It is unclear whether or 
not this criterion was applied in the studies above.
Another interesting report with respect to sleep 
apnea and PLMS was a study by Fry, DiPhillipo, and 
Pressman (1989) which found a significant increase in PLMS 
when apnea patients were treated with nasal continuous 
positive airway pressure (CPAP). Similar results were 
reported by two other groups, but only for patients who 
had relatively severe apnea (Gokcebay, Hirshkowitz, Clay, 
Minhoto, and Karacan, 1993; Shaffer et al., 1993).
Shaffer et al. concluded that the improved sleep 
continuity during CPAP treatment allowed PLMS to emerge in
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those patients whose sleep had been previously severely 
disrupted by sleep apnea. In contrast to these findings, 
George et al. (1995) reported only 18% of 174 apnea 
patients with PLMS had an increase in their PLMi during 
CPAP treatment (82% had a decrease in their PLMi). These 
later results, which were based on a very large sample, 
indicated that CPAP tended to improve rather than 
exacerbate PLMS.
A higher than normal (or high) prevalence of PLMS has 
been reported in nine additional medical disorders, in 
which the total number of subjects included across studies 
was less than 50. Because of the small number of subjects 
studied with each of these disorders, these results should 
probably be viewed as preliminary findings. As such, the 
disorders will only be mentioned here. These nine 
disorders include the following: congestive heart failure
(Hanly and Zuberi-Khokhar, 1996), diabetes (Schiavi et 
al., 1993), multiple sclerosis (Ferini-Strambi et al.,
1994; Potolicchio, Calderon, and Richert, 1991), 
fibrositis syndrome (Moldofsky, Tullis, and Lue, 1986), 
chronic fatigue syndrome (Morehouse, MacDonald, Haase, 
Marrie, and Braha, 1994), leukemia (Kotagal et al., 1985), 
coma (Oskenberg, 1989), neuroleptic-induced akathisia 
(Walters, Hening, Rubinstein, and Chokroverty, 1991), and
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in family members of children with hereditary progressive 
dystonia (Gadoth, Costeff, Harel, and Lavie, 1989) . There 
are also case reports of PLMS in patients with spinal cord 
injury (Dickel, Renfrow, Moore, and Berry, 1994; Yokota, 
Hirose, Tanabe, and Tsukagoshi, 1991) and head injury 
(Budha, 1996) .
Unlike RLS, there is no one factor or pathology 
common to all of these conditions, although anemia and/or 
circulatory problems are common in several of them 
(leukemia, uremia, diabetes, impotence, and congestive 
heart failure), and abnormalities of dopamine or dopamine 
receptors have been reported (or postulated) in hereditary 
progressive dystonia (Segawa, Ohmi, and Itoh, 1971), 
neuroleptic-induced akathisia (Sachdev, 1995), and 
impotence (Lai et al., 1989). One general aspect of 
several of the remaining conditions (narcolepsy, multiple 
sclerosis, and coma) is that they are disorders in which a 
major pathology of the central nervous system is involved.
Eathophygj.q3-Qqj.gaJ. .Einriinga
Most studies of RLS based on large case study series 
of patients are in agreement that physical and 
neurological examinations are usually normal in idiopathic 
RLS patients (K. A. Ekbom, 1945; Gorman et al., 1965; 
Morgan, 1967; Walters and Hening, 1987). The neurological
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examination may be abnormal if the patient has diabetes, 
uremia, or rheumatoid arthritis (Gorman et al., 1965; 
Nielsen, 1971a, Salih et al., 1994), but such cases would 
be considered secondary, rather than idiopathic, RLS. The 
physical and neurological examinations are also usually 
normal in PLMS patients (Coleman et al., 1980; 
Guilleminault et al., 1975), although a recent study by 
McCall, Edinger, and Lininger (1991) found that nine of 17 
PLMS patients (53%) had one or more neurological 
abnormalities. Unfortunately, the percentage of these 
patients with diabetes, uremia, or other conditions that 
might have led to these abnormal findings was not 
reported.
Many studies of RLS patients have reported that a 
significant number of them (up to 20% to 30%) have iron 
deficiency (K. A. Ekbom, 1960; Norlander, 1953; O'Keeffe, 
Gavin, and Lavan, 1994; Parrow and Werner, 1966), although 
other authors have reported only isolated cases in their 
samples (Gorman et al., 1965; Morgan, 1967; Young et al., 
1969) . A recent study by Baran, Goldberg, DiPhillipo, 
Curran, and Fry (1996) found that three of 20 PLMS 
patients had low ferritin levels. Some studies have found 
elevated blood urea nitrogen values suggestive of uremia 
in PLMS patients (Bliwise, Petta, Siedel, and Dement,
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1985; Coleman et al., 1980). Because RLS may be 
associated with iron deficiency or other anemias, 
diabetes, and uremia, it is generally recommended that 
laboratory tests for these conditions be done whenever a 
patient presents with RLS (Montplaisir et al., 1994). 
However, the question of what percentage of RLS patients 
have secondary versus idiopathic RLS (or PLMS) is not a 
well-investigated issue. The only data pertinent to this 
question are from the prevalence study by O'Keeffe et al. 
(1993) . They found that 15 of 307 patients seen at a 
geriatric outpatient care facility had RLS. Eight of 
these 15 patients (53%) had conditions that are known to 
be associated with RLS (4 had iron deficiency anemia, and 
2 had diabetes, and 2 had chronic lung disease).
The theory that RLS (and PLMS) is caused by 
peripheral neuropathy has been popular over the years, and 
a large number of neurophysiological studies in RLS and 
PLMS patients have been reported. A total of eight such 
studies in idiopathic or unselected RLS patients and four 
in PLMS patients have been reported. Each of these will 
be briefly discussed below.
Gorman et al. (1965) briefly mentioned that 
electromyogram (EMG) studies were performed in 11 RLS 
patients, and found to be abnormal in only two of these
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patients. In both cases, the abnormalities were thought 
to be secondary to diabetes. Coccagna and Lugaresi (1981) 
briefly mentioned in a review paper that they found 
positive Babinski signs and delayed nerve conduction time 
in their RLS patients in the evening when symptoms were 
present, and in addition, they found that these signs were 
reduced or absent the following morning. It was unclear 
from their paper how many subjects they actually studied, 
and what percentage of them had abnormal findings. 
Guilleminault and Flagg (1984) mentioned that EMGs and 
nerve conduction studies were normal in the five PLMS 
patients they studied. Mcsko and Nudleman (1986) found no 
differences in auditory and somatosensory evoked 
potentials between a group of ten RLS/PLMS patients and 
ten normal controls. Wechsler, Stakes, Shahani, and Busis
(1986) performed nerve conduction, EMG, evoked potential, 
and reflex studies in six PLMS patients. The nerve 
conduction, EMG, and evoked potential studies were normal 
in all cases, but two patients had abnormal H-reflexes and 
all six had abnormal blink reflexes (consisting of 
additional long latency components). Wechsler et al. 
concluded that these findings were indicative of increased 
excitability of brainstem and spinal reflexes. Akpinar
(1987) briefly mentioned that neurological examinations,
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Martinelli, Coccagna, and Lugaresi (1987) found abnormal 
H-reflexes and other reflexes in three of six RLS/PLMS 
patients they studied. Zucconi et al. (1989) performed 
neurological examinations and sensory and motor nerve 
conduction studies on nine RLS patients, and found that 
only one patient had abnormal findings (which were 
suggestive of Parkinson's disease). Bliwise, Ingham,
Date, and Dement (1989) performed sensory and motor nerve 
conduction studies in both upper and lower extremities of 
24 elderly PLMS patients. Although no control group was 
used, the values obtained were stated to be within the 
normal range for the age group of the subjects. Smith et 
al. (1992) used central magnetic stimulation to study 
motor nerve conduction in four RLS patients and nine PLMS 
patients. There were no differences in conduction times 
between these subjects and normal controls. Montplaisir, 
Lapierre, and LaVigne (1994) performed spectral analyses 
of EEGs that were recorded during the evening when 
symptoms were present in RLS patients, and reported that 
there was periodic slowing that was correlated with waking 
leg movements in these subjects. They concluded that this 
slowing was indicative of drowsiness, and postulated that 
leg movements in both RLS and PLMS required a critical
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level of cortical arousal to appear. Iannaccone et al.
(1995) performed neurological examinations, sensory and 
motor nerve conduction studies, EMGs, and temperature 
perception tests in eight patients with primary RLS. The 
neurological examinations and nerve conduction studies 
were normal in all patients, but five of them had abnormal 
EMGs and seven had impaired temperature perception test 
results.
Overall, the large majority of the patients in these 
twelve studies had no abnormal electrophysiological 
findings. Thus, there is little support for the idea that 
RLS (or PLMS) is caused by peripheral neuropathy. The 
abnormal reflex findings (Coccagna and Lugaresi, 1981; 
Martinelli et al., 1986; Wechsler et al., 1986) are 
probably the most consistent across studies. The report 
by Coccagna and Lugaresi (1981) that abnormalities were 
seen primarily during symptom presentation is also very 
interesting, but unfortunately, there has not been any 
attempt to replicate those results.
Four studies have investigated the prevalence of 
neurophysiological abnormalities in patients with 
secondary RLS (three studies with uremic RLS patients, one 
in RLS patients with rheumatoid arthritis). Because 
peripheral neuropathy is known to occur in both uremia and
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rheumatoid arthritis (Good et al., 1965; Nielsen, 1971a),
it is not surprising that some RLS patients with uremia or
rheumatoid arthritis have peripheral neuropathy. What is 
of interest is the question of whether or not peripheral 
neuropathy occurs in more commonly in the uremic and
arthritis patients who do have RLS than in those who do
not. Callaghan (1966) was the first author to suggest 
that RLS could be caused by peripheral neuropathy. In his 
1966 study, he reported that five patients who had RLS 
secondary to uremia all had either clinical or 
neurophysiological evidence of peripheral neuropathy. 
However, he did not include any non-RLS patients in his 
study. Nielsen (1971b) studied 109 patients with uremia, 
and found no relationship between the presence or absence 
of RLS and clinical signs suggestive of peripheral 
neuropathy (i.e. peripheral neuropathy was equally common 
in RLS and non-RLS patients). Similar results were 
reported by Roger et al. (1991) in 55 uremic patients who 
were receiving either renal or peritoneal dialysis. Salih 
et al. (1994) performed sensory and motor nerve conduction 
studies and somatosensory evoked potentials on 14 
rheumatoid arthritis patients with RLS and nine rheumatoid 
arthritis patients without RLS. Ten of the 14 RLS 
patients (71%) had abnormal studies while only three of
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nine non-RLS patients (33%) had abnormal findings.
However, there was clinical and laboratory data which 
suggested that the RLS group had more severe arthritis 
than the non-RLS group, so the groups were not equated for 
disease severity. Taken together, the results from these 
last three studies do not provide convincing evidence that 
secondary RLS is caused by peripheral neuropathy.
Two studies have used muscle and/or nerve biopsies to 
further investigate the possibility of neuropathy or 
myopathy in RLS patients. Harriman, Taverner, and Woolf 
(1970) examined biopsies of the peroneus brevis muscle 
(and associated nerve endings) in ten patients diagnosed 
with RLS. Although a number of abnormalities were found 
(e.g. excessive axonal sprouting, end-plate abnormalities, 
spherical axonal swellings), these were seen with equal 
frequency in an age-matched control group. Iannaccone et 
al. (1995) examined sural nerve biopsies in eight patients 
with primary RLS. The RLS biopsies showed significantly 
lower myelinated fiber density and more evidence of axonal 
atrophy and myelin alterations than biopsies from age- 
matched controls. Despite these abnormal findings, it 
should be noted that the sensory and motor nerve 
conduction studies in these subjects were normal.
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Two studies have used neuroradiological techniques to 
investigate possible CNS abnormalities in RLS/PLMS 
patients. Staedt et al. (1995a) used single photon 
emission computed tomography to investigate striatal D2 
dopamine receptor density in 20 RLS/PLMS patients (14 with 
RLS, 6 with only PLMS) and 10 age matched controls. A 
ratio of basal ganglia to cortical tracer uptake was used 
as the dependent variable. The actual values of tracer 
uptake in the cortex and basal ganglia were not presented; 
only the ratio was used. The value for the patients 
(1.40) was about nine percent lower than the value for the 
controls (1.53), a difference that was statistically 
significant. Both values indicate that dopamine receptor 
density is higher in the basal ganglia, while the lower 
value for the RLS/PLMS group indicates that their basal 
ganglia dopamine receptor density was lower than that of 
the controls. In a follow-up study on four patients who 
were treated with L-Dopa, an unexpected up-regulation in 
striatal dopamine receptor density was found (Staedt et 
al., 1995b). Staedt et al. suggested that this might 
indicate a dysfunction in the corticostriatal input to the 
basal ganglia. Walters et al. (1995) used positron 
emission tomography to investigate global and regional 
brain glucose metabolism in five RLS patients and 20
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normal controls. There were no significant differences 
between the groups.
A number of authors have noted that RLS and PLMS 
patients often complain of cold feet (Ancoli-Israel et 
al., 1986; K. A. Ekbom, 1945; Ware et al., 1988). Ware et 
al. performed photoplethysmographic examinations of 
peripheral blood flow in two RLS patients who complained 
of cold feet, and found evidence suggestive of excessive 
peripheral vasoconstriction in both of these patients. 
Similar examinations on their next ten PLMS patients found 
that four of these subjects also had evidence of excessive 
peripheral vasoconstriction. Ware et al. suggested that 
this excessive vascular tone was caused by excessive 
sympathetic nervous system activity. Unfortunately, no 
control group was included in this study, so it remains 
unclear if RLS/PLMS patients are more likely to have 
impaired peripheral circulation than normal controls.
In summary, there are few pathophysiological findings 
in the majority of patients with both RLS and PLMS. Some 
RLS patients do have anemia, uremia, diabetes, and 
associated peripheral neuropathy, and such secondary RLS 
cases may represent a significant percentage of total RLS 
cases. Most other abnormal findings which have been
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reported have not yet been replicated, and there is 
obviously much work that remains to be done in this area.
Treatment
A large variety of drugs have been used to treat RLS 
and PLMS over the years. Ekbom was the first to attempt 
treatment of RLS (K. A. Ekbom, 1944, 1945). Based on his 
theory that RLS was caused by impaired peripheral 
circulation, Ekbom administered the vasodilators carbachol 
(an acetylcholine agonist) and tolazoline (an alpha 
adrenergic blocker) to a large number of RLS patients, and 
he reported that about two thirds of his patients had an 
improvement in their symptoms with each of these drugs (K. 
A. Ekbom, 1945) . Ekbom defined "improvement" as a report 
from the patient that "the symptoms occurred so seldom or 
in such a mild degree that the patient no longer bothered 
much about them." (K. A. Ekbom, 1945; p. 51). However, 
other investigators found that only small percentages of 
patients improved with either carbachol (Brenning, 1971) 
or tolazoline (Parrow and Werner, 1966). Norlander (1953) 
found that injections of iron-dextran had a beneficial 
effect on RLS symptoms even in patients who were not iron 
deficient. This led him to suspect that the dextran 
component of the iron-dextran injections was exerting a 
therapeutic effect. When he used dextran alone in three
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patients, two of the three had an improvement in their RLS 
symptoms. In one of the two patients who improved, there 
was a complete remission of symptoms, while in the other, 
symptoms remitted only for one day. Parrow and Werner 
(1966; p. 402) later reported that 55 of 64 RLS patients 
(86%) they treated with dextran injections became 
completely symptom free, while an additional four patients 
"improved but were not completely free from symptoms".
This improvement often lasted weeks or months. Dextran is 
a high molecular weight branched polysaccharide which is 
used clinically as a plasma volume expander in patients 
who have lost large amounts of blood (Mattox et al.,
1991). Because it expands plasma volume, the hematocrit 
is lowered; this lowers the blood viscosity and improves 
blood flow in the microcirculation (Kreimeier, Brucker, 
Niemczyk, and Messmer, 1990). Because the plasma half 
life of dextran is only about 15 hours, the mechanism by 
which it might have acted to produce the long-lasting 
relief of symptoms reported by Parrow and Werner is not 
evident. Kanter (1995) recently reported that 
sclerotherapy treatment of varicose veins had the 
unexpected beneficial side effect of producing dramatic 
relief from RLS symptoms in 111 of 113 varicose vein 
patients who also had RLS. Relief was defined in this
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
45
study by a patient report of "either complete resolution 
or sustained marked improvement of symptoms" (Kanter,
1995; p. 329). Sclerotherapy is a technique in which a 
sclerosing agent (usually sodium tetradecyl sulphate) is 
injected into a varicose vein after it has been occluded. 
The vessels eventually undergo complete fibrosis and 
reabsorption, with a resulting improvement in peripheral 
venous circulation. This improvement in peripheral 
circulation was the apparent mechanism by which 
sclerotherapy improved RLS symptoms. Recently, a number 
of studies have shown that the anti-hypertensive agent 
clonidine has a beneficial effect on RLS symptoms (Bastani 
and Westervelt, 1987; Handwerker and Palmer, 1985;
Steiner, 1987; Wagner et al., 1996), although in the one 
study in which polysomnography was performed, no reduction 
in PLMs was observed (Wagner et al., 1996). Clonidine is 
an alpha-2 adrenergic agonist which is believed to reduce 
total peripheral vascular resistance by acting on central 
adrenergic autoreceptors (Hoffman and Lefkowitz, 1990).
It may also have a direct peripheral vasodilatory effect 
(Shaw, Hunyor, and Korner, 1971). Unfortunately, side 
effects such as sedation and dry mouth are common with 
clonidine (Hoffman and Lefkowitz, 1990). Such side 
effects were noted by both Bastani and Westervelt (1987)
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and Wagner et al. (1996), and were severe enough to 
necessitate cessation of therapy in three of six patients 
in the Bastani and Westervelt study and in three of seven 
"responders" in the Wagner et al. study. These side 
effects may limit the clinical usefulness of clonidine in 
treating RLS. Despite this, the results of the above 
studies, when taken together, suggest that drugs which 
exert a vasodilatory effect or which improve circulation 
have a beneficial effect on RLS symptoms.
Several studies over the years have noted that 
correction of anemia and iron or folate deficiency are 
effective in relieving RLS symptoms. Norlander (1953) 
found that blood transfusions to correct anemia were 
effective in all six RLS patients to whom they were 
administered. Both Norlander (1953) and Parrow and Werner 
(1966) found injections of iron-dextran to be effective in 
treating RLS patients; although, as noted above, this 
effect may have been partially mediated by the dextran 
component of the iron-dextran injections. However, both 
Norlander (1953) and O'Keeffe et al. (1993) also found 
that oral iron supplementation was effective in relieving 
RLS symptoms. Finally, Botez and his colleagues found 
folate supplements to be effective in treating RLS 
symptoms in patients who were folate deficient (Botez,
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1976; Botez et al., 1976). These studies are consistent 
in finding that correction of anemia and related 
deficiency states is effective in treating RLS, and they 
further suggest a causative role for anemia in the 
pathogenesis of some RLS cases.
Ekbom noted in his 1945 monograph that several of his 
RLS patients had discovered on their own that opioids were 
very effective in relieving RLS symptoms. This 
observation was subsequently confirmed by a number of 
investigators in both open {Akpinar, 1982; Hening et al., 
1986; Trzepacz, Violette, and Sateia, 1984) and placebo 
controlled trials (Walters et al., 1993). For example, 
all five RLS patients studied by Akpinar (1982) and all 
three patients studied by Trzepacz et al. (1984) were 
reported to have improved with opioid treatment (in both 
studies "improvement" was assessed by patient report 
and/or clinical interviews; objective measures of RLS 
symptomatology were not obtained). Four of five patients 
studied by Hening et al. had decreases in waking leg 
movements of 65% or more. In the placebo controlled study 
conducted by Walters et al. (1993), rating scales were 
used to assess waking leg sensations and motor 
restlessness. Both variables decreased significantly 
during the treatment period. An examination of the data
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presented for individual subjects showed that six of ten 
subjects had a 70% or more decrease in their ratings of 
leg sensations while five of ten had similar decreases in 
their ratings of motor restlessness. The effect of 
opioids on PLMS appears to be less pronounced. Walters et 
al. (1993) found a 53% decrease in the PLMi from baseline 
with oxycodone, while Kaplan, Allen, Buchholz, and Walters 
(1993) reported a 35.4% decrease in the PLMi from placebo 
with propoxyphene (this decrease was not statistically 
significant) . Kavey, Waiters, Hening, and Guidro-Frank
(1988) used a variety of opioids in four PLMS patients, 
and found that two patients had their leg movements almost 
completely eliminated while there was no effect in the 
other two. The clinical use of opioids in RLS and PLMS 
patients is also limited by concerns about the possible 
development of tolerance, dependence, and abuse 
(Montplaisir et al., 1992).
A fairly large number of benzodiazepines have been 
used to treat both RLS and PLMS. Several early open 
trials found that diazepam was effective in treating RLS 
(K. A. Ekbom, 1970; Morgan, 1967; Spillane, 1970).
Matthews (1979) was the first to report that clonazepam 
was beneficial in treating RLS patients. The efficacy of 
clonazepam in treating both RLS and PLMS has subsequently
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been shown in a large number of studies (see Hurry, 1997, 
for a detailed review), including double-blind placebo 
controlled studies (Montagna, de Bianchi, Zucconi, 
Cirignotta, and Lugaresi, 1984; Peled and Lavie, 1987).
In the three studies in which clonazepam was used to treat 
PLMS, decreases in the PLMi of 34% (Mitler, Browman, Menn, 
Gujavarty, and Timms, 1986), 65% (Ohanna, Peled, Rubin, 
Zomer, and Lavie, 1985), and 43% (Peled and Lavie, 1987) 
have been reported. Scharf, Brown, and Hirschowitz (1986) 
reported that alprazolam was effective in treating eight 
of ten RLS patients in an open trial. Moldofsky, Tullis, 
Quance, and Lue (1986) found that nitrazepam produced a 
65% decrease in the PLMi of 13 PLMS patients they treated. 
Mitler et al. (1986) found that temazepam improved sleep 
quality but did not decrease the PLMi in ten PLMS patients 
they treated. Similar results (i.e. improved sleep 
quality but no decrease in PLMs) have been reported for 
triazolam in three studies (Bonnet and Arand, 1990, 1991; 
Doghramji, Browman, Gaddy, and Walsh, 1991). In summary, 
several benzodiazepines, including alprazolam, diazepam, 
clonazepam, and nitrazepam have been found to be 
beneficial in treating RLS and PLMS. Clonazepam is 
currently regarded as the treatment of choice for younger 
and less severely affected RLS/PLMS patients, although it
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is contraindicated in cases where there is a comorbid 
sleep-related respiratory disorder (Montplaisir et al.,
1992) .
Akpinar (1982) was the first to report that L-DOPA 
was effective in treating RLS symptoms. Because his 
results were published in a letter to the editor, they 
apparently went unnoticed for several years. Montplaisir 
and his colleagues independently discovered the 
effectiveness of L-DOPA in treating RLS several years 
later (Montplaisir, Godbout, Poirier, and Bedard, 1986). 
Since these two initial studies, a large number of studies 
have been published in which L-DOPA has been used to treat 
both RLS and PLMS. These have included both open trials 
(e.g. Akpinar, 1987), and double-blind placebo controlled 
studies (e.g. Boivin, Montplaisir, and Poirier, 1989; 
Brodeur, Montplaisir, Godbout, and Marinier, 1988; Kaplan 
et al, 1993) . There is almost uniform agreement across 
these studies that L-DOPA is very effective in treating 
RLS and PLMS, although it is interesting to note that PLMs 
are usually not completely eliminated (see Hurry, 1997, 
for a detailed review). The dopamine agonist 
bromocriptine has also been found to be effective in 
treating both RLS (Akpinar, 1982; Walters, Hening, Kavey, 
and Chokroverty, 1988) and PLMS (Boivin, Lorrain, and
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Montplaisir, 1993). Several studies have noted that a 
morning rebound or evening augmentation of RLS symptoms 
may occur with L-DOPA treatment in some RLS patients 
(Allen and Early, 1996b; Becker, Jamieson, and Brown,
1993; Guilleminault, Cetel, and Philip, 1993). Despite 
this, L-DOPA is clearly effective in treating both RLS and 
PLMS, and it is currently regarded as the treatment of 
choice for older and more severely affected RLS/PLMS 
patients (Montplaisir et al., 1992).
Several studies have found that anti-convulsants may 
be beneficial in treating RLS. Hogg (197 2) reported that 
phenytoin was effective in relieving RLS symptoms in seven 
of his RLS patients. Carbamezapine was later reported to 
be effective in treating RLS in three studies, two of 
which were double-blind placebo controlled trials 
(Lundvall, Abom, and Holm, 1983; Telstad et al., 1984; 
Zucconi et al, 1989), although in the one study in which 
nocturnal leg movements were recorded (Zucconi et al., 
1989), PLMs were not affected. More recently, gabapentin 
has been reported to be effective in treating RLS in two 
open trials (Cochran and Williams, 1996; Mellick and 
Mellick, 1996). These results were not replicated in a 
third study (Allen and Early, 1996a) which found that only 
5 of 11 RLS patients had any improvement with gabapentin.
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In summary, vasodilators, correction of anemia, 
opioids, benzodiazepines, dopamine agonists, and anti­
convulsants have all been reported to be effective in 
treating either RLS, PLMS, or both conditions. As 
mentioned earlier, clonazepam and L-DOPA are currently 
regarded as the treatments of choice. Problems such as 
drug tolerance and morning rebound and evening 
augmentation of symptoms are currently being managed by 
rotating patients to a different drug every few months, or 
more often, as needed (Allen and Early, 1996b).
Pathogenesis
Over the years many authors have speculated about the 
pathogenesis of RLS and PLMS, but only four theories of 
RLS and two of PLMS have been discussed with some 
frequency. These include the following for RLS: reduced
peripheral blood flow, peripheral neuropathy, opioid 
dysfunction, and dopaminergic dysfunction. The two major 
theories of PLMS include oscillations of reticular system 
excitability and the spontaneous Babinski response theory. 
In addition to these theories, it should be noted that 
before it became widely known that PLMS occurred in most 
RLS patients, a fairly large number of authors suggested 
that RLS was psychogenic in origin (e.g. Gorman et al., 
1965; Morgan, 1967; Spillane, 1970; Young et al., 1969).
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Ekbom was the first to speculate on the pathogenesis 
of RLS (K. A. Ekbom, 1944, 1945), and based on several 
lines of evidence, he proposed that RLS was caused by a 
buildup of toxic metabolites in the lower limbs secondary 
to reduced peripheral blood flow. Evidence that he cited 
in favor of this theory was as follows: the symptoms were 
relieved by drugs which had a peripheral vasodilatory 
effect, many patients complained of cold feet, the 
symptoms seemed to be caused by prolonged exposure to cold 
in several patients, and the symptoms resembled 
acroparesthesia, an upper limb paresthesia which was 
thought to be vascular in origin. Ekbom (1945) also 
pointed out that RLS symptoms were intermittent rather 
continuous; continuous symptoms would have suggested a 
physical lesion, whereas intermittent symptoms were 
consistent with a transient ischemia-induced paresthesia. 
In his later reviews (K. A. Ekbom, 1960, 1970), Ekbom also 
noted that anemia and iron deficiency exercerbated the 
symptoms of RLS. In fact, as noted earlier, most of the 
medical conditions in which a higher than normal 
prevalence of RLS and PLMS has been demonstrated are 
associated with either anemia or impaired circulation.
Like Ekbom, other researchers have also reported that many 
RLS (and PLMS) patients complain of cold feet (Ancoli-
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
54
Israel et al., 1986; Ware et al., 1988). Ware et al. also 
found direct evidence of reduced peripheral blood flow in 
two of two RLS patients and four of ten PLMS patients.
Ware et al. suggested that excessive sympathetic nervous 
system activity might have caused this excessive vascular 
tone. They also suggested that oscillations of 
sympathetic nervous system activity might underlie the 
periodicity of PLMS, and cited a number of studies 
(primarily those on Mayer waves of peripheral blood 
pressure) in which a 20 to 40 second periodicity of 
sympathetic activity had been demonstrated. Finally, in 
their recent clonidine treatment study of RLS, Wagner et 
al. (1996) proposed that clonidine exerted its therapeutic 
effect by improving peripheral blood flow.
Callaghan (1966) was the first to suggest that RLS 
might be caused by peripheral neuropathy. This theory has 
been popular over the years, and despite the overall lack; 
of support for it, the occasional positive finding (e.g. 
Iannaccone et al, 1996; Wechsler et al., 1986) seems to 
have kept it alive. The high prevalence of peripheral 
neuropathy in several conditions in which RLS is common 
(e.g. uremia, rheumatoid arthritis, diabetes) is 
additional evidence in support of this theory, although as 
noted earlier, RLS is seen with the same frequency in
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uremic patients with and without peripheral neuropathy 
(Nielsen, 1971b).
Studies which have shown opioids to be effective in 
treating RLS have led to the theory that RLS might be 
caused by some dysfunction in the endogenous opioid system 
(Hening et al., 1986; Walters, Hening, Cote, and Fahn, 
1986). Walters et al. (1986) have specifically suggested 
that the mu opioid receptor might be involved in RLS, 
since all of the drugs which have been shown to be 
effective in treating RLS are mu agonists. Apart from the 
treatment data, there is essentially no other evidence 
which supports this theory.
The finding that L-DOPA was very effective in 
treating RLS led to the theory that RLS is caused by a 
dopaminergic dysfunction. As reviewed earlier, there is 
substantial evidence that dopamine agonists are very 
effective in treating both RLS and PLMS. Also noted 
earlier was the study of Staedt et al. (1995a) which found 
direct evidence of reduced dopamine receptor density in 
the basal ganglia of RLS and PLMS patients. The finding 
that iron deficiency can cause reductions in dopamine 
receptor density (Ashkenazi et al.,1982) coupled with the 
high prevalence of iron deficiency in many conditions in 
which RLS is common (pregnancy, hemodialysis, gastrectomy)
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is further evidence in support of the dopamine theory. 
Finally, several authors have pointed out RLS has many 
similarities to neuroleptic induced akathisia (NIA), a 
disorder which is seen as a side effect of dopamine 
blocking neuroleptic medications (Blom and Ekbom, 1961; 
Waiters et al., 1991) .
In one of the earliest descriptions of PLMS in RLS 
patients, Behrman (1958) suggested that these symptoms 
were "a manifestation of a raised excitatory state 
referable to bulbar reticular activity". In their 1968 
review paper, Lugaresi et al. (1968) agreed with Behrman 
that both RLS and PLMS might be caused by abnormal 
activity in the brainstem reticular formation. They 
specifically suggested that RLS and PLMS might result from 
"rhythmical fluctuations of reticular excitability" which 
in turn might be caused by periodic oscillations in blood 
flow (i.e. Mayer waves) to the brainstem. In a later 
study Lugaresi, Coccagna, Mantovani, and LeBrun (1972) 
showed that several periodic phenomena in sleep (PLMs, 
apneic events in persons with sleep apnea, Mayer waves of 
systemic blood pressure in normal subjects) all had 
similar periodicities of 20 to 30 seconds. They suggested 
that all of these phenomena might be caused by 
oscillations of reticular excitability, and again
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due to periodic oscillations in blood flow or to 
oscillations in pH, 02, and C02 secondary to these blood 
flow changes. Unfortunately, Lugaresi and colleagues 
never did measure systemic blood pressure or reticular 
activity in PLMS patients, so direct confirmation of this 
theory is lacking. Despite this, the idea that a 
brainstem oscillator mediates the periodicity of PLMs has 
been generally well accepted over the years.
Smith (1985) proposed that PLMs were spontaneously 
occurring Babinski responses. He based this idea on 
videotaped analyses of PLMs which showed that they did in 
fact appear to be similar to Babinski responses. The 
Babinski response is an abnormal reflex which is seen 
following damage to the pyramidal tracts (van Gijn, 1995). 
It is thought to be inhibited in normal individuals by 
descending inhibition from the pyramidal tracts. In 
support of Smith's idea that there is a reduction in this 
descending inhibition during NREM sleep, two studies have 
shown that the Babinski response can be elicited during 
NREM (but not REM) sleep in normal individuals (Batini, 
Fressy, and Gastaut, 1964; Fujiki, Shimizu, Yamada, 
Yamamoto, and Kaneko, 1971). The absence of PLMs (and 
Babinski responses) during REM sleep may both be
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attributable to the generalized muscle atonia seen in this 
sleep stage. This atonia has been shown to be mediated by 
the nucleus reticularis gigantocellularis, a medullary 
reticular nucleus which projects to all levels of the 
spinal cord (Kanamori, Sakai, and Jouvet, 1980). Apart 
from his observation that PLMs appear to be spontaneously 
occurring Babinski responses, Smith has offered little 
additional explanation of how such responses might occur 
spontaneously, why they occur in some individuals but not 
others, and how they might be linked to RLS symptoms.
Thus, this theory represents primarily an explanation for 
what PLMs are, rather than why they occur.
Critique of Pathogenic Theories 
There are several major problems with the pathogenic 
theories of RLS and PLMS discussed above. The first and 
most important of these is the small number of studies 
which have directly investigated the main tenets of the 
theories discussed above (the peripheral neuropathy theory 
of RLS is the one exception to this). For example, there
have been no studies attempting to determine if there are
opioid receptor abnormalities in RLS/PLMS patients, and 
only one such study investigating (D2) dopamine receptor 
distributions in RLS/PLMS patients. The only study 
investigating peripheral blood flow in RLS and PLMS
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patients included only two RLS patients and did not have a 
control group of normal subjects. There has been no 
attempt to determine if Mayer waves, sympathetic nervous 
system activity, or reticular system activity are 
correlated with (and time-locked with) periodic leg 
movements. There also has not been any attempt to 
determine if RLS/PLMS patients are more likely to show 
elicited Babinski responses during NREM sleep than normal 
controls. The eventual acceptance or rejection of the 
theories above can only be based on such direct 
investigation, and there is clearly much work that remains 
to be done in this regard.
Another problem with these theories is that they are 
vague and poorly developed. For example, there has been 
no attempt to suggest which peripheral nerves might be 
most likely to be involved in producing RLS symptoms, if 
RLS is indeed due to peripheral neuropathy. There also 
has been no suggestion of which brain or spinal cord areas 
rich in opioid receptors might be responsible for 
producing RLS. Similarly, there has been little 
discussion of which dopaminergic projections within the 
CNS might be involved in RLS/PLMS. In general, the 
pathogenic theories of RLS and PLMS consist primarily of 
unelaborated statements and proposals, such as the idea
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that RLS is due to an opioid (or dopaminergic) 
dysfunction.
A related problem is that there has been no attempt 
on the part of the proponents of the theories listed above 
to explain all of the well-established features of either 
RLS or PLMS in terms of their theories. Instead, most 
authors have emphasized only those features of the 
disorder that they can explain in terms of their theories. 
Hurry (1997) suggested that there are at least seven 
unique and well established features of RLS and PLMS that 
any pathogenic theory of the two disorders should be able 
to (or attempt to) explain. These seven features are:
(1) the restriction of RLS paresthesias to the lower legs 
excluding the feet; (2) the precipitation of RLS symptoms 
by inactivity; (3) the relief of RLS symptoms by movement; 
(4) the circadian (and/or sleep-related) appearence of 
symptoms in RLS and PLMS; (5) the higher than normal 
prevalence of RLS and PLMS in the various disorders 
reviewed above; (6) the reason for the effectiveness of 
the various drugs that have been shown to be beneficial in 
treating RLS and PLMS; and (7) the mechanism responsible 
for the periodicity of PLMs. In addition, any theory of 
either RLS or PLMS should be able to explain the strong 
tendency of the two disorders to occur together. Below,
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each of the major pathogenic theories of RLS and PLMS will 
be considered with respect to how well it appears to be 
able to explain all of these features. Only brief comment 
will be made on Smith's spontaneous Babinski response 
theory, since, as noted earlier, it is primarily an 
explanation of what PLMs are rather than why they occur 
and how they are related to RLS.
The reduced peripheral blood flow theory (and the 
related suggestion of excessive sympathetic tone; Ware et 
al., 1984) can potentially explain many of the features of 
RLS and PLMS, but the restriction of sensory symptoms to 
the lower legs excluding the feet represents a very 
difficult issue for this theory. If RLS is in fact caused 
by reduced blood flow to the lower legs, then it is very 
difficult to understand why the paresthesias in RLS are 
not generally seen in the feet. The reduced peripheral 
blood flow theory would presumably suggest that they 
should be most common in the feet because all of the major 
arteries which supply blood to the lower legs also supply 
the feet (see Moore, 1985, Figure 4-31, p. 432), and if 
blood flow is reduced in general, then the most distal 
areas supplied by a given artery should be affected the 
most. The precipitation of RLS symptoms with inactivity 
and their relief with movement are potentially explainable
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in terms of this theory, since a number of studies have 
shown that blood flow to legs is substantially less while 
an individual is at rest than while he or she is engaging 
in even mild or moderate exercise (Hinsenkamp, 
d'Hollander, Coussaert, Rasquin, and Schoutens, 1980; 
Lassen and Kampp, 1965). Similarly, this theory can 
potentially explain the circadian variation in RLS/PLMS 
symptoms, since there are well known reductions in heart 
rate, blood pressure, and peripheral blood flow during the 
evening and during non-REM sleep (Kanecko, Zechman, and 
Smith, 1968; Littler, Honour, Carter, and Sleight, 1975; 
Millar-Craig, Bishop, and Raftery, 1978; Synder, Hobson, 
Morrison, and Goldfrank, 1964). As noted earlier, anemia 
and/or impaired circulation are common to the large 
majority of medical conditions in which there is a higher 
than normal prevalence of RLS and PLMS, so the reduced 
peripheral blood flow theory can potentially account for 
much of these data as well. Although some of the 
treatment data can be explained in terms of the reduced 
peripheral blood flow theory (e.g. correction of anemia, 
vasodilators), some of these data are more difficult to 
explain. This includes the beneficial effects of opioids, 
benzodiazepines, and anticonvulsants. It is apparently 
not well known among RLS researchers that dopamine
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agonists have been shown to increase both peripheral and 
cerebral blood flow (Bogaert and De Schaepdryver, 1967;
Edvinsson, MacKenzie, and McCulloch, 1993, p. 245). 
Finally, the periodicity of PLMs is also potentially 
explainable in terms of the reduced peripheral blood flow 
theory. Both Ware et al. (1988) and Lugaresi et al.
(1972) suggested that the 20 to 40 second oscillations in 
systemic blood pressure known as Mayer waves might 
underlie this periodicity. Although neither author gave a 
detailed proposal of how Mayer waves might actually cause 
PLMs, these oscillations are one of the few physiologic 
phenomena that are known to have the same period (i.e. 20 
to 40 seconds) as PLMs. In summary, the reduced 
peripheral blood flow theory of RLS and PLMS can 
potentially explain most of the well established features 
of both disorders. Its main shortcomings are its apparent 
inability to explain the anatomic distribution of 
paresthesias in RLS and its inability to explain some 
treatment data.
As reviewed above, there have been a large number of 
studies attempting to demonstrate peripheral neuropathy in 
RLS and PLMS patients; however, most of these studies have 
failed to document such pathology in the large majority of 
RLS and PLMS patients. In addition to this lack of direct
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evidence, the peripheral neuropathy of RLS also has 
difficulty in explaining many of the well established 
features of RLS and PLMS. The anatomic distribution of 
paresthesias in RLS is the first of these. A careful 
review of the dermatomes supplied by the nerve roots at 
various spinal cord segments, and of the cutaneous areas 
of the legs supplied by individual peripheral nerves, 
shows that none of these areas match the areas on the 
lower legs where the paresthesias in RLS typically occur 
(see Carpenter and Sutin, 1983, pp 190-191 for a review of 
dermatomes and peripheral nerve distributions). The 
intermittent nature of RLS symptoms (i.e. their appearance 
at rest, their relief with movement, and their circadian 
variation) are also difficult to explain in terms of the 
peripheral neuropathy theory, since peripheral neuropathy 
generally produces persistent rather than intermittent 
symptoms (Thomas, 1984). A similar argument could apply 
to the periodic nature of PLMS. As noted earlier, some of 
the conditions in which a higher than normal prevalence of 
RLS and PLMS occur do have peripheral neuropathy as an 
associated feature (e.g. uremia, rheumatoid arthritis, 
diabetes), so the peripheral neuropathy theory of RLS 
could potentially account for some of this data. However, 
many of those conditions are not associated with
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peripheral neuropathy, and as reviewed earlier, many RLS 
patients with uremia, rheumatoid arthritis, and diabetes 
do not have any evidence of peripheral neuropathy. The 
treatment data are also difficult to understand in terms 
of the peripheral neuropathy theory, since the standard 
therapy for peripheral neuropathy consists of treating the 
underlying condition which caused it, and utilizing 
various forms of physical therapy to overcome its residual 
effects (Stillwell, 1984). In summary, not only does the 
peripheral neuropathy theory of RLS have little empirical 
support, but it is also apparently unable to explain most 
of the well established features of RLS and PLMS.
As reviewed above, the opioid theory is based solely 
on the treatment data which has shown opioids, and mu 
agonists in particular, to be effective in treating RLS. 
The putative opioid dysfunction in RLS could consist of 
decreased levels of endogenous opioids, decreased levels 
of opioid receptors, or some combination of these factors. 
In attempting to explain the anatomical distribution of 
the paresthesias in RLS in terms of the opioid theory, it 
is first necessary to review which CNS areas mediate 
somatosensation in the lower legs. Because there is 
clinical evidence that several sensory modalities may be 
involved in the paresthesia of RLS (e.g. deep tactile
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sense, pain), all of the dorsal horn lamina and ascending 
tracts of the spinal cord might potentially need to be 
considered, although those that mediate touch and 
proprioceptive information from the lower legs (e.g. 
fasiculus gracilis, anterior spinothalamic tract, nucleus 
dorsalis of Clark) are obviously more important. Within 
the brainstem and diencephalon, the nucleus gracilis in 
the medulla and the ventral posterior nuclear complex of 
the thalamus both mediate somatosensory information from 
the lower legs. In the cerebral cortex, the somatosensory 
cortex for the lower legs is on the part of the post­
central gyrus that begins just dorsal to the cingulate 
gyrus, and ends on the cortical surface near the 
longitudinal fissure.
Opioid receptors are widely distributed within brain 
and spinal cord. In lumbosacral segments of the human 
spinal cord, there are dense concentrations of kappa 
receptors in Lamina II and III, while binding of ligands 
specific for mu and delta receptors is very low in all 
lamina (Gouarderes, Kopp, Cros, and Quirion, 1986) .
Quirion and Pilapil (1991) have reviewed the distribution 
of opioid receptors in the human brain in detail.
According to their report, mu receptors are the most 
abundant opioid receptors, and are found in high
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concentrations in the cerebellum, most basal ganglia 
structures, the amygdala, the motor and premotor cortices, 
the auditory cortex and inferior lobe in the temporal 
cortex, Brodmann's area 40 in the parietal lobe, and in 
the visual cortex. The distribution of delta receptors 
closely parallels that of mu receptors, except that they 
are not present in the cerebellum, and are present in high 
concentrations in the hippocampal formation. Kappa 
receptors are found in premotor, motor, and somatosensory 
cortices, some thalamic nuclei (specific nuclei were not 
mentioned), the amygdala, the hippocampal formation, the 
hypothalamus, the neostriatum, the pallidum, and the 
cerebellum. Thus, only the kappa receptor, and not the mu 
receptor, is localized in those areas mentioned above that 
mediate somatosensation in the lower legs, and these areas 
represent only a small portion of its total distribution 
within the brain. Thus, the anatomical distribution of 
paresthesias in RLS is difficult to explain in terms of 
the opioid theory. The intermittent nature of RLS and 
PLMS symptoms (e.g. their appearance at rest, their relief 
with movement, their circadian variation, and the 
periodicity of PLMs) are also difficult to understand in 
terms of the opioid theory, since the putative opioid 
deficiency (e.g. decreased receptor density) should
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produce symptoms that are persistent rather than 
intermittent. The prevalence data are also difficult to 
understand in terms of the opioid theory, since none of 
the conditions in which a higher than normal prevalence of 
RLS or PLMS occurs has been associated with opioid 
abnormalities. Finally, the opioid theory can explain 
only a small part of the treatment data, since most of the 
drugs shown to be effective in RLS and PLMS are unlikely 
to affect opioid functioning within the CNS. In summary, 
although opioids are clearly effective in treating RLS, 
most of the well-established features of RLS and PLMS are 
difficult to understand in terms of this theory.
The putative dopamine abnormality in RLS and PLMS 
could consist of reduced dopamine levels, reduced number 
of receptors, impaired receptor functioning, or some 
combination of these factors. Much is known about the 
distribution of dopamine releasing neurons and dopamine 
receptors in the CNS (Bjorklund and Lindvall, 1984; Joyce 
and Murray, 1994), and some dysfunction of one or more of 
these pathways or receptors could be responsible for 
producing the paresthesias in RLS. There are eight major 
dopamine pathways in the mammalian CNS (Bjorklund and 
Lindvall, 1984), three of which potentially could be 
involved in RLS: the mesostriatal pathway, the
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mesolimbocortical pathway, and the diencephalospinal 
pathway. The reduced D2 dopamine receptor density in the 
basal ganglia shown by Staedt et al. (1995) implicates the 
mesostriatal pathway in the pathogenesis of RLS. However, 
when dopamine release by this pathway is substantially 
decreased, symptoms of Parkinsonianism (e.g. rigidity, 
akinesia, bradykinesia) are the result (Adams and Victor, 
1993). These symptoms are quite different from the 
paresthesias and motor hyperactivity seen in RLS.
Blockade of dopamine receptors that are the targets of the 
mesolimbocortical dopamine neurons is believed to be the 
cause of neuroleptic-induced akathisia (NIA, Marsden and 
Jenner, 1980; Sachdev, 1995). As mentioned earlier, NIA 
does resemble RLS in some respects. Neuroleptic-induced 
akathisia is characterized by an inner sense of 
restlessness which leads to motor hyperactivity (Braude, 
Barnes, and Gore, 1983; Sachdev and Kruk, 1994). The 
motor hyperactivity is most commonly manifested in an 
inability to keep the legs still, body rocking, walking in 
place, and shifting position when seated. In addition, 
about half of all patients with akathisia do report 
abnormal leg sensations (Braude et al., 1983; Sachdev and 
Kruk, 1994). However, because the cortical projections of 
the mesolimbocortical pathway do not include the
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somatosensory cortex (Bjorklund and Lindvall, 1984; Joyce 
and Murray, 1994), it is difficult to understand how a 
dysfunction of this pathway could produce the paresthesias 
seen in RLS. Several authors have suggested that the 
diencephalospinal dopamine pathway might be involved in 
RLS (Guilleminault et al., 1993; Sandyk, Iacono, and 
Bamford, 1988). This pathway has its cell bodies of 
origin in the hypothalamus, the zona incerta, and the 
caudal thalamus, and projects to the dorsal horn grey 
matter at all levels of the spinal cord (Bjorklund and 
Lindvall, 1984; Lindvall, Bjorklund, and Skagerberg,
1983). It is believed to be involved in pain modulation 
and in autonomic and motor responses (Lindvall et al.,
1983) . However, because it projects to all levels of the 
spinal cord, it is difficult to understand how a 
dysfunction in this pathway could produce a paresthesia 
that is restricted to the lower legs, excluding the feet. 
In summary, given the distribution of the three major 
dopamine pathways listed above, and the symptoms that are 
known to be caused by their dysfunction, it is difficult 
to understand how a dopaminergic dysfunction could cause 
the paresthesias seen in RLS. The intermittent nature of 
RLS and PLMS symptoms are also difficult to understand in 
terms of the dopamine theory for reasons similar to those
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mentioned above for the peripheral neuropathy and opioid 
theories (i.e. a dopaminergic dysfunction should produce 
persistent rather than intermittent symptoms). As noted 
earlier, because iron deficiency causes reductions in 
dopamine receptor density (Ashkenazi et al., 1982), the 
dopamine theory can account for the higher than normal 
prevalence of RLS that is seen in conditions associated 
with iron deficiency (pregnancy, hemodialysis, 
gastrectomy). However, these conditions represent only a 
few of those in which a higher than normal prevalence of
RLS and PLMS has been shown to occur. Similarly, the
dopamine theory can only account for a small portion of 
treatment data as well, since many of the drugs effective 
for RLS and PLMS apparently do not affect dopamine 
pathways. In summary, although dopamine agonists are 
effective in treating RLS, and a small reduction in 
striatal dopamine receptor density has been demonstrated 
in RLS/PLMS patients, it is difficult to explain many of
the features of RLS and PLMS in terms of the dopamine
theory.
Before discussing the theory that RLS and PLMS are 
caused by oscillations of reticular system excitability, 
the anatomy and functions of this system should be 
reviewed briefly. The reticular system consists of the
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reticular formation and its associated nuclei within the 
medulla, pons, and midbrain. Some of the more important 
nuclei are the gigantocellular nucleus, the oral and 
caudal pontine nuclei, the Raphe nuclei, and the locus 
coeruleus (Barr and Kiernan, 1993; Carpenter, 1991, pp. 
212-215). This system begins caudally within the upper 
segments of the spinal cord, and ends rostrally in the 
midbrain. The reticular formation consists of numerous 
small groups of cell bodies that are extensively 
interconnected with each other and interspersed with white 
matter. Afferents to the reticular system originate in 
the cerebral cortex, the cerebellum, and the spinal cord 
(Carpenter, 1991, pp. 127-128). Sensory afferents include 
both spinoreticular fibers and axon collaterals that are 
given off by tracts transmitting information from cranial 
nerve nuclei as they ascend to the thalamus. Efferent 
projections include reticulospinal fibers, cerebellar 
projections, and projections to the cortex which are 
relayed via both thalamic and non-thalamic routes. The 
ascending cortical projections exert a potent arousing 
effect on the cortex, a finding which has led to the 
concept of the ascending reticular activating system. As 
reviewed by Carpenter (1991, p. 103), stimulation of the 
pontine and medullary reticular formation can exert a
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variety of (descending) effects which include facilitation 
and inhibition of motor activity (including motor 
reflexes), changes in the level of muscle tone (mediated 
via the gamma system), changes in respiratory and 
cardiovascular activity, and facilitation and inhibition 
of the central transmission of sensory information from 
the spinal cord. The Raphe nuclei are also known to be 
involved in modulating pain sensation (Barr and Kiernan,
1993) .
Given that the reticular formation can exert an 
influence on the transmission of sensory information from 
the spinal cord, it is plausible that this system might be 
involved in producing the paresthesia seen in RLS.
However, the descending reticulospinal fibers originating 
in both the medulla and pons project to all levels of the 
spinal cord (Carpenter, 1991, pp. 101-103), so it is 
difficult to understand how oscillations in reticular 
system activity could cause a paresthesia that is 
restricted only to the lower legs. However, the 
intermittent nature of RLS and PLMS symptoms are 
potentially explainable in terms of the reticular system 
theory. For example, during inactivity and sleep, it is 
reasonable to assume that there is a reduction in afferent 
input to the reticular system (from both the sensory and
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cortical afferents). Likewise, during waking activity 
(and perhaps during REM sleep), these inputs should be 
increased. In addition, as it will be noted in the next 
section, several periodic physiologic phenomena (blood 
pressure, respiration, and cortical arousal oscillations) 
have been shown to have a period similar to that of PLMs 
(20 to 40 seconds), and all of these phenomena could 
potentially be caused by oscillations in reticular system 
activity. Despite this, it is difficult to understand how 
the reticular system could directly cause PLMs, especially 
if it is correct that these movements are in fact Babinski 
responses (which are caused by damage to the corticospinal 
tracts rather than the reticulospinal tracts). The 
prevalence data are also potentially explainable in terms 
of the reticular system theory. Because most of these 
conditions have been associated with anemia or impaired 
oxygen transport secondary to impaired circulation, it is 
reasonable to assume that patients with many of these 
conditions may have altered levels of blood gases. 
Moreover, most brainstem neurons, including those of the 
reticular system are very sensitive to changes in blood 
gases (Dell, 1958; Jiang and Haddad, 1992) . Thus, it is 
possible that many patients with secondary RLS might have 
alterations in blood gases, and consequently, reticular
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system activity levels. The treatment data, however, are 
somewhat difficult to explain in terms of the reticular 
system theory. Many of the drugs effective in RLS 
(opioids, benzodiazepines, anti-convulsants) have well 
known depressant effects on the CNS, while dopamine 
agonists generally exert an arousing effect on the 
cerebral cortex and basal ganglia (Edvinsson et al., 1993, 
pp. 240-241) . Given the opposing effects of these drugs 
on cortical (and reticular system) arousal levels, it is 
difficult to understand how they could all exert a 
therapeutic effect on RLS and PLMS via a reticular system 
mechanism. In summary, the reticular system theory can 
possibly explain some of the features of RLS and PLMS 
(especially the intermittent nature of the symptoms) , but 
it is difficult to explain other features of the two 
disorders, particularly the anatomical distribution of 
paresthesias in RLS, in terms of this theory.
Smith (1985) proposed that PLMs were spontaneously 
occurring Babinski responses, and he suggested that they 
occurred during sleep because of a sleep-related reduction 
in descending pyramidal tract activity. Apart from these 
suggestions, Smith did little else in the way of 
attempting to integrate his theory with other theories of 
RLS and PLMS. He also did not attempt to explain how RLS
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and PLMS might be related, and why some persons have these 
conditions while others do not. Moreover, because 
cortical activity, and descending inhibition from the 
pyramidal tracts, is at its lowest level during slow wave 
sleep, his theory is at odds with the data reviewed above 
which has shown that PLMs are most common in sleep stages 
1 and 2. Despite this, Smith's observation that PLMs 
appear similar to the Babinski response was an important 
one, and it is generally well accepted.
In summary, none of the major theories of RLS and 
PLMS appears to be able to explain all of the well- 
established features of either disorder. The feature that 
appears to be the most difficult to explain is the 
localization of the paresthesias in RLS to the lower legs, 
excluding the feet.
Before turning to a detailed description of the 
periodic cerebral ischemia theory of RLS and PLMS, it will 
first be necessary to review the literature on a number of 
periodic physiologic phenomena that have been shown to 
have the same periodicity as PLMs. It will also be 
necessary to present a selected review of several general 
principles related to the control of cerebral blood flow. 
The next two sections are devoted to a review of these two 
topics.
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Mayer Waves, B Waves, and Other Periodic Phenomena 
Maver Waves and Traube-Herinq Waves 
Mayer waves and Traube-Hering waves are both periodic 
oscillations of systemic blood pressure levels. In the 
case of Traube-Hering waves, the oscillations are 
synchronous with respiration, with one cycle of blood 
pressure oscillation occurring during each respiration. 
Traube-Hering waves are also known as second order blood 
pressure waves (first order waves are blood pressure 
oscillations associated with each heartbeat). Mayer waves 
are slower oscillations of blood pressure with a period of 
between 20 and 40 seconds in humans, and slightly less 
than this in cats and dogs. Mayer waves are also known as 
third order blood pressure waves. Both Mayer waves and 
Traube-Hering waves are vasomotor in origin; that is, they 
are caused by periodic vasoconstriction and vasodilation. 
Electrophysiologic studies have shown that the periodic 
vasomotor activity is synchronous with single unit 
activity in sympathetic vasoconstrictor fibers (Polosa, 
1984; Preiss and Polosa, 1974), so it is generally 
accepted that the vasomotor oscillations have a neural 
rather than humoral or paracrine origin (for example, they 
are not caused by periodic release of endothelium-derived 
relaxing factor). Mayer waves have also been shown to be
77
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accompanied by corresponding oscillations of blood flow 
volume, although the exact relationship is dependent on 
which vascular bed is studied (Killip, 1962). Killip 
found that during the systemic blood pressure peaks, blood 
flow in the aorta, muscles, and intestines was decreased, 
while blood flow in the skin and renal arteries was 
increased.
Traube-Hering waves are thought to be present 
continuously (Andersson, Kenney, and Neil, 1950; Koepchen,
1984), while Mayer waves are most commonly observed after 
an animal has had some sort of insult to the circulatory 
system (e.g. hemorrhage; Koepchen, 1984). Mayer waves are 
somewhat difficult to produce experimentally, although 
several methods (e.g. hemorrhage, complete or partial 
carotid artery occlusion, hypobaric ischemia, metabolic 
acidosis) can produce them reliably in experimental 
animals (Andersson et al., 1950; Ferretti et al., 1965; 
Miyakawa, 1984; Polosa, 1984b; Ueda et al., 1984). In 
addition, it has also been shown that Mayer waves can be 
elicited in spinal animals by increasing the CSF pressure 
in the subarachnoid space (Kaminski, Meyer, and Winter, 
1970). In humans, Mayer waves have been recorded in 
patients with raised intracranial pressure and in normal 
subjects during sleep (Hayashi et al, 1984; Lugaresi et
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al, 1972). Traube-Hering and Mayer waves are usually 
recorded from the femoral artery, but they have also been 
recorded in foot and pulmonary arteries (Ferretti et al, 
1965; Hayashi et al., 1984), so it is likely that they 
occur throughout the peripheral vasculature. Oscillations 
of cerebral blood flow similar to and synchronous with 
peripheral Mayer waves have also been reported (Einhaupl 
et al., 1986; these are referred to as B-waves, and will 
be described in detail in the next section).
The amplitude of Traube-Hering waves is generally 
relatively small(e.g. about five to fifteen percent of the 
mean systemic pressure; Cherniak, Edelmann, and Fishman, 
1969; Cherniak, Heymann, and Chisholm, 1967), while the 
amplitude of Mayer waves is much larger and more variable. 
For example, in hemorrhaged animals (with or without 
carotid artery occlusion) Mayer wave amplitudes of 25% to 
80% of the mean arterial pressure have been reported 
(Andersson et al., 1950; Cherniak et al., 1969; Killip, 
1962). In the human subjects studied by Lugaresi et al. 
(1972) the Mayer waves recorded during sleep had 
amplitudes ranging from 15 to 20 mm Hg (mean blood 
pressure values were not reported).
Several studies in experimental animals have found 
that the procedures used to produce Mayer waves also
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produced periodic breathing that was synchronous with the 
blood pressure waves (Andersson et al., 1950; Killip,
1962; Preiss, Iscoe, and Polosa, 1975). This pattern of 
periodic breathing was characterized by a waxing and 
waning of tidal volume without actual apnea. Even though 
no periods of apnea were present, the waxing and waning of 
tidal volume was quite similar to that seen in Cheyne- 
Stokes breathing. The nadir of the tidal volume in these 
experiments was synchronous with the nadir of blood 
pressure; thus, the two oscillations were in phase with 
each other.
Both Traube (1865) and Hering (1869) proposed that 
blood pressure oscillations they observed were caused by 
an irradiation of excitation from medullary respiratory 
centers to medullary vasomotor centers. The finding that 
phenoxybenzamine administration abolishes Traube-Hering 
waves (Cherniak et al., 1969) is consistent with a 
vasomotor origin for the waves (as opposed to a fluid 
mechanics origin), and indirectly supports the original 
theories of Traube and Hering.
In his historical review of the literature, Koepchen 
(1984) pointed out that Mayer (1876) believed he had 
observed waves that were essentially the same as those 
reported by Traube and Hering despite the fact that they
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were not synchronous with respiration. Other authors in 
the first half of this century disputed this, and showed 
that there were clearly two types of waves: one type that
was synchronous with each respiration and since referred 
to as Traube-Hering waves, and one type with a longer 
period since referred to as Mayer waves (see Koepchen, 
1984, for a review of this early literature). In the 
1950s, 1960s, and 1970s, a number of studies were reported 
in which efforts were undertaken to determine the cause of 
the slower 20 to 40 second vasomotor oscillation. Based 
on those studies, two theories, the peripheral feedback 
and central oscillator theories, have emerged (Polosa, 
1984).
Andersson et al., (1959) used hemorrhage combined 
with either unilateral or bilateral carotid artery 
occlusion to produce Mayer waves in cats. Because the 
waves could be abolished by either cooling or sectioning 
the vagus and carotid sinus nerves, Andersson et al. 
concluded that peripheral feedback from the chemoreceptors 
and baroreceptors was the source of the oscillations. In 
addition, because the mean systemic pressure in their 
animals was quite low (40 to 70 mm Hg), they concluded 
that afferent information from the chemoreceptors was more 
important than that from the baroreceptors. Guyton and
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Harris (1951) performed experiments in which the 
baroreceptors were selectively denervated. This procedure 
either abolished or greatly reduced the amplitude of the 
Mayer waves, leading these authors to conclude that 
afferent feedback from the baroreceptors was more 
important than the feedback from the chemoreceptors. 
Armstrong and Irby (1962) used intra-arterial injections 
of acetic acid to destroy the carotid and aortic 
chemoreceptors, and found that Mayer waves persisted 
following this manipulation. When both the chemoreceptors 
and baroreceptors were destroyed, no Mayer waves could be 
elicited. Like Guyton and Harris (1951), Armstrong and 
Irby also concluded that the baroreceptors were more 
important than chemoreceptors in producing Mayer waves.
In contrast to the findings by Armstrong and Irby (1962), 
two groups of researchers found that Mayer waves could 
persist after total denervation of the peripheral 
chemoreceptors and baroreceptors (Cherniak et al., 1969; 
Ferretti et al., 1965), although they were often reduced 
in amplitude. This suggested one of two possibilities; 
first, central chemoreceptors might be generating periodic 
excitation of the vasomotor centers; or second, a central 
oscillator might be providing periodic excitation to the 
vasomotor centers independent of the sensory input from
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the chemoreceptors and baroreceptors. One of the 
experiments done by Ferretti et al. suggested that the 
first possibility was correct. In this experiment, 
injections of dilute hydrochloric acid were used to 
produce metabolic acidosis of sufficient intensity to 
cause Mayer waves in dogs that had undergone complete 
denervation of the chemoreceptors and baroreceptors. 
Subsequent injection of a buffer solution eliminated the 
Mayer waves. A later study by Preiss et al. (1975) found 
evidence which strongly suggested that a central 
oscillator was generating the Mayer waves. In this study, 
sympathetic nerve activity was found to be synchronous 
with the blood pressure oscillations. This sympathetic 
nerve activity persisted after several manipulations 
designed to eliminate rhythmic sensory input from both 
central and peripheral chemoreceptors and (peripheral) 
baroreceptors. These manipulations included simultaneous 
artificial ventilation to maintain constant blood gas 
levels, chemoreceptor and baroreceptor denervation, and 
alpha adrenergic blockage to eliminate the actual 
vasomotor oscillations. In other animals, the vasomotor 
oscillations were eliminated by connecting a pressure 
stabilizing device to the animals' aorta. The persistence 
of periodic sympathetic activity in spite of all these
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manipulations indicated that although peripheral afferent 
mechanisms may have initially triggered the waves (the 
waves were produced by hemorrhage), they were not needed 
to maintain the periodic sympathetic output once the 
circulatory insult had occurred. The results of all of 
these experiments can be summarized by noting that there 
is evidence to support both the peripheral and central 
theories.
In spite of all this work, there is no clear 
consensus among researchers on how important the various 
central and peripheral mechanisms are in the generation of 
Mayer waves. Moreover, although there is some evidence to 
indicate that a central oscillator does exist, its precise 
anatomical location remains obscure. Langhorst, Schulz, 
and Lambertz (1984) and Lugaresi et al. (1972), among many 
others, have argued that the brainstem reticular formation 
represents this central oscillator. Unfortunately, there 
is little direct experimental evidence that reticular 
neurons have periodic oscillations in their firing rates 
with periods similar to those of Mayer waves. For 
example, Langhorst et al. (1984) recorded the spontaneous 
activity of medullary reticular neurons, and although some 
neurons with periodic firing were found, their period 
durations were usually about six seconds (this was twice
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the respiration rate). It should be noted that Mayer 
waves were not observed in their animals, nor was there 
any attempt to generate them experimentally. Oakson and 
Steriade (1982) found oscillations in the firing rates of 
mesencephalic reticular neurons with periods varying 
between eight to twelve seconds (5 to 7.5 waves per 
minute). Of interest was the finding that these 
oscillations appeared only during quiet waking (i.e. 
wakefulness without movement) and non-REM sleep. Other 
investigators who have studied the firing rates of 
brainstem reticular neurons during the sleep-wake cycle 
have not found such oscillations (Manohar, Noda, and Adey, 
1972; Vertes, 1979), although it is likely that 
methodological differences between these studies and that 
of Oakson and Steriade (1982) account for the negative 
findings (see Oakson and Steriade, 1982, for a review of 
the pertinent methodological issues) . Despite this, it is 
worth emphasizing that oscillations of reticular neuron 
firing rates with periods longer than about 12 seconds 
have not been reported.
Another approach to studying firing rate rhythmicity 
was employed by Corner and Crain (1972). These 
investigators studied single unit activity of medullary 
neurons in slices of fetal tissue (from rodents) that were
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maintained in vitro. The advantage of this technique was 
that the neurons studied were isolated from peripheral 
(i.e. chemoreceptor and baroreceptor) afferent input.
About half of the neurons studied by these investigators 
showed periodicity in their firing. The majority of these 
neurons had active and inactive phases of approximately 
equal length, with the length of the total cycle varying 
between 1.0 and 5.0 minutes. Shorter period durations 
(always less than two minutes) were seen in two other 
periodically firing neurons in which the active phase was 
much shorter than the inactive phase. Unfortunately, the 
total number of neurons studied in this experiment was low 
(n = 39), and no detailed information on the anatomical 
location of the periodic neurons was provided. A more 
recent in vitro study of medullary neurons by Bingmann, 
Baker, and Ballantyne (1991) also found periodic neuronal 
activity, but the mean period duration of these neurons 
was 2.7 seconds (the range was 0.5 to 10 seconds). These 
authors noted that periodicity was not confined to any one 
anatomic region. They also suggested that the 2.7 second 
periodicity reflected the activity of respiratory-related 
neurons. In summary, these is very little direct 
experimental evidence to support the idea that neurons in
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the reticular system have an intrinsic slow oscillation in 
their firing rates.
Still other work has shown that pharmacologic 
depression of the ventrolateral surface of the medulla 
(the central chemosensitive area) with lidocaine and 
benzodiazepines can abolish Mayer waves produced by 
hypoxia or hypercapnia (Haxhiu, Van Lunteren, Deal, and 
Cherniak, 1989). Other investigators have demonstrated 
that lesions of the area postrema in the dorsal medulla 
can also abolish Mayer waves (Pollick, Barnes, and 
Ferrario, 1987) .
Finally, as mentioned earlier, a study by Kaminski et 
al. (1970) found that Mayer waves could be produced in 
spinal animals by increasing the subarachnoid CSF 
pressure. Kaminski et al. suggested that the increased 
pressure produced local spinal ischemia and a resulting 
excitation (and vasopressor response) of sympathetic 
neurons. They suggested that the resulting increased 
blood pressure improved spinal perfusion which then led to 
a decrease in sympathetic output and further oscillations 
of the system. The data from this study clearly indicate 
that spinal sympathetic vasomotor neurons are capable of 
periodic oscillations irrespective of their supraspinal 
afferent input. The issue of whether or not this
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oscillation is due to a feedback mechanism or an 
endogenous periodicity in these neurons remains 
unresolved.
B Waves
The term "B wave" was introduced by Lundberg (1960) 
to refer to oscillations of intracranial pressure (ICP) 
with a frequency ranging from .5 to 2 per minute. In his 
1960 study, Lundberg reported on his experience with 
continuous monitoring of ICP, and drainage of 
cerebrospinal fluid (CSF) to control this pressure, in a 
large sample of patients. These techniques were just 
coming into widespread clinical use at that time. In his 
report, Lundberg described three types of oscillations or 
short term increases in ICP. Lundberg initially referred 
to these as A, B, and C waves, and although he also 
proposed more descriptive names (plateau waves, one-per- 
minute waves, and six-per-minute waves, respectively), the 
term "B wave" has persisted in the literature. A-waves 
were large increases in ICP levels which usually lasted 
from five to twenty minutes. These were often accompanied 
by adverse neurological consequences. As mentioned 
earlier, B waves were ICP oscillations of variable 
amplitude which had a period ranging from about 30 seconds 
to about two minutes. In Lundberg's sample of patients
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with intracranial hypertension, periods of approximately 
one minute predominated. C waves were relatively low 
amplitude ICP oscillations which occurred at a frequency 
of approximately six waves per minute. In contrast to A 
and B waves, C waves were observed only infrequently.
Two important observations with respect to B waves 
were pointed out by Lundberg (1960). First, the waves 
occurred most commonly during natural sleep and during 
periods of impaired consciousness, stupor, and coma. 
Second, like Mayer waves, B waves were frequently 
accompanied by Cheyne-Stokes respiration or periodic 
breathing, with the periods of apnea (or decreased tidal 
volume) occurring in phase with the low pressure points of 
the ICP tracing. Although the association of B waves and 
periodic breathing was common, B wave activity was also 
noted in some patients who were artificially ventilated. 
More recent studies have confirmed that B-waves may occur 
both with (Einhaupl et al., 1986; Hashimoto et al., 1989) 
and without (Einhaupl et al., 1986; Newell, Aaslid,
Stooss, and Reulen, 1992) Cheyne-Stokes respiration or 
periodic breathing.
Lundberg (1960) proposed that both B and C waves were 
caused by oscillations of cerebral blood flow which led to 
corresponding oscillations of cerebral blood volume. He
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suggested that B waves were caused by periodic 
vasodilation and vasoconstriction which occurred because 
of the oscillating blood gas levels produced by the 
Cheyne-Stokes respiration. However, Lundberg also noted 
that some authors (e.g. Hoff and Breckenridge, 1954) 
believed that Cheyne-Stokes respiration was due to an 
intrinsic brain stem rhythm, and he suggested that a 
similar rhythm affecting the vasomotor center might be 
responsible for generating the B waves that were observed 
in patients who were artificially ventilated. With 
respect to the C waves, Lundberg suggested that these were 
caused by oscillations of blood flow due to Traube-Hering 
waves (which he incorrectly referred to as Traube-Hering- 
Mayer waves). It should be pointed out that in the 
original studies by Traube (1865) and Hering (1869) the 
blood pressure waves that were observed had a frequency of 
about six per minute. It should also be noted that 
historically, the terms Traube-Hering waves and Mayer 
waves have often been used interchangeably; apparently 
because many researchers were not aware of the literature 
showing that these were two distinct phenomena (Koepchen,
1984). Although the predominant B wave frequency in 
Lundberg's patients was about one per minute, Lundberg did 
note that waves with frequencies in between those of B and
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C waves (i.e. waves with frequencies between 2 and 4 per 
minute) sometimes occurred.
Although Lundberg's proposal that B and C waves were 
caused by oscillations in cerebral blood volume was 
generally well accepted, direct evidence to support this 
theory wasn't obtained until Auer and Sayama (1983) showed 
that B waves in experimental animals were accompanied by 
synchronous vasodilation and vasoconstriction of cerebral 
(pial) arteries.
Other more recent studies have shown that blood flow 
velocity in the middle cerebral artery (as assessed by 
transcranial Doppler sonography) shows oscillations that 
are synchronous with the B waves seen in the ICP tracing 
(Droste and Krauss, 1993; Mautner et al., 1989; Nakatani, 
Ozaki, Hara, and Mogami, 1989; Newell et al., 1992).
These oscillations are in phase with each other, with 
increased flow velocity (and total blood flow volume) 
occurring during the periods of increased ICP. A number 
of researchers have used transcranial Doppler sonography 
(alone) to investigate whether or not similar oscillations 
of blood flow velocity occur in normal subjects. These 
studies have shown that B wave-like oscillations in blood 
flow velocity occur in the majority of subjects studied in 
both wakefulness (Mautner et al., 1989; Diehl, Diehl,
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Sitzer, and Hennerici, 1991) and during sleep (Droste, 
Berger, Schuler, and Krauss, 1993) . For example, Mautner 
et al. studied 20 normal subjects, and found that 16 had B 
wave activity. The mean amplitude of the B waves in these 
subjects was 9.2% of the mean blood flow velocity. In two 
subjects, amplitudes representing 19 and 21 percent of the 
mean flow velocity were found. Diehl et al. found mean B 
wave amplitudes of up to 30% of the mean flow velocity in 
the normal subjects they studied; and in addition, they 
reported that the amplitude of these B waves was 
significantly higher in a group of older subjects with a 
mean age of 70.0 years than a group of younger subjects 
with a mean age of 26.2 years (B waves were found in all 
subjects studied). Diehl et al. did not report group 
means for the period of the B waves in their normal 
subjects, but they did note that all subjects had B wave 
periods similar to one normal subject whose spectral 
analysis showed two B wave peaks representing periods of 
37 and 150 seconds. Droste et al. (1993) found B wave 
periods during sleep which ranged from 20 to 75 seconds, 
and like Diehl et al., they also found that some subjects 
had two B wave peaks in their spectral analyses. For 
example, one subject whose data was presented graphically 
had B wave period peaks at 25 and 45 seconds.
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Several studies have simultaneously monitored both 
ICP and systemic blood pressure in an attempt to determine 
if B waves occur synchronously with Mayer waves. Hayashi 
et al. (1984) found that B waves and Mayer waves (recorded 
from the femoral or foot arteries) occurred synchronously 
and in phase with each other (i.e. the peak of ICP 
occurred at the same time as the peak in systemic blood 
pressure) in most of their patients who had intracranial 
hypertension. Patients who were in terminal stages often 
had ICP B waves without any corresponding oscillations of 
systemic blood pressure. Newell et al. (1992) studied 20 
patients with intracranial hypertension secondary to head 
injury, and found that B wave activity in the ICP and 
transcranial Doppler recordings was generally not 
accompanied by Mayer waves in the systemic blood pressure 
recordings. When both Mayer and B waves did occur, they 
were in phase with each other. Einhaupl et al. (1986) 
found that B waves and Mayer waves occurred in phase with 
each other 78% of the time in patients who had Cheyne- 
Stokes respiration and 72% of the time in patients who did 
not have Cheyne-Stokes respiration. Thus, B waves and 
Mayer waves were out of phase with each other about one 
fifth of the time in their patients. Hashimoto et al. 
(1989) found that B waves and Mayer waves occurred
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synchronously and in phase with each other in 20 patients 
with raised ICP. They also noted that the B wave peak 
occurred shortly before the Mayer wave peak (by a few 
seconds). The recording site used for monitoring systemic 
blood pressure was not specified in their report.
In contrast to these studies in human patients, 
Higashi et al. (1989) found that B waves and Mayer waves 
did not occur in phase with each other in cats whose ICP 
was raised by infusion of mock CSF. The two waves were 
approximately 180 degrees out of phase (i.e. the B wave 
peaks corresponded to the Mayer wave troughs). This 
relationship was reversed only when the ICP was raised to 
the level of the systemic blood pressure. Simultaneous 
recording of unit activity from sympathetic nerves showed 
that distinct oscillations synchronous with the Mayer 
waves were present only during the experiments where the 
ICP was raised to match the systemic blood pressure. In 
these experiments the peaks of the sympathetic nerve 
discharge were synchronous with the troughs of the 
systemic blood pressure. This relationship was identical 
to that observed by Preiss and Polosa (1974) for Mayer 
waves produced by hemorrhage and carotid artery occlusion 
in cats. When Higashi et al. performed a bilateral 
cervical sympathectomy (i.e. the sympathetic innervation
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to the cerebral vasculature was removed), the B waves 
persisted. This finding led Higashi et al. to suggest 
that an intrinsic noradrenergic pathway contained entirely 
within the brain mediated the B wave activity. These 
findings, taken together with those showing that B waves 
can occur in humans in the absence of Mayer waves, provide 
convincing evidence that neural pathways intrinsic to the 
brain may mediate the vasomotor oscillations that cause B 
waves. Reis (1984) reviewed evidence that several 
brainstem nuclei, including the dorsal medullary reticular 
formation and parabrachial nuclei in the pons, can exert 
potent influences on cerebral blood flow. Thus, it seems 
quite possible that separate neural pathways may mediate B 
waves and Mayer waves under at least some circumstances.
The research reviewed above has been conducted 
primarily by investigators whose main research interest 
was the study of intracranial hypertension in human 
patients. A separate line of work in experimental animals 
and humans was conducted in the late 1950s and the 1960s 
in which intracerebral electrodes were used to monitor 
oxygen availability and blood flow levels. Clark,
Misrahy, and Fox (1958) conducted one of the earliest of 
these studies in experimental animals. Using chronically 
implanted platinum electrodes through which a small
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electrical current was passed (i.e. polarographic 
electrodes), these researchers found oscillations of 
oxygen availability with a frequency of about six waves 
per minute and an amplitude of up to 30 percent of mean 
oxygen levels in unanesthetized cats. Waves recorded from 
several different sites in the same animal were usually 
not synchronous with each other. Moreover, the waves did 
not correspond to any observed oscillations in heart rate, 
respiration, or systemic blood pressure; thus, they were 
not Traube-Hering waves. Similar waves with a frequency 
of about six per minute were observed in human psychiatric 
and epileptic patients in a series of studies by a group 
of researchers in England (Cooper, Crow, Walter, and 
Winter, 1966; Moskalenko, Cooper, Crow, and Walter, 1964; 
Walter and Crow, 1964). The psychiatric patients studied 
by these workers were undergoing electrolytic frontal 
leucotomy, while the epileptic patients had the electrodes 
implanted for the purpose of identifying seizure foci. In 
addition to the six per minute waves in these patients, 
some of the figures presented by Cooper et al. (1966) 
appear to show slower waves with a period of about 50 
seconds (for example, see Figure 2, p. 178, of Cooper et 
al., 1966). A later reanalysis of this data using 
spectral analysis showed that slower waves with a period
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similar to that of B waves were indeed present in these 
subjects (Moskalenko, 1980, p. 122). Cooper and Hulme 
(1966) also implanted polarographic electrodes in a sample 
of 24 patients who were undergoing continuous monitoring 
of intracranial pressure. Like Lundberg, they observed 
both A and B waves, and noted that both were more common 
during sleep. The A waves occurred most commonly during 
REM sleep. The most important finding pertinent to this 
review is that the B waves were accompanied by synchronous 
oscillations of oxygen availability (see Cooper and Hulme, 
1966, Figure 5, p. 567). In these instances, the peaks of 
ICP were associated with decreases in oxygen availability; 
thus, the two waves were approximately 180 degrees out of 
phase. In a later report, Cooper and Hulme (1968) showed 
that the ICP peaks which occurred during the B waves were 
also accompanied by bursts of slow wave activity in the 
EEG.
In summary, patients with intracranial hypertension 
frequently show oscillations of intracranial pressure 
which have a frequency ranging from .5 to 2 per minute. 
These so-called "B waves" are caused by oscillations of 
cerebral blood flow, and are more common during sleep than 
during wakefulness. Similar oscillations of cerebral 
blood flow (velocity) have been documented in normal human
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subjects, and the amplitude of these waves has been shown 
to be larger in older subjects (Diehl et al., 1991). In 
patients with intracranial hypertension, these B waves are 
often accompanied by Mayer waves, Cheyne-Stokes 
respiration or periodic breathing, and periodic bursts of 
slow wave activity in the EEG. The synchronous occurrence 
of these phenomena suggests that they may all be caused by 
an intrinsic brainstem rhythm.
In November, 1996 a study was published by Droste, 
Krauss, Hagedorn, and Kaps (1996) in which B-waves of 
cerebral blood flow velocity were documented in four 
patients with PLMS. In this study it was found that the 
flow velocity values were significantly higher at the 
moment the PLMs occurred than during the interval between 
PLMs. Droste et al. concluded that B-waves and related 
oscillations in EEG activity (cyclic alternating pattern) 
were part of a common endogenous rhythm, and they further 
postulated that PLMs were an epiphenomenon of this rhythm. 
They did not elaborate on this, nor did they suggest that 
B-waves might cause PLMs, either directly or indirectly 
(e.g. by producing cerebral ischemia). This study is 
important because it provides the only direct evidence 
obtained thus far that abnormalities in cerebral blood 
flow (i.e. B-waves) are present in patients with PLMS.
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The finding by Droste et al. (1996) that flow 
velocity was higher at the moment the PLMs occurred 
deserves additional comment. Previous work has shown that 
B-waves in flow velocity and intracranial pressure are in 
phase with one another (Droste and Krauss, 1993; Mautner 
et al., 1989; Newell et al., 1992). However, Cooper and 
Hulme (1966) found that B-waves in oxygen availability and 
intracranial pressure were 180 degrees out of phase (i.e. 
oxygen availability was low when intracranial pressure was 
high). Based on these studies, it is reasonable to assume 
that cerebral oxygen levels are lowest when blood flow 
velocity is highest. This also makes sense when one 
considers that low oxygen (and high C02) are potent 
vasodilators, and vasodilation lowers the resistance to 
blood flow, resulting in an increase in flow velocity.
Thus, based on the data reported by Droste et al. (1996) 
it is reasonable to assume that PLMs occurred in their 
patients when cerebral oxygen levels were low. It should 
be noted though, that Cooper and Hulme (1966) studied 
psychiatric and epileptic patients; thus, it is unclear if 
their results are generalizable to normal subjects.
Chevne-Stokes Respiration and Periodic Breathing
Cheyne-Stokes respiration (CSR) is a form of periodic 
breathing in which short periods of respiration alternate
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with short periods of apnea (the total cycle duration 
varies from 0.5 to 1.5 minutes). When respirations are 
present, a characteristic waxing and waning of tidal 
volume is seen. Although the term periodic breathing has 
been used to refer to several forms of abnormal breathing 
(including central sleep apnea), it is most commonly used 
to refer to a pattern of respiration that is similar to 
CSR, but without periods of apnea (i.e. only a slow waxing 
and waning of tidal volume is observed). The original 
descriptions of these forms of abnormal respiration are 
attributed to Cheyne (1818) and Stokes (1854). A large 
number of studies investigating CSR have appeared since 
these early studies, and several excellent reviews of the 
CSR literature are available (Brown and Plum, 1961;
Dowell, Buckley, Cohen, Whalen, and Sieker, 1971; Tobin 
and Snyder, 1984). The following review draws heavily 
from these sources.
Cheyne-Stokes respiration is seen clinically in 
several diseases. These include heart disease (including 
congestive heart failure), neurological disease (including 
intracranial hypertension and bilateral cortical damage), 
and uremia. Cheyne-Stokes respiration is also seen in 
premature infants and in normal human subjects undergoing 
acclimatization to high altitude. Cheyne-Stokes
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respiration is often augmented during sleep, and periodic 
breathing of variable amplitude and duration is seen many 
normal subjects during sleep, especially near sleep onset 
(Robin, Whaley, Crump, and Travis, 1958; Bulow, 1963).
Most patients with CSR have both heart disease and 
neurological disease; however, CSR may occur if only one 
of these is present (Brown and Plum, 1961). Historically, 
the importance of heart disease versus neurological 
disease in the pathogenesis of CSR has been controversial. 
Stokes (1854) believed that CSR was always associated with 
heart disease. Heart disease is thought to cause CSR 
primarily by prolonging the lung to medullary 
chemoreceptor circulation times (Dowell et al., 1971). 
Brown and Plum (1961) described the clinical 
characteristics of CSR in detail in a sample of 28 
patients. All 28 of their patients had neurological 
disease, while only 23 had heart disease. This finding 
led Brown and Plum to conclude that neurological disease 
was necessary for CSR to occur. Brown and Plum also found 
that their patients had average C02 levels that were lower 
than normal (i.e. respiratory alkalosis), and had 
ventilatory responses to C02 administration that were 
three times higher than those seen in normal subjects.
They concluded that CSR was a pattern of "neurogenic
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hyperpnea in which intense hyperventilation alternates 
with posthyperventilation apnea" (Brown and Plum, 1961; p. 
859). They further suggested that the supramedullary 
neurological damage in their subjects was the source of 
the increased sensitivity to C02. This idea that 
neurological damage in CSR patients could produce an 
increased sensitivity of the medullary respiratory centers 
with subsequent hyperventilation had been suggested by 
several earlier workers, including Jackson (1895). This 
is in contrast to the opinion expressed by Hoff and 
Breckenridge (1954) that the neurologic damage in CSR 
released an intrinsic brainstem rhythm, which then 
resulted in a periodic activation of the medullary 
respiratory center.
A number of physiologic parameters alternate with 
respiration during CSR. With respect to blood gas levels, 
C02 levels are highest (and 02 levels are lowest) during 
the hyperventilation phase (Dowell et al., 1971; Tobin and 
Snyder, 1984). The pupils usually dilate during the 
hyperpneic phase and constrict during the apneic phase; 
this reflects the predominant autonomic activity during 
each phase. In their 1971 review, Dowell et al. reported 
that the EEG is characterized by predominately fast 
activity during the hyperpneic phase and slow activity
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during the apneic phase. Similarly, CSR patients are 
usually awake and responsive (and often agitated) during 
the hyperpneic phase, and confused, stuporous, and/or 
somnolent during the apneic phase (Dowell et al., 1971).
In patients with CSR, improvement in the underlying 
cardiac or neurological disease often eliminates the CSR, 
so the abnormal respiration itself is usually not treated. 
However, CSR can be eliminated with either respiratory 
stimulants, or by having the patient breath gas mixtures 
containing higher than normal amounts of either 02 or C02 
(Dowell et al., 1971; Tobin and Snyder, 1984).
In the 1950s and 1960s, several mathematical and 
computer models of CSR (and normal respiration) were 
developed in an effort to understand the causes of CSR.
The first of these models, developed by Grodins, Gray, 
Schroeder, Norins, and Jones (1954), was an attempt to 
model the normal respiratory response to hypercapnia.
This model used tissue C02 (rather than arterial C02) as 
the variable sensed by the respiratory controller. This 
model assumed that the sensor for C02 was the medullary 
respiratory center (i.e., peripheral chemoreceptors were 
neglected), and also assumed that circulation time was 
infinitely short (i.e., zero). The mathematical equations 
derived by Grodins et al. (1954) were used in simulations
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of the ventilatory response to C02 administration, and the 
results obtained were in good agreement with available 
physiologic data from human subjects. This model was used 
a starting point by later investigators who attempted to 
model CSR.
Millhorn and Guyton (1965) were to first to develop a 
computer model of the respiratory system in which CSR 
could be produced. In their model CSR could only be 
produced if either the arterial circulation time or the 
controller gain was manipulated. The "controller gain" 
refers to the amplitude of the ventilatory response (to 
CO; for example). Increases in this variable could be 
mediated physiologically by either respiratory motor 
neurons or sensory neurons which monitor blood gas levels. 
Millhorn and Guyton found that their model could produce 
sustained CSR if the circulation time was increased to 
three and half minutes or if the controller gain was 
increased to 13 times its normal value. Both of these 
values were obviously larger than those that were likely 
to be occurring in CSR patients, a problem which suggested 
inadequacies in their model.
Longobardo, Cherniack, and Fishman (1966) presented a 
model similar to that of Millhorn and Guyton (1965), and 
found that CSR could be induced in this model under
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physiologically (e.g. sustained hyperventilation in 
normals, congestive heart failure, neurologic disorders, 
and altitude acclimatization). However, in the simulation 
of hyperventilation in normals, the model had to be 
hyperventilated to a very low arterial C02 value of 14 mm 
Hg before CSR occurred, and in the simulated congestive 
heart failure condition (simulated by increasing the 
circulation time and decreasing the cardiac output), the 
model also had to be hyperventilated before CSR occurred. 
Overall, the results were similar to those obtained by 
Millhorn and Guyton in that the model showed that there 
were only two types of CSR, one caused by abnormal 
circulation times, and one caused by abnormal C02 
sensitivity. It should be pointed out that neither of 
these two models (Millhorn and Guyton, 1965; Longobardo et 
al., 1966) included peripheral chemoreceptors.
Khoo, Kronauer, Strohl, and Slutsky (1982) presented 
a model which included peripheral chemoreceptors, and 
which was also based on different mathematics than the 
earlier models presented above. The peripheral (carotid) 
chemoreceptors in this model were designed to respond to 
arterial 02 levels. CSR could be produced in this model 
by a combination of relatively mild hypoxia and
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 0 6
hypercapnia, similar to that seen in many subjects during 
sleep. The model also produced CSR when cardiac and 
neurological disease were simulated with abnormally long 
circulation times and abnormal controller gains 
respectively. Overall, the results indicated that the 
peripheral chemoreceptor input was relatively important in 
mediating CSR. In addition, the deviations in model 
parameters needed to produce CSR were much closer to those 
known to be present in actual CSR patients.
It should be pointed out that in none of the three 
models presented above was it necessary to include 
external oscillatory input (i.e. a brainstem oscillator) 
to produce CSR. CSR was produced in these models by 
directly manipulating the parameters of the respiratory 
system alone (sensors, output units, etc). Thus, the data 
obtained from these models is inconsistent with the idea 
of Hoff and Breckenridege (1954) that CSR is caused by 
disinhibition or release of an intrinsic brainstem rhythm.
Cyclic Alternating Pattern
Cyclic alternating pattern (CAP) is a term coined by 
Terzano, Mancia, Calzetti, Zachetti, and Maione (1981) to 
refer to oscillations in EEG activity occurring in coma 
and natural sleep. These oscillations have a period which 
averages about 40 seconds in normal subjects (Terzano and
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 0 7
Parrino, 1993). According to the scoring system developed 
by Terzano, CAP cycles are divided into two phases; Phase 
A reflects arousal and comprises approximately one third 
of the total cycle, and Phase B reflects decreased 
arousability and comprises approximately two thirds of the 
total cycle time (Terzano et al., 1985; Terzano and 
Parrino, 1993). The variation that is observed in the EEG 
activity during CAP sequences depends on the sleep stage 
(Terzano et al., 1985). In Stage 1, Phase A consists of 
alpha activity, while Phase B consists of the normal mixed 
frequency theta background. In Stage 2, Phase A consists 
of K complexes with associated alpha activity and alpha 
arousals, while Phase B consists of the normal Stage 2 
background activity with isolated K-complexes. In Stages 
3 and 4, Phase A consists of sequences of K-complexes 
and/or reactive delta waves, while Phase B consists of the 
normal amount of (randomly distributed) delta activity.
CAP was not identifiable in REM sleep (Terzano et al.,
1985). In comatose patients, Phase A is characterized by 
high amplitude slow wave activity which appears similar to 
the delta activity occurring during slow wave sleep.
Phase B is characterized by relatively fast medium voltage 
activity (Evans, 1976; Terzano et al., 1981).
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Although Terzano and his colleagues have done the 
most extensive work on CAP, a number of earlier 
investigators had described this phenomenon in both 
animals and humans. Bonvallet, Dell, and Hiebel (1954) 
recorded both EEG and blood pressure in anesthetized cats 
and dogs. They observed a simultaneous oscillation of 
both the EEG and blood pressure when the animals were not 
being subjected to any sensory stimulation. The 
activation in the EEG was synchronous (i.e. in phase) with 
the increases in blood pressure. A series of brainstem 
sectioning experiments indicated that the EEG arousal was 
being produced by the ascending reticular activating 
system (ARAS) in the rostral portions of the reticular 
formation, although Bonvallet et al. did not rule out the 
possibility of a humoral origin for the EEG waves.
Similar oscillations of EEG activity during six per minute 
waves in rats have been described more recently by 
Golanov, Yamamoto, and Reis (1994).
Poole (1960) briefly described oscillations of EEG 
activity in two patients with subacute encephalitis. The 
EEG waves were synchronous with oscillations of 
respiratory activity, but it was not stated if the 
respiratory oscillations were Cheyne-Stokes respiration.
A more detailed description of EEG oscillations in
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comatose patients was provided by Evans (1976) . The 
oscillations in these patients had a period which varied 
from 0.5 to 2.0 minutes, and they were synchronous with 
oscillations in heart rate and respiration rate. Evans 
noted the similarity of the EEG oscillations he described 
and the B waves described by Lundberg (1960). His paper 
is noteworthy in that it is the only paper in which the 
similarities of Mayer waves, B waves, Cheyne-Stokes 
respiration, and oscillations in EEG activity were 
specifically discussed. Despite this, Evans was hesitant 
to speculate on a pathogenic mechanism by which these 
phenomena might be interrelated, although he did note that 
previous investigators (including Lugaresi) had suggested 
that an intrinsic brainstem rhythm might be the source of 
these phenomena.
Terzano and his colleagues first described CAP in 
patients with Creutzfeldt-Jakob disease (Terzano et al,
1981), but they subsequently found that CAP occurred in 
both normal subjects (Terzano et al., 1985), and in 
patients with epilepsy (Terzano, Parrino, Anelli, and 
Halasz, 1989), insomnia (Terzano and Parrino, 1992), sleep 
apnea (Terzano, Parrino, and Spaggiari, 1990), and most 
recently in PLMS (Terzano and Parrino, 1993; Terzano, 
Parrino, Boselli, Di Giovanni, and Spaggiari, 1995).
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Montplaisir, Lapierre, and LaVigne (1994) also described 
periodic oscillations in EEG activity in RLS/PLMS 
patients. In this study, the oscillations were observed 
during both sleep and wakefulness (during a Forced 
Immobilization test). Both Terzano et al. (1995) and 
Montplaisir et al. (1994) noted that leg movements during 
sleep occurred in association with arousal, a finding 
which led Terzano et al. (1995) to propose that the 
arousal phase of CAP promoted the appearance of PLMs. 
However, Montplaisir et al. (1994) found that leg 
movements during wakefulness were associated with EEG 
slowing. This finding led Montplaisir et al. to conclude 
that leg movements in RLS and PLMS required a critical 
level of cortical arousal to appear. They further 
suggested that this critical level of arousal appeared 
during drowsiness in wakefulness (as indicated by EEG 
slowing), and during arousal in sleep. Also of interest 
was a recent study by Montplaisir, Boucher, Gosselin, 
Poirier, and LaVigne (1996) which found that periodic K- 
alpha arousals in RLS patients persisted after L-DOPA 
treatment even though nocturnal leg movements had been 
eliminated. Montplaisir et al. suggested that these data 
indicated that the periodic EEG arousal (CAP) was a 
primary phenomenon in RLS patients.
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The data obtained by Terzano and colleagues on CAP in 
normal subjects is noteworthy in several respects. First, 
CAP sequences occupy a significantly greater percentage of 
both total sleep time and non-REM sleep time in older 
subjects (38 to 50% of NREM time) than in younger subjects 
(18 to 25% of NREM time; Terzano et al., 1987; Terzano and 
Parrino, 1993). As noted earlier, the average cycle 
duration is 40 seconds (the standard deviation is 
approximately 23 seconds); however, the duration is longer 
in Stage 1 (54 seconds) than in Stages 2, 3, and 4 (range 
38 to 39 seconds). CAP sequences were not identifiable in 
REM sleep. Approximately two thirds of CAP sequences 
occur during the first half of the night. The percentage 
of CAP time during each sleep stage was as follows: Stage
1 - 57%, Stage 2 - 21%, Stage 3 - 31%, Stage 4 - 16% 
(Terzano et al., 1985). Some aspects of this CAP data are 
similar to PLMS data (e.g. CAP being more frequent in 
older subjects and apparently not present in REM sleep), 
while others are not (e.g. the cycle duration and sleep 
stage percentages).
One serious problem with the definition and scoring 
of CAP as developed by Terzano and his colleagues is that 
arousals caused by apneas and PLMs and the subsequent 
return of normal sleep EEG activity would be (and are)
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scored as CAP cycles. Thus, based on the scoring system 
developed by Terzano et al. (1985), no distinction is made 
between spontaneous periodic arousals, and those caused by 
specific events occurring during sleep. Both types of 
arousals would be scored as Phase A of CAP sequences. As 
mentioned above, Montplaisir et a l . (1996) found that
periodic arousals persisted in RLS patients even after leg 
movements had been eliminated with L-DOPA treatment. 
Although this did suggest that the arousals might be a 
primary phenomena, Montplaisir et al. also noted that PLMs 
recorded during a baseline night were associated with 
arousals only 49% of the time. Moreover, when the 
movements were associated with arousals, the arousals 
followed the leg movements 65% of the time (indicating 
that the movements generally caused the arousals). In 
summary, the scoring of arousals associated with apneas 
and PLMs as part of CAP sequences seems somewhat 
questionable. None-the-less, CAP is one of only two 
periodic phenomena discussed in this review which has 
actually been documented to be associated with RLS and 
PLMS (Montplaisir et al., 1994; Terzano et al., 1995).
Summary and Integration 
The four phenomena discussed above, Mayer waves, B 
waves, periodic respiration, and cyclic alternating
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pattern are related in several important ways. First, as 
noted above, two or more of these phenomena often occur 
simultaneously, both in human patients and in experimental 
animals. Second, as it will be discussed in more detail 
below, all of these phenomena are mediated by the 
brainstem reticular formation. Third, with the possible 
exception of Mayer waves, all of these phenomena are more 
likely to appear during sleep (or in patients with 
supramedullary neurological damage) than wakefulness.
The neural centers that mediate vasomotor functions, 
respiration, and cortical arousal are all located within 
the brainstem and are either coextensive with or receive 
input from several nuclei of the reticular formation. The 
brainstem vasomotor centers include a pressor region which 
begins rostrally in the pons (just below the cerebellar 
peduncles) and ends caudally in the medulla at about the 
level of cuneate nucleus (Gebber, 1980). At the level of 
the pons, the pressor region extends across the entire 
brainstem, but at the pontine/medullary junction the 
depressor region begins (it extends to caudal levels of 
the medulla), and occupies medial areas of the brainstem, 
while the pressor region flanks its lateral borders (see 
Gebber, 1980, Figure 1, p. H144). In the dorsoventral 
plane, both regions occupy almost the entire dorsoventral
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extent cf the brainstem at rostral levels, then become 
limited to the medial portions of the brainstem at the 
level of the medulla. These regions occupy fairly large 
areas within the brainstem, and are coextensive with the 
caudal pontine nucleus, the gigantocellular reticular 
nucleus, the parvocellular reticular area (which is just 
lateral to the gigantocellular reticular nucleus in the 
medulla), and the lateral reticular nucleus.
The respiratory centers are much more limited in 
their extent, and consist of two dorsomedially located 
dorsal respiratory groups which contain primarily 
inspiratory neurons, and two ventrolaterally located 
ventral respiratory groups which contain primarily 
expiratory motor neurons (Ganong, 1995; pp. 615-616).
Both groups begin rostrally near the level of the obex, 
but the ventral respiratory groups extend caudally about 
twice the length of the dorsal respiratory groups to the 
caudal extent of the medulla. The dorsal respiratory 
groups are located in and near the caudal portions of the 
nucleus of the solitary tract, while the ventral 
respiratory groups are located in and near the nucleus 
ambiguus and the nucleus retroambiguus. Although these 
groups are not coextensive with nuclei of the reticular 
formation, stimulation of various reticular nuclei can
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exert an influence on them. Stimulation of the 
gigantocellular reticular nucleus in the medulla augments 
inspiration, while stimulation of the more laterally 
located parvocellular reticular area augments expiration 
(Barr and Kiernan, 1993). Orem (1994) has suggested that 
the reticular formation comprises part of the anatomical 
substrate for the so-called wakefulness stimulus on 
respiration. The decreased ventilatory response to C02 
that is observed during sleep (Birchfield and Sieker,
1959) is one manifestation of this respiratory wakefulness 
stimulus system. In addition to these medullary centers, 
there are also a pair of pneumotaxic centers located in 
the pons; these are coextensive with the medial 
parabrachial nucleus and the Kollicker-Fuse nucleus, and 
appear to mediate the duration of both the inspiratory and 
expiratory phases of respiration (Ganong, 1995, pp. 616- 
617; Orem, 1994). Finally, there are several areas on the 
ventral surface of the medulla that are chemosensitive 
zones, the most well documented of these being the 
ventrolateral medullary surface (Millhorn and Eldridge, 
1986) . Neurons in this area project to (and influence) 
both respiratory centers and vasomotor centers (Millhorn 
and Eldridge, 1986) .
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The concept of the ascending reticular activating 
system (ARAS) was first proposed by Moruzzi and Magoun 
(1949), and was based on studies in which it was shown 
that electrical stimulation of the brainstem reticular 
formation exerted a potent arousing influence on cortical 
activity. This initial work showed that stimulation of 
the reticular formation along almost all of its entire 
rostrocaudal extent (i.e. mesencephalon to medulla) could 
elicit EEG activation. Later studies have shown that the 
mesencephalic reticular neurons are most responsible for 
this arousing effect (Steriade, 1996; Steriade, Oakson, 
and Ropert, 1982; Steriade, Ropert, Kitsikis, and Oakson, 
1980) .
Thus, vasomotor activity, respiration, and cortical 
arousal are all mediated by or influenced by the activity 
of the brainstem reticular formation. Because neurons in 
the reticular formation are extensively interconnected 
(Barr and Kiernan, 1993), it is perhaps not surprising 
that two or more of the periodic phenomena discussed above 
often occur simultaneously. The issue of how this happens 
(and why it is more likely to happen during sleep or coma) 
is less clear, but there are at least two possible 
explanations.
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The first of these is the idea that neurons in the 
brainstem reticular formation have an intrinsic slow 
rhythm that becomes relatively more prominent when 
afferent input to the reticular formation is reduced. 
Because the reticular formation receives substantial 
afferent input from both the cerebral cortex and from 
sensory systems (Barr and Kiernan, 1993; Carpenter, 1991, 
pp. 127-128), it is reasonable to assume that a 
substantial reduction of this input occurs during sleep 
and coma. The postulated inherent slow rhythm would then 
become more prominent, and would be reflected by 
oscillations in the physiologic parameters that are 
mediated by the reticular formation (e.g., arousal, 
respiration, cardiovascular activity). Unfortunately, as 
noted earlier, there is very little direct experimental 
evidence to support the idea of an intrinsic slow rhythm 
in the firing rate of reticular neurons, although the 
studies mentioned earlier (Manohar et al., 1972; Oakson 
and Steriade, 1982; Steriade et al., 1982, Vertes, 1979) 
did find that most reticular neurons have a substantial 
decrease in their firing rate in non-REM sleep as compared 
to wakefulness and REM sleep.
The second explanation is that wakefulness exerts a 
tonic excitatory influence on the vegetative functions of
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respiration, cardiac activity, vasomotor functions, and 
arousal level. This wakefulness stimulus is transmitted 
from the cortex and peripheral sensory systems to the 
brainstem areas mediating the physiologic functions 
mentioned above by the reticular formation. Removal of 
this wakefulness stimulus could then be expected to alter 
the properties of one or more of the components of the 
systems regulating these functions, making the system more 
unstable and more likely to oscillate. Each system could 
be affected independently, or they could all be affected 
simultaneously, depending on the nature and extent of the 
removal of the wakefulness stimulus (i.e. whether it was 
due to natural sleep or to neurological damage).
With respect to respiration, the wakefulness stimulus 
is thought to be mediated by both the reticular formation 
and by various forebrain structures, including the limbic 
system and motor areas in the frontal lobe (Orem, 1994). 
The removal of this stimulus is reflected physiologically 
by a decrease in ventilation during sleep (by about 15% in 
slow wave sleep; Krieger, 1994), a reduced ventilatory 
response to C02 during sleep (Birchfield and Sieker,
1959), and by the observation that it is easier to produce 
post-hyperventilation apnea during sleep or anesthesia 
than it is during wakefulness (Krieger, 1994). In
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contrast to these data (which indicate a reduction in 
respiratory drive during sleep) are the findings of Brown 
and Plum (1961) in patients with coexisting neurological 
damage and Cheyne-Stokes respiration. These investigators 
found that neurological damage caused an increased 
ventilatory response to C02, and suggested that 
supramedullary centers exerted a tonic inhibitory 
influence on respiratory sensitivity. None-the-less, the 
idea that the sensitivity of the respiratory system varies 
during the sleep-wake cycle in neurologically intact 
subjects is a well established principle (Krieger, 1994; 
Orem, 1994). Moreover, as mentioned above, when sleep 
related changes in chemosensitivity and blood gas levels 
are simulated in computer models of the respiratory 
system, periodic breathing can be produced (Khoo et al.,
1982) .
This idea of the wakefulness stimulus can be extended 
to the regulation of cardiac and vasomotor functions (and 
to a somewhat lesser extent, arousal). Unfortunately, 
there is no available information on changes in vasomotor 
functions and reflexes (such as the baroreceptor reflex or 
the cardiovascular response to passive tilting) during the 
sleep-wake cycle. Although there are reductions in both 
heart rate and blood pressure during non-REM sleep
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(Littler et al., 1975; Millar-Craig et al., 1978), like 
the changes in ventilation, these may be secondary to 
reductions in metabolic rate during non-REM sleep, rather 
a reflection of an altered sensitivity of the 
cardiovascular system or one of its components. Despite 
this, the regulation of vasomotor tone is similar to the 
regulation of respiration in that both are based on 
negative feedback systems; thus, removal of the 
wakefulness stimulus might be a plausible explanation for 
the sleep-related appearance of B-waves and Mayer waves in 
addition to that of periodic breathing.
As mentioned earlier, it is common for one or more of 
the periodic phenomena discussed above to occur together. 
However, only the cyclic alternating pattern and B-waves 
have been shown to be present in patients with RLS and/or 
PLMS (Droste et al., 1996; Montplaisir et a., 1994;
Terzano et al., 1995), and it is unclear from these
studies how these phenomena might actually cause RLS 
and/or PLMS, or if in fact they even do. The periodic
cerebral ischemia theory of RLS proposes that B-waves are
present in both RLS and PLMS, and that they represent the 
one of the primary physiologic mechanisms responsible for 
producing both disorders. Because B-waves and Mayer waves 
are closely related (i.e. both are vasomotor waves), it is
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possible that Mayer waves might also be present in RLS and 
PLMS. Despite this possibility, neither Mayer waves nor 
periodic breathing have been shown to be present in 
RLS/PLMS. Thus, the question of why B-waves and CAP would 
be present in RLS/PLMS while Mayer waves and/or periodic 
breathing would not be present has to be asked. 
Unfortunately, there is no easy answer to this question. 
One possibility is that removal of the wakefulness 
stimulus affects vasomotor functions to a greater extent 
than respiratory functions because the vasomotor centers 
of the brainstem are more extensive than those of the 
respiratory centers. Another possibility is the brainstem 
centers that generate vasomotor waves and CAP are more 
intimately associated with the reticular formation than 
are the centers that generate the respiratory rhythm.
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Regulation of Cerebral Blood Flow: A Selected Review
Some Basic Principles 
In this section, the anatomy and innervation of the 
cerebral vasculature will be briefly reviewed, and two 
basic principles which govern the regulation of cerebral 
blood flow, autoregulation and flow-metabolism coupling, 
will be briefly discussed.
Blood flows into the cranial vault via two pairs of 
arteries: the internal carotid arteries which are located
anteriorly, and the vertebral arteries which are located 
posteriorly. At the level of the caudal pons the paired 
vertebral arteries join to form the basilar artery.
Before bifurcating near the mammillary bodies to form the 
posterior cerebral arteries, the basilar artery gives off 
three large pairs of arteries: the anterior inferior
cerebellar arteries, the labyrinthine arteries, and the 
superior cerebellar arteries. The anterior inferior 
cerebellar arteries and the superior cerebellar arteries 
supply the cerebellum, while the labyrinthine arteries 
supply the cochlea and vestibular apparatus (Carpenter, 
1991, pp. 449-455). Each of the posterior cerebral 
arteries divides into two main branches, the posterior 
temporal artery which supplies part of the ventral surface 
of the temporal lobe, and the internal occipital artery
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which supplies most of the occipital lobe and part of the 
parietal lobe.
Just lateral to the optic chiasm, the internal 
carotid arteries bifurcate to form the middle and anterior 
cerebral arteries. The middle cerebral arteries are the 
largest of the cerebral arteries, and represent a 
continuation of the internal carotid arteries. Each 
middle cerebral artery passes between the medial aspect of 
the temporal lobe and the insula, and gives off a large 
number of branches which emerge from the lateral sulcus. 
These branches spread out over the surface of the cerebral 
cortex, and supply large areas of the frontal, temporal, 
and parietal lobes.
The anterior cerebral arteries course medially from 
their point of origin, and then enter the longitudinal 
cerebral fissure at the midline. The anterior arteries 
are also connected to one another at the midline via the 
small anterior communicating artery. Each anterior 
cerebral artery gives off three large branches and two 
small branches. The large branches include the 
frontopolar artery which supplies medial areas of the 
frontal lobe, the callosomarginal artery which supplies 
the paracentral lobule and dorsal parts of the cingulate 
gyrus, and the pericallosal artery which supplies medial
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areas of the parietal lobe. The small branches of the 
anterior cerebral artery include the medial striate artery 
which supplies the anterior parts of the caudate nucleus 
and internal capsule, and the orbital artery which 
supplies orbital and medial surfaces of the frontal lobe.
The posterior cerebral arteries are connected to the 
internal carotid arteries via the posterior communicating 
arteries near the point where the carotids bifurcate into 
the middle and anterior cerebral arteries. This 
connection between the posterior cerebral arteries and the 
internal carotids along with the connection between the 
two anterior cerebral arteries forms the Circle of Willis. 
There is normally little or no blood flow through the 
posterior communicating arteries because the pressure in 
the posterior cerebral arteries and the internal carotids 
is nearly equal (Carpenter, 1991, p. 440) .
At the boundaries of the territories perfused by the 
three major cerebral arteries in each hemisphere there are 
arterial anastomoses through which the terminal branches 
of the three major cerebral arteries are interconnected 
(Edvinsson, MacKenzie, and McCulloch, 1993, p. 13; Vander 
Eecken and Adams, 1953). These anastomoses are believed 
to provide a collateral source of blood flow to ischemic 
regions in the event of an occlusion in one of the major
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arteries (Vander Eecken and Adams, 1953). It has also 
been suggested that the presence of these anastomoses 
makes the boundaries of the territories perfused by the 
major cerebral arteries dynamic rather than static (Van 
der Zwan, Hillen, Tulleken, Dujovny, and Dragovic, 1992). 
For example, Van der Zwan and Hillen (1990) found that the 
boundary of the anterior cerebral artery could be shifted 
laterally over the cortical surface by a distance of three 
centimeters if the perfusion pressure in the middle 
cerebral artery was suddenly reduced. Van der Zwan et al. 
(1992) also found that there was a large degree of 
individual variability in the territories perfused by the 
major cerebral arteries.
The venous drainage of the brain is accomplished 
primarily via a series of large venous sinuses which are 
actually spaces between the periosteal and meningeal 
layers of the dura mater. These dural sinuses receive and 
drain a large number of smaller veins which run along the 
surface of the cerebral cortex. The principle venous 
sinuses include the superior sagittal sinus which runs 
along the longitudinal cerebral fissure in the falx 
cerebri, and the paired transverse sinuses which run 
between the cerebellum and occipital lobe in the tentorium 
cerebelli. Other dural venous sinuses include the
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inferior sagittal sinus, and the occipital sinus. The 
transverse sinuses run laterally and rostrally around the 
cerebellum, and then turn medially to become the sigmoid 
sinuses. The sigmoid sinuses empty into the large paired 
internal jugular veins. The internal jugular veins also 
drain the cavernous sinus, a network of veins which 
surrounds the pituitary gland and other diencephalic 
structures. The cavernous sinus receives blood from 
several large veins and sinuses including the middle 
cerebral veins, the sphenoparietal sinuses, and the 
superior and inferior petrosal sinuses (Carpenter, 1991, 
p. 457).
The innervation of the cerebral vasculature has been 
reviewed in detail by Edvinsson, MacKenzie, and McCulloch 
(1993, pp. 57-91) and can be briefly summarized as 
follows. Sympathetic (vasoconstrictor) fibers arise from 
the superior cervical and stellate ganglia, and release 
the neurotransmitters norepinephrine and neuropeptide Y. 
Parasympathetic (vasodilator) fibers arise from the 
sphenopalatine and otic ganglia, and release acetylcholine 
and vasoactive intestinal polypeptide. There is also a 
serotonergic innervation that arises from the raphe 
nuclei; these fibers exert a vasodilatory influence when 
vascular tone is high and a vasoconstrictor influence when
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vascular tone is low. Finally, there are sensory nerve 
endings on the cerebral vessels which have their cell 
bodies in the trigeminal ganglia. These fibers release 
substance P, neurokinin A, and calcitonin gene-related 
peptide from their axon terminals which synapse on second 
order neurons in the brainstem.
It should also be pointed out that dopamine Dl and D2 
receptors have been localized within all layers of 
cerebral arteries, and stimulation of these receptors 
causes vasodilation (Amenta, Ricci, and Vega, 1991; Bacic, 
LJematsu, McCarron, and Spatz, 1991). The source of the 
dopamine that binds to these receptors is unclear (e.g. 
axonal endings, CSF), although there is some evidence of a 
dopaminergic innervation of the cerebral vasculature 
(Edvinsson, MacKenzie, and McCulloch, 1993, pp. 231-233). 
In addition, dopamine receptors have also been localized 
in peripheral vessels, particularly those in the kidney, 
and are believed to play a role in the regulation of fluid 
volume (Lokhandwala and Chen, 1994).
The brain is one of several organs in which blood 
flow is autoregulated. This term refers to the ability of 
an organ to regulate its own blood flow (Ganong, 1995; p. 
542). In the case of the brain, it specifically refers to 
the observation that fairly constant levels of total blood
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flow are maintained over a range of systemic blood 
pressure values which vary from 60 to 140 mm Hg 
(Edvinsson, MacKenzie, and McCulloch, 1993, p. 553;
Ganong, 1995, p. 563). Above and below those blood 
pressure values, total cerebral blood flow varies directly 
with the perfusion pressure. There are three theories 
concerning the mechanism of autoregulation: the myogenic
theory, the metabolic theory, and the neurogenic theory 
(Edvinsson et al., 1993, pp. 565-570).
The myogenic theory proposes that autoregulation is 
an intrinsic property of vascular smooth muscle.
According to this theory, as pressure on the arterial wall 
increases, there is a corresponding contraction of the 
vascular smooth muscle (and vice-versa with respect to 
decreased pressure). As noted by Edvinsson et al. (1993, 
pp. 565-567), the intracellular and biochemical mechanisms 
by which this is accomplished remain unclear. Despite 
this, the myogenic theory of autoregulation is generally 
well accepted.
The metabolic theory of autoregulation proposes that 
global (or regional) reductions in blood flow result in an 
increased production of vasodilator metabolites which act 
to restore blood flow to adequate levels. This theory is 
thus a flow-metabolism coupling theory, although it should
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be noted that the term fiow-metabolism coupling is 
generally used to refer to regional variations in cerebral 
blood flow that occur in response to regional changes in 
metabolic rate. Although this theory can potentially 
explain the dilatory response to reduced blood flow, it 
does not address the contractile response to increased 
blood flow (and/or increased systemic blood pressure) , and 
is thus an incomplete explanation for the phenomenon of 
cerebral autoregulation.
The neurogenic theory of autoregulation proposes that 
the innervation of the cerebral vasculature (including the 
sensory nerve fibers and possibly peripheral baroreceptors 
as well) mediates autoregulation. According to this 
theory, perfusion pressure is sensed by either peripheral 
baroreceptors or cerebrovascular sensory nerves, and 
corresponding adjustments in vascular tone are effected by 
the autonomic innervation. However, when either afferent 
or efferent fibers in these putative circuits are 
sectioned, the capacity for autoregulation remains 
(McCulloch, 1988), so this theory has poor empirical 
support. In summary, cerebral blood flow is maintained at 
fairly constant levels accross a wide range of perfusion 
pressures. This autoregulation of cerebral blood flow is
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thought to be effected primarily by intrinsic contractile 
properties of cerebrovascular smooth muscle.
Another well-established principle of cerebral blood 
flow is that regional blood flow is closely coupled to 
regional metabolic rate. The same principle also applies 
to global cerebral blood flow and metabolism. The 
existence of flow-metabolism coupling has been established 
by a number of indirect lines of evidence {e.g. cerebral 
blood flow is low during coma and high during seizures; 
see Reivich, 1974, for a review), and by more rigorous 
studies in which it has been demonstrated that there are 
high correlations between regional glucose or oxygen 
uptake and regional blood flow when both variables are 
measured simultaneously {Buxton and Frank, 1997; Ginsberg, 
Smith, Wachtel, Gonzalez-Carvajal, and Busto, 1986). Most 
of the early work in which both cerebral metabolic rate 
and cerebral blood flow were measured simultaneously was 
done with either anesthetized animals or under resting 
conditions with human subjects. More recent studies using 
positron emission tomography and functional MRI have found 
that cerebral blood flow apparently increases to a much 
greater extent than cerebral metabolism (i.e. oxygen 
uptake) during functional activation produced by 
somatosensory stimulation and mental tasks (Buxton and
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Frank, 1997; Fox and Raichle, 1986; Hedera et al., 1995). 
These studies were initially interpreted as representing 
an uncoupling of flow and metabolism during functional 
activation (Fox and Raichle, 1986). However, Buxton and 
Frank (1997) recently presented a mathematical model of 
cerebral oxygen delivery in which small increases in 
metabolic rate were accompanied by relatively large 
increases in blood flow. This model indicated that the 
disproportionately large increases in cerebral blood flow 
seen during functional activation are in fact reflective 
of a tight coupling (rather than an uncoupling) of 
cerebral blood flow and metabolism. Critical to the model 
was the assumption that increases in cerebral blood flow 
are effected primarily by increases in blood flow velocity 
rather than by recruitment of previously closed 
capillaries (see Buxton and Frank for evidence in support 
of this assumption) . The increased flow velocity lowers 
the amount of oxygen that can be extracted from the blood 
because the transit time of the blood through the 
capillaries is decreased. This model is important because 
it can explain the confusing earlier evidence of flow- 
metabolism uncoupling during functional activation.
It is generally well-accepted that flow-metabolism 
coupling is mediated by an increased regional (or global)
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production of metabolic by-products which have a 
vasodilatory effect (Edvinsson et al., 1993, pp. 567-568; 
Ganong, 1995, pp. 560-563) . These so-called vasodilator 
metabolites include hydrogen ions (lowered pH), decreased 
0-, increased CO;, potassium ions, and adenosine, although 
it is unclear which of these is most important (Edvinsson 
et al., 1993, pp. 567-568). Hypoxia and hypercapnia that 
result from systemic disease, such as COPD or anemia, can 
also produce increases in cerebral blood flow (Wade and 
Brown, 1988).
Poiseuille's Law and Flow Through Bifurcations
In this section the effects of arterial bifurcations 
and artery length and radius on blood flow will be 
discussed. These concepts will be applied to blood flow 
in the cerebral arteries (and to the pathogenesis of RLS 
and PLMS) in the next major section.
The flow (F) of blood through arteries and veins, 
like the flow of any fluid in a tube, is affected by 
several variables. These include the length (L) and 
radius (r) of the artery (or tube) , the viscosity (ti) of 
the blood (or fluid), and the difference in pressure 
between the two ends of the artery (or tube).
Poiseuille's law is a formula which describes how these 
variables affect the amount of flow. This formula is
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usually cited in most physiology texts (e.g. Ganong, 1995, 
p. 530), and is written as follows:
F = (PA - Pg) x (ti/8) x (1/ri) x (r4/L)
where PA - P5 is the difference in pressure between the
proximal and distal ends of the tube.
Flow is also equal to the pressure difference (PA - 
Pa) divided by the resistance to flow (R) (Ganong, 1995, 
p. 531). Thus, resistance to flow (R) can also be 
described in terms of the variables mentioned above; that 
is, the length and radius of the artery (or tube) and the 
viscosity of the blood (or fluid). The equation which 
describes how these variables affect resistance is written 
as follows (Ganong, 1995, p. 531):
R = 8tjL/7tr4.
It can be seen from this equation that resistance to blood 
flow is directly proportional to the length (L) of an 
artery and inversely proportional to fourth power of the 
radius of the artery (r4) . This means that small 
increases in the radius of an artery greatly reduce the 
resistance to flow, while small decreases in the radius 
greatly increase the resistance to flow.
Blood flow in arteries is laminar under normal 
conditions (Ganong, 1995, p. 530). Laminar flow refers to
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the observation that blood flows in a straight line 
fashion, but with different velocities in different 
concentric "layers" or lamina within an artery. For 
example, the flow velocity is highest in the middle of the 
artery, and lowest (approaching zero) at the artery wall. 
The lamina closest to the wall of the artery is referred 
to as the boundary layer. A variety of factors can cause 
disruptions or turbulence in the normal laminar flow.
These include increased flow velocity, increased vessel 
diameter, increased fluid density, and decreased blood 
viscosity. The Reynolds number is a ratio which indicates 
how likely turbulence is to occur. It takes into account 
the variables listed above, and is computed as follows:
Re = pDV/t|
where p equals the density of the fluid, D equals the 
diameter of the tube, V equals the flow velocity, and ti 
equals the viscosity of the fluid. Under normal 
conditions in straight vessels, turbulent flow usually 
does not occur until the Reynolds number reaches about 
2300, a value which is usually not attained (Nichols and 
O'Rourke, 1990).
Turbulent flow and other types of non-laminar flow 
such as eddying commonly occur at arterial bends and
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bifurcations (Fox and Hugh, 1966; Friedman, Deters, Mark, 
Bargeron, and Hutchins, 1983; Roach, 1977). The turbulent 
flow and eddying that occurs at these sites has been shown 
to produce regions of both high and low shear stress, and 
both high and low shear stress have been implicated in the 
genesis and progression of atherosclerosis (Friedman et 
al, 1983; Gutstein, Schneck, and Marks, 1968; Nichols and 
O'Rourke, 1990; Roach, 1977). Friedman et al. (1983) 
performed flow studies in casts of human aortas, and 
demonstrated that individual differences in arterial 
geometry could account for the variations in shear stress 
that were observed. Roach and her colleagues proposed 
that turbulent flow and points of increased shear stress 
at bifurcations in the Circle of Willis could lead to the 
development and progression of cerebral aneurysms and 
cerebral atherosclerosis (Roach, 1977; Roach, Scott, and 
Ferguson, 1972).
The turbulence and eddying that occurs at 
bifurcations also impedes the flow of blood through these 
regions by decreasing the area available for blood flow. 
This has been clearly demonstrated in studies which have 
shown that blood flows around, rather than through, the 
regions of eddying and turbulence (Crowe and Krovetz,
1966; Fox and Hugh, 1966).
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There are several geometrical features of 
bifurcations that appear to increase the probability that 
turbulence and eddying will occur. These include 
branching asymmetry and increases in the angle of the 
bifurcation (Crowe and Krovetz, 1972; Roach, Scott, and 
Ferguson, 1972). Because these factors affect turbulence, 
they also affect flow rates. Crowe and Krovetz (1972) 
demonstrated that flow rates in arterial branches were 
greater in symmetrical "Y" type bifurcations than in the 
daughter branches of asymmetrical "parent vessel/daughter 
vessel" bifurcations, a finding which indicated that more 
turbulence and flow disruption occurred in the asymetrical 
bifurcations. Crowe and Krovetz (1972) also showed that 
as the angle of bifurcation in an asymetrical bifurcation 
increases, the flow rate through the ''daughter vessel" 
decreases. Similarly, Roach et al. (1972) showed that the 
critical Reynolds number (the Reynolds number at which 
turbulence develops) decreased as the angle of bifurcation 
increased, although it should be noted that these results 
were for symetrical "Y" type bifurcations. Taken 
together, these results suggest that individual 
differences in arterial geometry can affect both flow rate 
and shear stress. Friedman et al. (1983) suggested that
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such individual differences might represent a risk factor 
for the development of coronary atherosclerosis.
Cerebral Blood Flow Purina Sleep
A fairly large number of studies have investigated 
cerebral blood flow during normal human sleep and 
wakefulness. Overall, the results are very consistent 
with respect to global cerebral blood flow levels during 
the different sleep-wake states. During non-REM sleep 
there is a progressive decrease in total cerebral blood 
flow with the lowest levels being achieved in slow-wave 
sleep (SWS)(Masden et al., 1991; Sakai, Meyer, Karacan, 
Derman, and Yamamoto, 1980; Townsend, Prinz, and Obrist, 
1973). The average decrease in cerebral blood flow during 
SWS (as compared to wakefulness) in these studies was 25% 
in the Masden et al. study, 28% in the Sakai et al. study, 
and 10% in the Townsend et al. study. All of these 
studies used the 133Xe inhalation technique to assess 
cerebral blood flow. During REM sleep, total cerebral 
blood flow was either not significantly different from 
levels observed during wakefulness (Masden et al., 1991) 
or was higher than that observed during wakefulness (Sakai 
et al., 1980; Townsend et al., 1973).
Similar results have been reported for cerebral 
metabolic rate as assessed by positron emission tomography
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of [ :aF]2-fluoro-2-deoxy-D-glucose uptake. For example, 
Buchsbaum et al. (1989) reported that glucose uptake 
decreased by 23% during NREM sleep as compared to 
wakefulness, while there was only a small non-significant 
decrease during REM sleep. Maquet et al. (1990) found a 
43.8% percent decrease in glucose uptake during SWS as 
compared to wakefulness, and a small non-significant 
increase during REM sleep.
The similar pattern of results obtained for cerebral 
blood flow and cerebral glucose utilization have been 
cited as evidence that flow-metabolism coupling of 
cerebral blood flow persists throughout the sleep-wake 
cycle (Masden et al., 1991). However, there are a number 
of findings which suggest that cerebral blood flow and 
cerebral metabolism are not tightly coupled during sleep, 
particularly during non-REM sleep. The most important of 
these is that end-tidal C02 levels increase during non-REM 
sleep as compared to wakefulness (Sakai et a l ., 1980; 
Townsend et al., 1973). If flow-metabolism coupling 
persisted during non-REM sleep, then one would expect an 
increase in cerebral blood flow in response to these 
increased C02 levels. The decreased cerebral blood flow 
in spite of these increased C02 levels suggests that there 
is a decrease in cerebral vasomotor responsiveness to C02
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during non-REM sleep (Sakai et al., 1980). Results 
similar to these were obtained in a recent study which 
near-infrared spectroscopy (NIRS) was used to assess 
cerebral oxygenation and blood flow accross an entire 
night in seven normal healthy subjects (Hoshi, Mizukami, 
and Tamura, 1994). NIRS is a technique in which cerebral 
oxyhemoglobin, deoxyhemoglobin, and total hemoglobin can 
be measured. The total hemoglobin measurement is thought 
to correlate well with total blood volume (Brazy, 1991), 
and as such, reflects total cerebral blood flow. The 
study by Hoshi et al. showed that oxyhemoglobin decreased 
during non-REM sleep, and returned to waking levels during 
REM sleep. Despite the decrease in cerebral oxygen 
levels, total blood flow (as assessed by the total 
hemoglobin measurement) decreased during non-REM sleep. 
Hoshi et al. (1994, p. 257) concluded that their results 
suggested that "the flow-metabolic coupling mechanism is 
reset to a new level during sleep."
A similar conclusion was reached in another recent 
study in which transcranial Doppler sonography was used to 
assess cerebral blood flow velocity across the entire 
night (Hajak et al., 1994). As noted earlier, cerebral 
blood flow velocity correlates fairly well with cerebral 
blood flow volume. Hajak et al. found that cerebral blood
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flow velocity decreased during progressively during non- 
REM sleep (as compared to pre-sleep baseline values), and 
increased during REM relative to the preceding non-REM 
sleep values. These results were similar to those 
obtained by the authors cited above who used the :33Xe 
technique to assess cerebral blood flow. However, Hajak 
et al. observed several things which suggested that flow- 
metabolism coupling was not present during sleep. First, 
there was a general trend for flow velocity to decrease 
across the night. For example, flow velocity values for 
both non-REM and REM sleep were found to decrease as 
compared to those seen in earlier sleep cycles. Second, 
during spontaneous or provoked arcusals, there was often 
no response in flow velocity, and in many subjects there 
was actually a decrease in flow velocity in response to 
the arousal. Finally, upon awakening in the morning, 
there was often a delay of up to 30 minutes before flow 
velocity returned to the pre-sleep baseline level. These 
findings led Hajak et al. (1994, p. 11) to conclude that 
"these results imply an uncoupling between cerebral 
electrical activity and cerebral perfusion during 
sleep...".
Like Hajak et al., Hoshi et al. (1994) also used 
auditory stimulation to study the cerebral blood flow
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response to arousal during sleep. Hoshi et a l . observed 
large disproportionate increases in total hemoglobin 
during arousais produced during REM sleep, and relatively 
smaller increases during non-REM sleep. They noted that 
the large arousal-induced increases in blood flow during 
REM sleep were gualitatively similar to those observed by 
other authors during wakefulness in response to 
somatosensory stimulation (e.g. Fox and Raichle, 1986), 
while the arousal-induced increases in blood flow during 
non-REM sleep were much more subdued.
The findings suggestive of flow-metabolism uncoupling 
during non-REM sleep has led several of the authors in the 
studies cited above to conclude that cerebral blood flow 
during sleep may be regulated primarily by central 
neurogenic mechanisms rather than by local flow-metabolism 
coupling (Hajak et al, 1994; Hoshi et al., 1994, Sakai et 
al., 1980; Townsend et al., 1973). As it will be noted in 
the section to follow, these changes in the regulation of 
cerebral blood flow across the sleep-wake cycle can 
potentially explain the sleep-related appearance of both 
RLS and PLMS.
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Periodic Cerebral Ischemia: A New Theory for the
Pathogenesis of Restless Legs Syndrome and 
Periodic Limb Movements in Sleep
Anatomical Considerations Regarding the Paresthesia j.n RLS
As reviewed above, the pathogenic theory of RLS that
has the best support is the reduced peripheral blood flow
theory. However, because the same arteries that supply
blood to the lower legs also supply the feet (Moore, 1985,
p. 432), this theory cannot explain the restriction of the
paresthesia in RLS to the lower legs. Despite this, there
is much evidence to suggest that some impairment in
circulation is present in RLS and PLMS (e.g. the
prevalence data, most of the treatment data, the transient
nature of the symptoms). Thus, it is reasonable to assume
that the paresthesia in RLS is caused by a transient
"functional" lesion of neurons mediating somatosensation
in the legs, and further that this transient "functional"
lesion is caused by ischemia (and/or hypercapnia)
secondary to insufficient blood flow somewhere in the
nervous system.
If this assumption is taken as an initial working
hypothesis, the next question that arises is which neurons
that mediate somatosensation in the lower legs undergo
this reduction in blood flow. Because there are only four
levels of neurons in the somatosensory pathway (for
142
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proprioception and light touch), there are a limited 
number of possible answers to this question. The primary 
or first order sensory neurons in this pathway have their 
cell bodies in the dorsal root ganglion of lumbar and 
sacral regions of the spinal cord (Carpenter, 1991, pp. 
75-77). The peripheral processes of these neurons form 
the peripheral nerves, while the central processes (axons) 
ascend in the fasiculus gracilis of the dorsal funiculus 
of the spinal cord. These axons synapse on second order 
neurons in the ipsilateral nucleus gracilis of the 
medulla. The second order neurons in the nucleus gracilis 
send axons to the ventral posterolateral nucleus of the 
contralateral thalamus via the medial lemniscus. The 
third order neurons in the ventral posterolateral nucleus 
of the thalamus then project to fourth order neurons in 
the leg area of the somatosensory cortex of the 
ipsilateral cerebral hemisphere. This area of the 
somatosensory cortex is located almost entirely within the 
longitudinal fissure dorsal to the cingulate gyrus (see 
Carpenter, 1991; Figure 13.13, p. 404). Thus, to produce 
the paresthesia in RLS, a reduction in blood flow would 
probably have to occur in one of the following areas; the 
fasiculus gracilis in the spinal cord, the nucleus 
gracilis in the medulla, the ventral posterolateral
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nucleus in the thalamus, and/or the leg area of the 
somatosensory cortex.
These possibilities can be narrowed down further if 
PLMs are taken into account. Recall that Smith (1985) 
observed that PLMs appear to be spontaneously occurring 
Babinski responses. As noted earlier, Babinski responses 
occur only when pyramidal tract damage is present (van 
Gijn, 1978; 1995). Thus, like the paresthesia in RLS,
PLMs may also be caused by a ischemia-induced "functional" 
lesion, but in the case of PLMs, the lesion would need to 
be somewhere within the pyramidal tract (and it would need 
to occur periodically). A large percentage of the cell 
bodies of axons that form the pyramidal tracts are located 
within the motor and premotor areas of the frontal cortex; 
however, many other pyramidal tract neurons are located in 
the somatosensory cortex on the post-central gyrus of the 
parietal lobe (Carpenter, 1991, pp. 94-96). Thus, a 
"functional" lesion of the leg area of the somatosensory 
cortex could cause both the waking paresthesia of RLS, and 
the PLMs that are seen in these patients during sleep.
If the blood supply to this area, and to the other 
areas listed above, is examined it becomes clear that the 
most likely site of the reduced blood flow responsible for
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the paresthesia in RLS (and for PLMs) is in the leg area 
of the somatosensory cortex.
Beginning first with the fasiculus gracilis, it can 
be seen from Gilman and Newman (1992; Figure 27, p. 93) 
that this area is supplied by branches arising from the 
posterior spinal arteries. However, the posterior spinal 
arteries also supply the fasiculus cuneatus which mediates 
somatosensation in the trunk and upper extremities, so it 
is unlikely that reduced flow in these arteries could 
produce a paresthesia restricted primarily to the lower 
legs. Moreover, the pyramidal tracts descend in the 
lateral funiculus, which is supplied by the anterior 
spinal artery (see Gilman and Newman, 1992; Figure 27). 
Thus, in order to account for both RLS and PLMS via a 
spinal blood flow mechanism, one would have to postulate 
reduced flow in all of the major spinal arteries. If this 
did happen, it seems likely that the symptoms produced 
would be restricted to the dermatomes that were affected, 
and would include symptoms in addition to those typically 
reported in RLS (e.g. numbness, pain, tingling). However, 
as noted earlier, the anatomical distribution of the 
paresthesia in RLS does not match any of the body areas 
supplied by any dermatome.
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If RLS were due to reduced blood flow in the region 
of the nucleus gracilis (which is located in the dorsal 
medulla), then the artery most likely to be involved would 
be the posterior inferior cerebellar artery. In addition 
to supplying the cerebellum, this artery supplies parts of 
the medulla (Carpenter, 1991; see Figure 14.3, p. 439). 
However, the pyramidal tracts (which are located in the 
ventral medulla) are supplied by branches from the 
anterior spinal artery near its point of origin. Thus, to 
account for both RLS and PLMS via reduced blood flow to 
the medulla, one would have to postulate reduced blood 
flow in at least two arteries. Moreover, the regions of 
the medulla supplied by these arteries are very likely to 
include other body areas in addition to the lower legs.
If the paresthesia in RLS was due to reduced blood 
flow in the ventral posterolateral nucleus of the 
thalamus, then the arteries most likely to be involved 
would be the anterior choroidal artery (which arises from 
the anterior cerebral artery) and the thalamogeniculate 
arteries (which arise from the posterior cerebral artery; 
see Carpenter, 1991; Figures 14.9 and 14.10, p. 447). 
However, the ventral posterolateral nucleus of the 
thalamus is a relatively small nucleus which also mediates 
somatosensation in the trunk and upper limbs. Thus, it
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seems unlikely that reduced blood flow in this area could 
produce a paresthesia restricted primarily to the lower 
legs. In regards to PLMS, it can be seen from Carpenter 
(1991; Figure 14.10) that the pyramidal tracts descend 
near the thalamus in the internal capsule. However, it 
can also be seen in Carpenter (1991; Figure 14.10) that 
the internal capsule is supplied by both the anterior 
choroidal artery and by other branches from the middle 
cerebral artery. Therefore, in order to account for both 
RLS and PLMS via reduced blood flow in the region of the 
thalamus and internal capsule, one would have to postulate 
that blood flow would be reduced in several arteries.
The course of the anterior cerebral artery and its 
major branches are best seen in mid-sagittal sections of 
the brain (e.g. see Carpenter, 1991; Figure 14.5, p. 442), 
while the territory perfused by this artery is best seen 
in coronal and mid-sagittal sections (see Gilman and 
Newman, 1992; Figure 76, p. 267, for a coronal section 
showing the territory perfused by the anterior cerebral 
artery). If one compares the somatosensory cortex for the 
leg (see Carpenter, 1991, Figure 13.13) with mid-sagittal 
and coronal views of the territory perfused by the 
anterior cerebral artery, it can be seen that the distal 
territory of the callosomarginal branch of the anterior
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cerebral artery roughly corresponds to the somatosensory 
area for the legs. The more proximal territory of the 
callosomarginal branch of the anterior cerebral artery 
corresponds to the motor area for the legs. Thus, if 
blood flow were preferentially reduced in the 
callosomarginal branch of the anterior cerebral artery, 
one would expect to see symptoms of leg paresthesias, and 
in addition, one would expect that this reduced flow might 
produce a transient "functional"' pyramidal tract lesion.
A careful examination of figures presented in 
Carpenter (1991; Figure 13.13) and Gilman and Newman 
(1992; Figure 76) shows that the territory perfused by the 
callosomarginal branch of the anterior cerebral artery 
includes the entire lower extremity, including the feet. 
Thus, the familiar question of why the paresthesias in RLS 
occur primarily in the lower legs but not the feet arises 
again. The answer to this question can be found in the 
data presented by Van der Zwan and Hillen (1990). These 
authors demonstrated that the territories perfused by the 
major cerebral arteries were dynamic, and could shift 
(i.e. contract or expand) if the perfusion pressure 
suddenly dropped in one of the major arteries. Thus, if 
blood flow was preferentially reduced in the 
callosomarginal branch of the anterior artery, one could
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expect that the core area of the territory perfused by 
this artery would experience the greatest reduction in 
blood flow and the most severe ischemia. An examination 
of the figures mentioned above (Carpenter, 1991, Figure 
13.13; Gilman and Newman, 1992, Figure 76) shows that the 
core area perfused by the callosomarginal branch of the 
anterior cerebral artery roughly corresponds to the lower 
legs and does not include the somatosensory cortex for the 
feet or lower torso/upper thigh. Therefore, reduced blood 
flow in this artery could explain why the paresthesia in 
RLS is restricted to the lower legs excluding the feet.
In summary, if one assumes that the basic pathology 
of both RLS and PLMS involves some impairment of blood 
flow, then it can be argued that the most likely artery 
and location for this impairment in blood flow is the 
distal territory perfused by the callosomarginal branch of 
the anterior cerebral artery. This argument forms the 
basis of the periodic cerebral ischemia theory of RLS and 
PLMS.
Some Additional Questions
Even if one accepts the argument presented above, 
several additional questions or problems arise as to how 
such a reduction in blood flow might occur. The first of 
these questions concerns the issue of how blood flow could
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 5 0
be preferentially reduced in a single branch of one of the 
three major cerebral arteries. The second question 
concerns the issue of how such an abnormal decrease in 
blood flow could continue, to an extent sufficient to 
produce paresthesia, without eliciting a rapid 
compensatory increase in cerebral blood flow. The third 
question concerns the issue of why such changes apparently 
begin during wakefulness in RLS patients, but do not begin 
until sleep is achieved in PLMS patients. The fourth and 
final question concerns the periodicity of PLMs both 
during wakefulness (in RLS patients) and sleep (in PLMS 
patients).
The first question mentioned above is the most 
important. The Periodic Cerebral Ischemia theory of RLS 
and PLMS asserts, as argued in the section above, that 
both disorders are caused by periodic reductions in 
cerebral blood flow that are largest in the distal 
territory perfused by the callosomarginal branches of the 
anterior cerebral arteries. The answer to the question of 
how this could happen can be found in the information 
presented earlier about the effects of bifurcations and 
artery length and radius on resistance to blood flow: 
both increasing the length of an artery and decreasing its 
radius result in an increased resistance to blood flow.
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An examination of Figure 14.5 in Carpenter (1991) shows 
that the anterior cerebral artery and its callosomarginal
branch are relatively long arteries whose most distal
territories lie a long way from the point of origin of the
anterior cerebral artery. Although it is not depicted as
such in Carpenter's figure, the anterior cerebral artery 
has the smallest radius of the three major cerebral 
arteries (e.g. see Moore, 1985, Figure 7.77, p. 880). The 
nature of the bifurcations present in the anterior 
cerebral artery and its branches also contribute to the 
proposed preferential reduction in blood flow in the 
callosomarginal branch of the anterior cerebral artery. 
Recall that the amount of blood flow into the daughter 
branch of an asymmetrical bifurcation is lower than the 
flow in the main trunk (Crowe and Krovetz, 1972) .
Moreover, two studies have shown that as the angle of 
bifurcation increases, the region of turbulence or 
probability of turbulence in the daughter branch 
increases, with a corresponding decrease in total flow 
through the daughter branch (Crowe and Krovetz, 1972;
Roach et al., 1972). An examination of figures presented 
in Carpenter (1991; Figure 14.3 and 14.5) shows that the 
anterior cerebral artery has several asymmetrical 
bifurcations. The first of these is its point of origin
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where it branches off as a daughter branch from the 
internal carotid/middle cerebral artery. The second 
bifurcation occurs where the anterior communicating artery 
branches off from the anterior artery. Finally, the 
callosomarginal branch is a daughter branch of the 
anterior cerebral artery, and the callosomarginal branch 
has several bifurcations prior to terminating in its most 
distal territory. The combination of these bifurcations 
and the long length and small radius of the anterior 
cerebral artery and its branches could thus result in a 
relative reduction in blood flow that is greatest in the 
distal territory perfused by the callosomarginal branch of 
the anterior artery. Another likely possibility that may 
contribute to the development of both RLS and PLMS in 
certain individuals is that there is probably a 
significant variation among individuals in the three 
factors listed above: length and radius of the anterior
cerebral artery, and the angle of its bifurcations. Thus, 
certain individuals might be at an increased risk of 
developing RLS and/or PLMS because of their individual 
arterial geometry.
The second question concerns the issue of why the 
proposed reduction in blood flow and subsequent ischemia 
are not corrected before they proceed to an extent
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sufficient to produce RLS and PLMS symptoms. The answer 
to this question can be found in the data presented above 
which suggests that flow-metabolism coupling and cerebral 
vasomotor responsiveness to C02 are greatly reduced during 
non-REM sleep (Hajak et al., 1994; Hoshi et al. , 1994; 
Sakai et al., 1980; Townsend et al., 1973). All of the 
authors in these four studies suggested that cerebral 
blood flow during sleep was regulated primarily by central 
neurogenic mechanisms rather than by flow-metabolism 
coupling. Thus, the presence of ischemia in a relatively 
small area of the cerebral cortex (one not involved in the 
regulation of cerebral blood flow during sleep) might not 
be sufficient to provoke a compensatory increase in 
regional or global cerebral blood flow.
In regards to the third question listed above, the 
Periodic Cerebral Ischemia theory of RLS and PLMS proposes 
that the same pathology operates in both disorders, with 
the major difference between the two disorders being that 
the abnormalities of cerebral blood flow (i.e. shift from 
flow-metabolism coupling to central neurogenic control 
with high amplitude B-wave activity) begin during 
wakefulness in RLS, but not until sleep is achieved in 
PLMS. The shift in how cerebral blood flow is regulated 
in RLS is proposed to occur when triggered by prolonged
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motor inactivity (perhaps with some associated drowsiness) 
rather than by sleep itself. There is some limited 
evidence to support this assertion. First, Montplaisir et 
al. (1994) found periodic slowing in the EEG of RLS 
patients during a Forced Immobilization Task administered 
while the patients were awake. While this is not direct 
evidence of B-wave activity, the close association of CAP 
and B-wave activity suggests that B-wave activity may very 
well have been present. Second, Oakson and Steriade 
(1982) found that mesencephalic reticular formation 
neurons had periodic oscillations in their firing rates 
with periods varying between eight and twelve seconds.
The pertinent finding of interest in their study was that 
these oscillations occurred only during non-REM sleep and 
during quiet wakefulness without movement. Finally, at 
least two studies which used transcranial Doppler 
sonography to test for the presence of B-waves in normal 
subjects found that these oscillations were present during 
wakefulness (Diehl et al., 1991; Mautner et al., 1989). 
Thus, it is not unreasonable to posit that a shift in the 
regulation of cerebral blood flow from a regional flow- 
metabolic coupling mechanism to a central neurogenic 
mechanism (with B-wave activity) can be precipitated by 
prolonged motor inactivity during wakefulness.
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The fourth question concerns the periodicity of PLMs, 
and a possible periodicity of RLS sensory symptoms. The 
Periodic Cerebral Ischemia theory of RLS and PLMS proposes 
that high amplitude B-waves during prolonged motor 
inactivity and non-REM sleep are a constant feature of the 
cerebral hemodynamics of RLS and PLMS patients. This 
oscillation in total cerebral blood flow (coupled with the 
anatomical and geometrical features peculiar to the 
anterior cerebral artery) causes a periodic cerebral 
ischemia that is greatest in magnitude in the distal 
territory of the callosomarginal branch of the anterior 
cerebral artery. This periodic ischemia produces both the 
sensory and motor symptoms of RLS (which are predicted to 
be periodic in nature), and a periodic "functional" lesion 
of the pyramidal tracts that is sufficient to cause the 
spontaneous occurrence of a Babinski response (i.e. to 
cause a PLM). As noted earlier, several investigators 
have found that the leg movements that occur during 
wakefulness in RLS patients may be periodic (e.g. 
Montplaisir et al., 1994). One prediction of this theory 
that has not been directly tested is that the paresthesias 
in RLS should occur in a periodic fashion similar to PLMs. 
This hypothesis actually does receive some support from 
the study of Pelletier et al. (1992), which found that
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sensory events in RLS patients were almost always 
accompanied by waking PLMs. Unfortunately, no specific 
data regarding the periodicity and duration of the sensory 
events experienced by the subjects were presented by these 
authors.
Although it is proposed that high amplitude B-wave 
activity is one of primary abnormalities in RLS/PLMS, 
another possibility is that total cerebral blood flow is 
lower (perhaps due to excessive vasoconstriction), while 
B-wave amplitude is the same. If this were the case, then 
periodic cerebral ischemia would still occur at the B-wave 
troughs. Although this is possible, it seems unlikely for 
several reasons. First, during wakefulness, total 
cerebral blood flow is tightly regulated, and the brain is 
very sensitive to hypoxia (e.g. unconsciousness results in 
as little as ten seconds if the blood supply to the brain 
is cut off, Ganong, 1995, p. 564). Second, if total blood 
flow were abnormally low, one would probably see a variety 
of neurological and cognitive symptoms suggestive of 
ischemia. Third, studies of B-wave activity in normal 
subjects (Diehl et al., 1991; Droste et al., 1993; Newell 
et al., 1992) have found large individual differences in 
B-wave amplitude (e.g. from + 10 to 30 percent of the mean 
flow velocity), so it has already been demonstrated that
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some individuals have B-waves that are much larger in 
amplitude than others. Thus, it is proposed that there 
are two pathologies in RLS and PLMS patients which 
contribute to producing a periodic ischemia which is 
greatest in the distal territory of the callosomarginal 
branch of the anterior cerebral artery: 1) abnormally
large amplitude B-waves, and 2) abnormal structural 
geometry in the anterior cerebral artery and its branches.
The Periodic Cerebral Ischemia Theory of RLS and PLMS
The arguments presented above can be briefly 
summarized into the following statement of the Periodic 
Cerebral Ischemia theory of RLS and PLMS.
It is proposed that both RLS and PLMS are caused by a 
combination of sleep-related changes in the regulation of 
cerebral blood flow and the unique anatomical features of 
the anterior cerebral artery and its branches. These 
factors combine to produce a periodic cerebral ischemia 
which is greatest in magnitude in the distal territory 
perfused by the callosomarginal branch of the anterior 
cerebral artery. This cortical territory contains the 
somatosensory and motor cortices for the legs; the central 
core of this territory overlaps well with bodily areas in 
which RLS paresthesias most commonly occur (i.e. the lower 
legs excluding the feet). The sleep-related changes in
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cerebral blood flow, referred to above, include a shift 
from a local flow-metabolism coupling control mechanism to 
a central neurogenic control mechanism. Associated with 
the central neurogenic control of cerebral blood flow are 
high amplitude B-waves (i.e. oscillations in total 
cerebral blood volume). These B-waves are proposed to be 
significantly higher in amplitude among persons who have 
RLS and PLMS than in those who do not, and to begin during 
inactive wakefulness in RLS patients and after sleep onset 
in patients with PLMS alone.
The periodic ischemia in the motor and somatosensory 
cortices of the leg area occurs during both wakefulness 
(in RLS patients) and non-REM sleep (in PLMS patients and 
most RLS patients). During wakefulness, this periodic 
ischemia produces the waking sensory and motor symptoms of 
RLS. During non-REM sleep, the ischemia produces a 
periodic "functional lesion" of the pyramidal tracts which 
results in the spontaneous occurrence of a Babinski 
response. This Babinski response equates to the observed 
PLM. PLMs are not generally seen in REM sleep for two 
reasons: first, because of the generalized muscle atonia 
seen in this sleep stage (Kanamori et al., 1980), and 
second, because total cerebral blood flow during REM sleep
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is similar to that seen in wakefulness (e.g. Townsend et 
al., 1973) .
As was done for the existing major pathogenic 
theories of RLS and PLMS presented earlier, an attempt 
will be made to see how well the Periodic Cerebral 
Ischemia of RLS and PLMS can account for the major 
features of both disorders.
The restriction of paresthesias in RLS to the lower 
legs excluding the feet can be explained by the 
observation that the territories perfused by the cerebral 
arteries are dynamic and can contract when the perfusion 
pressure falls. It is suggested that this occurs in the 
callosomarginal branch of the anterior cerebral artery, 
with the result that only the central core of this 
territory (which includes the somatosensory areas for the 
lower legs but not the feet) is affected.
The precipitation of RLS symptoms by inactivity can 
be explained by the observation that prolonged inactivity 
may trigger a shift in how cerebral blood flow is 
regulated (from a local flow-metabolic coupling mechanism 
to a central neurogenic control mechanism). Associated 
with this shift to a central neurogenic control of 
cerebral blood flow are high amplitude B-waves and a
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reduced cerebral vasomotor responsiveness to vasodilator 
metabolites, including C02.
The relief of RLS symptoms by vigorous activity can be 
explained by suggesting that such activity causes a shift 
from the central neurogenic control of cerebral blood flow 
back to the flow-metabolism coupling control seen in 
normal active wakefulness. The vigorous leg activity in 
particular causes increased metabolism in the sensory and 
motor cortices for the legs, with a subsequent increase in 
cerebral blood flow to this region. This increased blood 
flow alleviates the ischemia that was causing the 
symptoms.
The circadian and sleep-related appearance of RLS and 
PLMS can be explained by suggesting that there is a normal 
tendency for the control of cerebral blood flow to shift 
to a central neurogenic control mechanism in the evening 
and during sleep.
The higher than normal prevalence of RLS and PLMS in 
the various patient groups mentioned above can be 
explained by the observation that most of these disorders 
are associated with either anemia or circulatory 
impairments. Thus, persons with these disorders already 
have a tendency towards insufficient oxygen delivery to 
the body and brain.
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The effectiveness of the various drugs reviewed above 
in treating RLS and PLMS can be explained by the 
observations that several of them appear to improve 
circulation, including cerebral blood flow, directly (e.g. 
correction of anemia, dextran, L-DOPA, clonidine, 
sclerotherapy) while others (benzodiazepines, opioids, 
anti-convulsants) may reduce the amplitude of B-waves by 
acting directly on brainstem vasomotor areas (e.g. see 
Haxhiu et al., 1989).
Finally, the periodicity of PLMS can be explained by 
the suggestion that it is high amplitude B-wave activity 
that underlies the generation of these movements.
The issue of treatment of RLS and PLMS deserves 
further comment. If the above theory is correct, then the 
best type of drug to treat both RLS and PLMS would clearly 
be some type of vasodilator. In addition, if the above 
theory is correct, it would suggest that the effectiveness 
of most of the drugs currently used to treat RLS and PLMS 
is the result of their hemodynamic effects. This 
underscores the fact that the mechanism by which these 
drugs exert their beneficial effects on RLS and PLMS 
remains unknown. Although some of these drugs do have 
hemodynamic effects (e.g. vasodilation in the case of L- 
DOPA, reduced cardiac output and peripheral vasodilation
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in the case of cionidine, and reduction of B-wave 
amplitude in the case of some benzodiazepines), these are 
usually not the primary effect of these drugs. In 
addition, many of these drugs have significant undesirable 
side effects. For example, L-DOPA has been shown to cause 
morning rebound and daytime augmentation of symptoms in 
RLS patients, while cionidine and anti-convulsants may 
cause excessive sedation. Benzodiazepines are respiratory 
depressants, and as such, are contraindicated in many 
older patients who have sleep-related breathing disorders. 
Although vasodilators are not without side effects and 
risks, they are probably as safe or safer than many of the 
drugs currently being used to RLS and PLMS. In summary, 
if the PCI theory of RLS and PLMS can be shown to be 
correct, major changes in the treatment of these disorders 
would be indicated.
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Study Overview. Technical Considerations, and Hypotheses 
The study described below represented an attempt to 
test several of the main tenets of the theory outlined 
above. Near infrared spectroscopy (NIRS) was utilized to 
assess regional cerebral hemoglobin oxygen saturation and 
total cerebral blood flow in RLS patients, PLMS patients, 
and normal controls. Studies were conducted during both 
wakefulness (during a Suggested Immobilization Test, SIT) 
and sleep. It was predicted that the RLS patients would 
have B-wave activity during both wakefulness and sleep, 
and that the amplitude of those oscillations would be 
greater than those in normal controls. In addition, it 
was predicted that the PLMS patients would have B wave 
activity primarily during sleep, and that the amplitudes 
of their B-waves during sleep would be greater than those 
in normal controls, but not significantly different from 
those in RLS patients. Although it was considered likely 
that both PLMS patients and normal controls would have 
some B-wave activity while awake (i.e. during the SIT), it 
was predicted that the waking B-wave amplitude in both 
groups would be significantly lower than that seen in the 
RLS patients. It was also predicted that the B-wave 
troughs would be associated with the sensory and motor
163
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symptoms experienced by the RLS patients during 
wakefulness, and with PLMs experienced by both RLS and 
PLMS patients during sleep.
Before proceeding, some methodological aspects of 
NIRS assessment of regional cerebral oxygenation, and some 
specific details of the cerebral oximeter used (the 
Somanetics INVOS 3100A Cerebral Oximeter) need to be 
briefly reviewed. Several excellent reviews of NIRS and 
the Somanetics oximeter have been published (Dujovny, 
Slavin, Cui, Lewis, and Ausman, 1994; McCormick et al., 
1991; Slavin et al., 1994), and the following review is 
based on these sources.
The wavelengths of light used in NIRS are in the 
near-infrared range (700 to 1100 nanometers), and easily 
penetrate most human tissues, including bone. The light 
can penetrate to a depth of several centimeters, and is 
absorbed by several molecules, including oxyhemoglobin, 
deoxyhemoglobin, and oxidized cytochrome c oxidase 
(McCormick et al., 1991). Both oxyhemoglobin and 
deoxyhemoglobin can absorb near-infrared light throughout 
the range of wavelengths used in NIRS (typically 7 00 to 
900 run), but oxyhemoglobin absorbs a greater percentage of 
photons at longer wavelengths (e.g. at about 900 nm), 
while deoxyhemoglobin absorbs a greater percentage of
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photons at shorter wavelengths (e.g. at about 700 nm). At 
a wavelength that is referred to as the "isobestic point" 
(803 nm in humans), the percentage of infrared light 
photons absorbed by both oxyhemoglobin and deoxyhemoglobin 
is the same, and the amount of light absorbed will 
correlate with total hemoglobin. Thus, absorption at the 
isobestic point can be used as a measure of total blood 
volume. If absorption at one other wavelength is obtained 
(e.g. 700 nanometers), the two measures can be compared to 
determine how much hemoglobin is "saturated" with oxygen.
The cerebral oximeter manufactured by the Somanetics 
corporation (Troy, Michigan) emits near-infrared light at 
two wavelengths: 730 and 805 nm (Ron Widman, personal
communication, June, 1997). This provides measures of 
total hemoglobin and deoxyhemoglobin, which are then used 
to compute regional oxyhemoglobin levels. The value, 
which is referred to as the "rS02 index" is then displayed 
on the oximeter's monitor, and can be also stored 
digitally, and/or sent to an analog chart recording 
device. The measure of total hemoglobin (i.e. absorption 
at the isobestic point) can also be stored digitally for 
later review and analysis. In addition, the oximeter has 
an event marker button, which allows the user to mark 
clinically relevant events. These marks are displayed on
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the monitor, and can also be stored digitally for later 
review.
The light emitter and sensors used with the 
Somanetics oximeter are unique in that they are designed 
in such a way as to provide a measure of oxyhemoglobin in 
brain tissue only. They are specifically designed so that 
the rS02 in both brain tissue and in the overlying bone 
and skin can be measured. This is accomplished by the use 
of two sensors which are located at different distances 
(30 and 40 mm) from the infrared light emitter. The 
sensor that is closer (at 30 mm) measures predominately 
extracerebral rS02 (i.e. in the scalp, bone, and 
meninges), while the sensor at 40 mm measures both 
cerebral and extracerebral rS02. The value obtained from 
the closer sensor is then subtracted from the value 
obtained from the more distant sensor, yielding a measure 
indicative of brain tissue rS02.
The term "rS02 index" is used (by the Somanetics 
corporation) to indicate that the displayed value is a 
measure of regional oxyhemoglobin which includes both 
arterial and venous oxyhemoglobin. It should not be 
confused with the signal measured by peripheral pulse 
oximetry, which is a measure of arterial oxyhemoglobin 
saturation only. The measure obtained by pulse oximetry
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is usually referred to as a Sa02 value (the lowercase "a" 
indicating "arterial"). Of the total blood volume in the 
brain, about 70 percent is venous blood (Mchedlishvilli, 
1986, pp. 55-60). Thus, the rS02 index, while measuring 
both arterial and venous oxyhemoglobin, has average values 
which are much closer to the oxyhemoglobin saturation of 
venous blood. For example, a normative study of 100 
subjects by Dujovny et al. (1992) found a mean rS02 index 
of 68.6%, and a standard deviation of 5.6%. The 
preponderance of venous blood within the brain does not 
affect the ability of the Somanetics cerebral oximeter to 
detect cerebral hypoxia (Duncan, Ruckley, and Wildsmith, 
1995; Williams, Picton, Hardy, Mortimer, and McCollum; 
1994). In fact, because cerebral hypoxia often results 
from circulatory insufficiency rather than from abnormally 
low arterial oxyhemoglobin values in the blood entering 
the brain (e.g. such as those that might be caused by 
respiratory disease), the ability of NIRS to measure 
venous oxyhemoglobin actually enhances its ability to 
detect cerebral hypoxia. A large number of clinical 
studies have demonstrated the usefulness of NIRS in 
detecting cerebral hypoxia (e.g. Duncan et al., 1995; 
Slavin et al., 1994; Williams et al., 1994).
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The sampling rate and data averaging algorithms used 
by the Somanetics oximeter also need be mentioned. The 
absorption data from both sensors is sampled at a rate of 
15 Hz. Instead of being displayed and updated 
continuously, the oximeter collects 50 data points (which 
takes 3.33 seconds), and then averages these data and 
outputs the result to the monitor. The processing and 
outputting of the 50 data points takes approximately one 
and half seconds, and during this time the oximeter does 
not sample absorption data. The result is that the rS02 
value displayed on the monitor, and all data points stored 
in memory, including the rS02 index and the total 
hemoglobin measure, are updated approximately once every 
five seconds (it should be noted that a published review 
of the Somanetics instrument, Dujovny et al., 1994, 
incorrectly stated that the instrument updates the rS02 
value once every four seconds). This data averaging 
technique has the potential to slightly attenuate changes 
in the absorption signal such as those that might occur 
during oscillations of cerebral blood flow (i.e. B-waves). 
If oscillations are present, data averaging can also shift 
the peaks and troughs of the signal, although the degree 
of shifting is dependent on both the number of data points 
averaged and the period of the oscillation. However, the
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data averaging window used by the Somanetics oximeter is 
only 3.3 seconds, which should result in only very minimal 
signal attenuation and shifting. The primary drawback to 
the Somanetics NIRS instrument (at least for purposes of 
the present study) is that only one data point can be 
obtained every five seconds.
The sensors supplied for the Somanetics oximeter are 
small (3.75 by 1.75 inches) and self-adhesive. They are 
typically placed on the forehead, and it is recommended 
that they not be placed over the midline in order to avoid 
oversampling venous blood from the mid-sagittal sinus.
The recommended placement location on the forehead 
positions the sensor over the frontal poles— areas which 
are perfused predominately by the middle cerebral artery. 
This recommended sensor location was used in the present 
study. Because B-waves are thought to reflect vasomotor 
activity that occurs simultaneously throughout the entire 
cerebral arterial tree, an assumption was made in the 
present study, that recording rS02 over the frontal poles 
would accurately reflect the rS02 changes that were 
occurring elsewhere in the brain, including those in the 
distal territory of the callosomarginal branch of the 
anterior cerebral artery. Thus, it was assumed that the 
recording location used in this study would not prevent
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valid tests of the experimental hypotheses from being 
conducted. None the less, it should be pointed out that 
the variables measured by the Somanetics oximeter (rS02 
and absorption at the isobestic point) are not direct 
measures of intracranial pressure or blood flow velocity, 
and at present it is unknown if these oximetry variables 
correlate with variables measured by other techniques that 
have been used to measure B-waves (intracranial pressure, 
blood flow velocity).
In the present study, the rSO- data was sent to both 
a personal computer, and to a polygraph chart recorder to 
be displayed along with several other physiologic 
variables being monitored. Unfortunately, despite the use 
of a voltage attenuater with the polygraph, the small 
changes in rS02 that were present were essentially not 
visible on the chart recording. It was initially hoped 
that changes in the rS02 signal would be visible on the 
chart recorder so that figures showing the relationship 
between the rS02 signal and sensory/motor events could be 
generated from the analog chart recording.
The proposed study included three groups of subjects: 
one group with moderate to severe RLS, one group with PLMS 
only, and one group of control subjects who are without 
any sleep complaints. Each subject underwent a Suggested
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Immobilization Test (SIT) lasting one hour, just prior to 
one full night of polysomnography. During the SIT, the 
subject was required to lie supine on the bed while 
attempting to remain completely still. This test was 
originally designed as a method of documenting the 
excessive motor activity that occurs in RLS patients 
during prolonged inactivity (Lorrain and Montplaisir,
1990). During the SIT, lower leg motor activity and 
several other physiologic variables were recorded 
polygraphically. Abnormal leg sensations were recorded by 
having the subjects depress a switch which placed a mark 
on the time line signal of the polygraph. The 
polysomnographic recordings included measurements of 
cerebral oximetry (rS0;) , EEC activity, eye movements 
(electrooculogram, EOG), submental electromyogram (smEMG) 
activity, air flow, respiratory effort, electrocardiogram, 
and muscle activity from the anterior tibialis muscles 
(atEMG).
The following experimental hypotheses were tested:
1) It was predicted that the RLS patients would have 
significantly greater sensory and motor indices (number of 
events per hour) during the SIT than the PLMS subjects and 
the control subjects, while no significant difference 
between the PLMS and control subjects were expected.
2) It was predicted that the RLS and PLMS patients would 
have significantly higher PLM indices than the control 
subjects, and more disturbed sleep as indicated by the
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following: Lower sleep efficiency, lower slow wave sleep 
percent, higher Stage 1 percent, more sleep stage changes 
per hour of sleep, more Stage 1 periods per hour of sleep, 
and more transient arousals per hour of sleep (the sum of 
the spontaneous and PLM arousal indices was used)• In 
addition it was predicted that the RLS patients would have 
significantly less total bed time during the recording 
period, and a significantly longer sleep onset latency, 
than the PLMS and control subjects.
3) It was predicted that the abnormal leg sensations in 
RLS patients during the SIT would be brief (averaging less 
than five seconds in duration) and periodic (at least 80 
percent of the total number would to conform to the 
scoring criteria currently in use for PLMS).
4) It was predicted that the mean peak to trough amplitude 
of the B-wave activity (in the rS02 index) in RLS patients 
during periods where symptoms were present during the SIT 
would be significantly greater than the mean amplitude of 
B-wave activity occurring in normal subjects and PLMS 
patients during the SIT. The B-wave amplitudes between 
the PLMS and control groups were not expected to differ 
significantly.
5) It was predicted that the mean peak to trough amplitude 
of the B-wave activity in RLS and PLMS patients during 
sleep (when PLMs were present) would be significantly 
greater than the mean peak to trough amplitude of B-wave 
activity during sleep in the normal control subjects. The 
B-wave amplitudes between the RLS and PLMS groups were not 
expected to differ significantly.
6) It was predicted that the sensory and motor events in 
RLS patients during the SIT would occur at the rS02 B-wave 
troughs, and that the average rS02 values occurring at the 
beginning of the sensory and motor events would be 
significantly lower than the average B-wave trough rS02 
values (or average rS02 values if no B-waves were present) 
of the PLMS and normal control subjects. Similarly, it 
was predicted PLMs during sleep would occur at rS02 B-wave 
troughs, and that the average rS02 values at the beginning 
of PLMs in the RLS and PLMS subjects would be 
significantly lower than the average B-wave trough rS02 
values (or average rS02 values if no B-waves were present) 
of the normal controls during sleep.
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7) It was predicted that in RLS and PLMS subjects, the 
average rS02 values occurring at the beginning of each 
sensory and motor event during the SIT, and at the 
beginning of each PLM during sleep, would be significantly 
lower than the average rS02 values occurring at the next 
peak of the B-wave cycle (or the highest value in the next 
40 seconds if no B-waves were present).
8) It was predicted that in RLS and PLMS patients, a 
significantly greater percentage of sensory and motor 
events during the SIT, and PLMs during sleep, would occur 
at a single point in the B-wave cycle (i.e. trough, peak, 
ascending limb, descending limb) rather than occurring 
randomly in the cycle.
Subjects
Subjects were nine patients with moderate to severe 
RLS (five males, four females, mean age 50.3 years), six 
patients with PLMS (four males, two females, mean age 49.2 
years), and eleven normal controls (five males, six 
females, mean age 4 6.2 years) who were without clinically 
significant sleep complaints or abnormal sleep/wake 
cycles. Two additional subjects were run, but excluded 
from the data analyses; one because of unacceptably poor 
signal quality readings in the rS02 data for most of the 
night, and one because she could not be classified as 
either a PLMS or control subject based on the criteria 
described below. In addition, the SIT data from one 
control subject were not used because he fell asleep 
repeatedly during the SIT. There were no significant 
differences among the groups in age (F 2, 23, = 0.41, p = 
. 67) .
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In order to be included in the RLS patient group, 
subjects had meet the International RLS Study Group 
criteria for RLS (Walters, 1995). Briefly, they had to 
report all four of the following characteristics: 1) A
desire to move the limbs, usually associated with 
paresthesias, 2) Motor restlessness, 3)Symptoms worse at 
rest with at least partial relief by activity, and 4) 
Symptoms had to be worse in the evening and/or night. A 
modification of the ASDA severity criteria for RLS 
(D.C.S.C., 1990) was used to define "severe" RLS. 
Specifically, RLS patients were included only if they meet 
the following modification of the D.C.S.C. criteria for 
"severe" RLS: 1) symptoms cause significant delay of
sleep onset, moderate disruption of sleep, and mild 
impairment of daytime functions, and 2) symptoms occur 
three or more times a week. Significant delay of sleep 
onset was defined as a sleep onset latency of thirty 
minutes or greater during nights when symptoms were 
present, while moderate disruption of sleep was defined as 
a total sleep time of six and half hours or less during 
nights when symptoms were present or a self-report of 
moderately disturbed sleep. This modification of the 
severity criteria was based on clinical experience which 
has shown that many patients have symptoms that are
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relatively frequent while being moderate in severity.
Seven of the nine RLS patients had been previously 
diagnosed with RLS by a physician, and six of these were 
being treated at the time they entered the study (three 
with L-Dopa, two with clonazepam, and one with 
propoxyphene). As per the study protocol, these subjects 
did not take their RLS medications on the day (and night) 
they participated in the study. All of these subjects 
obtained written approval from their physician to 
participate in the study, and to abstain from their 
medication for 24 hours. Phone interviews and a 42-item 
self-report questionnaire called the "Restless Legs 
Questionnaire" (Hurry, unpublished; see Appendix 1) were 
used to assist in making a probable diagnosis of RLS in 
the two patients who had not formally diagnosed with RLS, 
and also to confirm the diagnosis in those who had been 
previously diagnosed. Seven of the nine RLS subjects had 
PLMS while asleep.
It was initially proposed to require PLMS subjects to 
have ten or more PLMs per hour of sleep. However, because 
of the difficulty in finding and recruiting these 
subjects, one subject with a PLMi of seven was included 
(the other five subjects all had a PLMi of ten or more). 
PLMs were recorded and scored according to standard
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criteria (ASDA Atlas Task Force, 1993). Briefly, each 
movement had to be a 0.5 to 5.0 second burst of anterior 
tibialis EMG activity that was part of a sequence of at 
least four such movements, each of which were separated by 
more than 5 but less than 90 seconds. In order to be 
certain that only unambiguous PLMs were used in the data 
analyses, only those PLMs which occurred in a series of at 
least ten PLMs were used in the data analyses. All six of 
the PLMS subjects were recruited as normal controls; none 
had any complaint of insomnia or non-restorative sleep.
The normal control subjects did not have any 
significant sleep disturbances or excessive daytime 
sleepiness as indicated by their responses on the 
screening questionnaires listed below. They also reported 
having relatively normal and typical sleep/wake cycles; 
e.g., bedtimes after sunset, wake times soon before or 
after sunrise daily, with no more than two hours variation 
each day. Three of the control subjects had PLM indices 
of five or more (5.5, 5.6, and 6.0), but were included as 
controls because none of their movements occurred in a 
series of at least ten movements. Another subject who had 
a PLMi of 14.8 with no movements occurring in a series of 
least ten movements was excluded from the study because
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the highly variable IMIs of her movements cast doubt on 
whether or not they were actually PLMs.
Four subjects (one with RLS, two with PLMS, and one 
control) had an Apnea plus Hypopnea Index of ten or more 
(the AHIs were 10, 14, 16, and 22, all indicative of a 
mild or moderate disorder). In two of these subjects, the 
events occurred primarily in supine REM, in one subject 
the events occurred primarily in REM regardless of sleep 
position, and in one subject the events occurred primarily 
near sleep onset regardless of sleep position. Because 
the respiratory events in these subjects were not related 
to any observed PLMs, and because sufficient sleep time 
free from respiratory events occurred in these subjects, 
all four of these subjects were included in the data 
analyses.
As part of the subject screening and selection 
process, all subjects (patients and controls) completed 
the Sleep Disorders Inventory, a 64-item questionnaire 
used to screen for a range of sleep disorders (Waters, 
unpublished; see Appendix 1) . Each subject was also 
required to complete two weeks each of an 11-item Sleep 
Diary (filled out each morning; modified from Lacks,
1987), and a 15-item Daily Sleepiness Scale-Form D (Hurry 
and Waters, 1996; see Appendix 1) which was filled out
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each evening. These measures were used to rule out 
subjects with suspected sleep apnea syndromes, 
psychophysiological insomnia, narcolepsy, and other sleep 
disorders.
RLS patients were recruited by several methods, 
including a mention of the study in a local (Baton Rouge, 
LA) newspaper editorial column (Smiley Anders' column in 
The Advocate), notices placed at several local area 
department and grocery stores, letters describing the 
study that were sent to members of the local Restless Legs 
Syndrome Foundation Support Group, and a notice describing 
the study that was placed on the Psychology experiment 
sign-up board in Audubon Hall. The RLS patients who were 
receiving medication for their RLS were required to obtain 
written approval from their physician to temporarily 
withdraw from treatment before participating in the 
research project (for one day/night).
As noted earlier, all six of the PLMS subjects were 
recruited as normal control subjects; none had been 
previously diagnosed with PLMS, nor were any of them 
receiving any medication for any sleep-related problem.
The PLMS subjects were recruited from among the older 
L.S.U. undergraduate psychology students and parents of 
younger L.S.U. students enrolled in undergraduate
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psychology courses. PLMS subjects who were students 
themselves were given extra credit in their psychology 
courses for their participation in the study. PLMS 
subjects who were the parents of students were not 
directly compensated for their participation. However, 
their children were given extra credit in their psychology 
courses for their assistance in recruiting their parents 
as subjects for the study.
The normal subjects were also recruited from among 
the older L.S.U. students and parents of students enrolled 
in undergraduate psychology classes. As with the PLMS 
group, control subjects who were students themselves were 
given extra credit in their psychology courses for their 
participation in the study. Control subjects who were the 
parents of students were not directly compensated for 
their participation; instead, their children were given 
extra credit in their psychology courses for their 
assistance in recruiting their parents as subjects for the 
study. Near the end of the data collection period, 
approval was obtained from the Institutional Review Board 
to recruit control subjects with notices placed at local 
department and grocery stores, and to compensate these 
subjects with a $25.00 payment for their participation.
Two control subjects were recruited in this manner.
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Cancellations, no-shows, and last-minute rescheduling 
were a problem during the data collection period, and 
contributed to the low sample sizes achieved. In all, 
there were eleven instances of cancellations, no-shows, or 
last-minute rescheduling; almost all of these involved 
weekend nights.
The SIT and polysomnograms were conducted in the 
L.S.U. Department of Psychology's Psychophysiological 
Laboratory, which contained a ten by eleven foot sound- 
attenuated subject room, and a similarly sized instrument 
room. The subject room was furnished with a full-size bed 
(measuring approximately 54 by 75 inches), a recliner, a 
nightstand, a television and VCR, and two cabinets 
containing supplies. The room was also equipped an 
infrared lamp (mounted above the door) , and a JVC model 
TK-S240V video camera. These were used to monitor the 
subject visually during the recordings. The camera was 
connected to a Toshiba TVM-1202 12 inch black and white 
monitor which was located in the instrument room.
The cerebral oximeter used in the study was the 
Somanetics (Troy, Michigan) INVOS 3100A cerebral oximeter 
with software version V5.13X5. This device consisted of a 
small sensor (3.5 by 1.75 inches) that connected to a 
small (7.5 by 5.3 by 1.75 inch) preamplifier via a five
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foot cable. The Somanetics corporation loaned us two of 
these instruments for use in the study. The preamplifiers 
were located in the subject room, and were connected to 
the oximeters via the supplied fifteen foot cable. The 
oximeters were located in the instrument room, and were 
relatively small in size (13.6 by 12.3 by 6.4 inches). 
Analog output (a zero to ten volt signal of the rS02 
index) from the oximeter was sent to the J5 input of a 
Grass Instruments Model 7P122 low level DC amplifier with 
the signal amplitude reduced down to a maximum of one volt 
with a locally constructed voltage divider (instructions 
for making the voltage divider were provided by the 
Somanetics corporation). The digital output from the 
oximeter was sent to a Dell Optiplex GXi Pentium 
processor-based personal computer via a null modem cable. 
The Hyperterminal program included with Windows 95 was 
used to display and store the data on the computer. The 
data were retrieved for subsequent analysis by loading 
them into a spreadsheet program (Microsoft Excel).
Leg movement activity from both legs, abnormal leg 
sensations, one channel of EEG (C4/A1), nasal airflow, 
respiratory effort, and peripheral pulse oximetry were 
recorded during the SIT on a Grass Instruments (Quincy, 
Massachusetts) Model 7D polygraph. Specifically, anterior
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tibialis EMG was recorded from both legs using Grass 
Instruments 10 mm gold cup electrodes, and standard 
electrode site placements (ASDA Atlas Task Force, 1993). 
Each of the tibialis EMG signals was sent to a Grass 
Instruments Model 7P511 EEG amplifier, with the 
sensitivity set so that a slow 30 degree dorsiflexion and 
plantarflexion of the great toe produced an EMG burst that 
was 7 5% of the amplitude of the full scale deflection 
range of the pen. Leg sensations were recorded by having 
the subjects depress a signal marker that was connected to 
the power supply of the Grass polygraph via an eight foot 
cable. This signal was displayed on the time line of the 
chart recorder. EEG (C4/A1) was recorded with Grass 
Instruments 10 mm gold cup electrodes, with the signal 
sent to a Grass Instruments Model 7P511 EEG amplifier with 
the sensitivity set at 5 uV/mm. Nasal airflow was 
recorded with Rochester Electro-Medical "no casing" wire- 
type thermocouple which was taped beneath the nose. 
Respiratory effort was recorded with an EPM Systems 
(Midlothian, Virginia) "Resp-EZ respiratory belt. Both 
the airflow and respiratory effort signals were sent to 
Grass Instruments Model 7P511 EEG amplifiers, with the 
sensitivity settings varied to keep the waveform between 
50 and 75% of the full scale deflection of the
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oscillograph pen. Peripheral pulse oximetry was recorded 
with a Criticare Systems (Waukesha, WI) Model 504 PONI 
oximeter. The "clothespin-type" sensor supplied with the 
oximeter was attached to either the index or middle finger 
of the left hand. The analog output signal from the 
oximeter was sent to a Grass Instruments Model 7P122 low- 
level DC amplifier.
The polysomnograms were recorded on a Bio-Logic 
Systems Sleepscan computerized polysomnograph. The EEG, 
EOG, submental EMG, electrocardiogram, and tibialis EMG 
signals were transduced with Grass Instruments 10 mm gold 
cup electrodes. The airflow signal was recorded with an 
oral/nasal thermocouple manufactured by Pro-Tech Services 
(Woodinville, Washington). Respiratory effort was 
recorded with an EPM Systems "Resp-EZ" respiratory belt.
Procedure
All subjects were initially screened by phone to 
determine if they were likely to meet criteria for 
inclusion into the study. If they did, they were sent a 
packet of questionnaires containing two copies of the 
consent form (see Appendix 2) , the Sleep Disorders 
Inventory, the Daily Sleep Dairy, and Daily Sleepiness 
Scales (RLS patients also received the Restless Legs 
Questionnaire). These packets took two weeks to complete. 
After they were returned, all questionnaires were
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reviewed, and a final decision was made to either include 
or exclude each potential subject in/from the study.
Subjects selected for inclusion into the study were 
required to report to Audubon Hall at L.S.U. approximately 
three hours prior to their normal bedtime. In order to 
run the SIT as close as possible to a subject's normal 
bedtime, all electrodes and recording devices were 
attached prior to conducting the SIT.
The EEG electrode sites conformed to the
international "Ten/Twenty" system specified by Jasper 
(1958), and included electrodes at the following sites on 
the scalp and mastoids: Oz, Al, A2, C3, and C 4 . One
channel of EEG (C4/A1) was recorded on the Grass 
polygraph, while two channels (C3/A2, 0z/C3) were recorded 
on the Sleepscan. The C4/A1 and C3/A2 derivations are the 
standard bipolar derivations recommended by Rechtschaffen 
and Kales (1968) for recording sleep. The occipital 
derivation (0z/C3) was included so that alpha activity 
could be optimally visualized. Submental EMG was recorded 
by placing gold cup electrodes on the chin and over the 
masseter muscle. Electrooculogram was recorded by placing
gold cup electrodes at sites that were one centimeter away
from the outer canthus of each eye, with both electrodes 
referred to the Al electrode. The oral/nasal thermocouple
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was taped just under the nares with a hypoallergenic cloth 
tape (Dermicel, Johnson & Johnson). The electrocardiogram 
was recorded by placing one gold cup electrode near each 
shoulder just under the clavicle, thus approximating the 
Lead 1 ECG lead. Respiratory effort was recorded by 
placing the respiratory belts over the bedclothes just 
below the ribcage (approximately three inches above the 
naval). Regional cerebral hemoglobin oxygen saturation 
was recorded by placing the Somanetics self-adhesive
sensor on the forehead just lateral to the midline. The
left side of the forehead was used for all but four 
subjects. The right side was used for two RLS subjects 
who reported having worse symptoms in their left legs, and 
for two of the controls (to control for any possible 
hemispheric differences in blood flow and hemoglobin 
oxygen saturation). In three bald subjects (two controls 
and one PLMS subject) two recording sites were used for 
measuring cerebral oximetry: the forehead and the vertex
of the head. For the vertex recording sites, the sensor 
was placed on the same side as the forehead sensor, with
the long edge of the sensor at the midline, and the
midpoint of the sensor at the Cz site. The light emitter 
end of the sensor was placed anteriorly. This site should 
have placed the sensor over the sensory/motor cortex for
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the legs and torso. Anterior tibialis EMG was recorded 
with gold cup electrodes placed over the anterior tibialis 
muscle as specified by the ASDA Atlas Task Force (1993). 
EEG electrodes were attached to the scalp using collodion 
soaked gauze squares, which were dried with a small air 
blower. Gold cup electrodes attached to sites other than 
the scalp were secured with nypoallergenic cloth tape 
(Dermicel, Johnson & Johnson). All electrode sites in 
which Grass gold cup electrodes were used (EEG, EOG, 
submental EMG, ECG, tibialis EMG) were cleaned and 
slightly abraded with a pumice based soap (Omni-Prep, D.O. 
Weaver & Co.). The gold cup electrodes were filled with a 
conductive paste (Ten20, D.O. Weaver & Co.). The 
recording site for the Somanetics sensor was cleaned with 
an alcohol/acetone prep pad as per the manufacturer's 
recommendations. The EEG electrodes were removed in the 
morning with gauze soaked in an acetone/water solution.
After all electrodes and recording devices were 
attached (which took approximately one hour and forty-five 
minutes), the subjects were allowed to move around for 
several minutes, so that any restlessness that developed 
during the electrode hookup could be alleviated. The 
Suggested Immobilization Test (SIT) began with the subject 
being instructed to lie down quietly in the bed with eyes
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open, while attempting to remain completely still. The 
subjects were further instructed that if they felt as if 
they had to move, they should move as little as possible 
and for as short of a period of time as possible. Only 
one RLS subject actually had to get up out of bed during 
the SIT. The subjects were also instructed to depress the 
button on the hand-held event marker whenever they felt an 
abnormal sensation in their legs. During the SIT, the 
experimenter continuously monitored the polygraph and 
cerebral oximeter, and about once every 90 seconds 
simultaneously marked the time on both instruments by 
depressing the event marker on each. The time associated 
with the event mark in the oximetry data (which was 
displayed on the computer monitor) was subsequently noted 
on the polygraph chart recording. The SIT lasted for a 
period of 60 minutes.
Following the SIT, subjects were allowed to use the 
restroom, and then the lights were turned out for the 
night. A recording period of at least six hours was 
required during each PSG. During the recording, the 
experimenter marked each PLM by depressing the event 
marker on the oximeter. The oximeter time and Sleepscan 
epoch were also frequently marked and noted on the chart 
recording. After the PSG was terminated, the electrodes
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and other recording devices were removed, and the patient 
was asked to fill out a Daily Sleep Diary. They were then 
thanked for their participation, and allowed to go home.
The polysomnograms were scored manually using sleep 
stage criteria specified by Rechtschaffen and Kales 
(1968), arousal scoring criteria specified by the American 
Sleep Disorders Association (1992), apnea and hypopnea 
scoring criteria specified by Bliwise, Bliwise, Kraemer, 
and Dement (1984), and leg movement scoring criteria 
specified by the ASDA Atlas Task Force (1993). The 
following summary statistics were derived from the PSG 
data: total bed time expressed as a percentage of total
lights out time, sleep efficiency (i.e. total sleep time 
expressed as a percentage of total bed time), sleep onset 
latency (time in minutes from lights out until the first 
three consecutive minutes of sleep), percent Stage 1 
sleep, percent Stage 2 sleep, percent slow wave sleep 
(Stage 3 plus Stage 4 time expressed as a percentage of 
total sleep time), percent REM sleep (expressed as a 
percentage of total sleep time), number of PLMs per hour 
of sleep, number of apneas plus hypopneas per hour of 
sleep (the Apnea plus Hypopnea Index, AHI), number of 
transient and PLM-related arousals per hour of sleep (this 
arousal index included all arousals not related to
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respiratory events), number of sleep stage changes per 
hour of sleep, and number of Stage 1 periods per hour of 
sleep.
The SIT recordings were marked in five second epochs 
according to the time marks noted during the recording, 
and the time data in the computer data file. Each five 
second epoch was then scored for movement in each leg and 
for sensory events. This information was then entered 
into the spreadsheet data file containing the downloaded 
oximetry data.
It was originally proposed to hand score individual 
B-waves (using a locally derived set of criteria) as any 
wave occurring in a series of at least four waves with a 
period of between 15 and 120 seconds, and an amplitude of 
at least ten percent of the mean rS02. This initially 
proved to be far too time-consuming, so spectral analysis 
(using the "Proc Spectra" procedure in SAS) was used to 
determine wave periodicities, while hand scoring was used 
to measure wave amplitudes. Subsequently, B-wave 
wavelengths were scored by hand for the rS02 index in 
order to calculate the wave-to-wave change in wavelength.
To control for individual variability in the absolute 
value of the rS02 index, the average B-wave amplitudes for 
each subject were expressed as a percentage of the mean
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rSO; index for that subject. Wave amplitudes were much 
lower than the originally proposed ten percent value.
Wave periods were determined from the spectral analysis 
graphs (called periodograms) which plotted spectral 
density on the y-axis and wave period on the x-axis. 
Spectral density is an indicator of relative wave 
frequency and amplitude. The periodograms typically 
showed multiple peaks (varying in number from 2 up to 8 or 
more on occasion) in the 15 to 90 second range. A peak 
was defined as any point that was 17% or higher than each 
of the adjacent troughs (17% represents one sixth of the 
trough amplitude). For each subject, up to two peaks were 
counted in each of four 20 second ranges: 11 to 30
seconds, 31 to 50 seconds, 51 to 70 seconds, and 71 to 90 
seconds. The period axis was divided into these four 
ranges because there was a clear tendency for the spectral 
density value to increase as the period increased (most 
likely due to higher amplitudes in waves with longer 
wavelengths) . The 0 to 10 second range was excluded 
because 10 seconds represented the minimum wavelength that 
could be measured with the oximeter's 0.2 Hz sampling 
rate; thus, the periodograms contained no spectral density 
values in the 0 to 10 second range. Peaks were counted 
only if they were at least 17% higher in amplitude than
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the third highest peak in the twenty second range (both 
peaks were counted if no third peak was present). The 
periods associated with these peaks were estimated to the 
nearest second directly from the graphs.
For the analyses investigating where PLMs and SIT 
sensory and motor events occurred in the B-wave cycle, a 
set of scoring rules were developed (see Appendix 3) to 
determine if a given rS02 point was a trough, an ascending 
point, a peak, a descending point, or a stable point. For 
similar analyses with the total hemoglobin data, only four 
points were scored (trough, ascending, peak, descending) , 
because the data points varied on a much finer scale, and 
were never stable for more than two observations. This 
was in contrast to the rS02 data which could remain at the 
same value for much longer periods of time. To assess the 
reliability of these scoring rules, two scorers 
independently scored eight rS02 files and thirteen total 
hemoglobin files. The percent agreement between the two 
scorers was 99% for the rS02 files and 92% for the total 
hemoglobin files.
If any subject had respiratory events during the PSG, 
then the oximetry data recorded during the event, and one 
minute prior to and after the event, were excluded from 
analysis. Similarly, if a normal control subject did have
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 9 2
PLMs during the PSG, the oximetry data throughout the PLM 
sequence(s) were excluded from the data analyses.
B-wave amplitudes and periods were scored for the 
entire SIT period for all subjects (no RLS subject had any 
substantial period during the SIT without any symptoms) . 
For the sleep data in PLMS subjects, B-wave amplitudes and 
periods were scored during all PLM series that contained 
at least ten PLMs each. Three of the thirteen subjects 
who did have PLMS had one such PLM series, seven had two 
series, two had three series, and one had four series.
The rS02 data (e.g. wave amplitudes, rS02 at PLMs) were 
averaged across all periods for each subject, with the 
duration of each series being used to weight the data 
points for each series. To obtain the rS02 data in non- 
PLMS subjects, single 60-minute sections of sleep were 
used for three subjects, and two 30-minute sections of 
sleep were used for eleven subjects. These sections of 
sleep were specifically selected to exclude awakenings and 
major arousals associated with sleep position changes, and 
were also matched to the sleep cycle of the sleep periods 
selected for the PLMS subjects (e.g. first, second, third, 
etc 90-minute sleep cycle).
Statistical Analyses
Because of the small sample sizes, and the number of 
tests needed to analyze all the questions of interest, an
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alpha level adjustment procedure (described below) was 
employed. The hypotheses stated above were divided into 
two groups which differed in their importance with respect 
to testing the PCI theory of RLS and PLMS, and with 
respect to the nature of the dependent variables involved. 
The most important hypotheses tested were those concerning 
group differences in the rS02 index during the SIT and 
PSG, the analyses concerning within subjects differences 
in the rS02 index at the beginning of RLS/PLMS symptoms 
compared to the rS02 index occurring at the B-wave peaks, 
and the analyses concerning within subjects differences in 
the percentage of RLS sensory/motor events and PLMs 
occurring at different points in the B-wave cycle. The 
hypotheses of secondary importance were those concerning 
group differences in the SIT and PSG variables.
Differences in these variables were expected to occur 
(based on the procedures used to define the groups), but 
were not directly relevant to tests of the PCI theory of 
the pathogenesis of RLS and PLMS.
In order to use alpha levels that reflected the 
differing importance of the experimental hypotheses, the 
statistical tests of the rS02 data employed an alpha level 
based on the total number of tests used to analyze the
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rSO: data (20), while the statistical tests of the SIT and 
PSG data employed an alpha level based on the total number 
of statistical tests used in the entire study (53). This 
use of different alpha levels to test hypotheses of 
differing importance is recommended by Tabachnick and 
Fidell (1989, pp. 49-50).
In addition to this, a multistage Bonferroni 
procedure for adjusting alpha levels described by 
Larzelere and Mulaik (1977) was used. Although this 
procedure was developed for use in correlational analyses, 
Huberty and Morris (1989) recommended it for studies in 
which multiple ANOVAs were to be used. The procedure is 
based on Monte Carlo studies, briefly described in 
Larzelere and Mulaik (1977), which showed that the 
Bonferroni procedure is unnecessarily conservative when a 
large percentage of the hypotheses tested involve null 
hypotheses that are actually false. This multistage 
Bonferroni correction procedure is conducted as follows.
In the first stage, the traditional Bonferroni procedure 
of dividing the alpha level (.05) by the number of tests 
(20 and 53 in the proposed study) is used to determine the 
initial alpha level. If none of the statistical tests 
reaches significance at this level, then one stops (with 
none of the null hypotheses having been rejected). If one
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or more tests do reach significance at this level, then 
one moves to the second stage. In the second stage, a new 
corrected alpha level is determined by dividing the 
traditional .05 alpha level by the number of tests in the 
first stage in which the null hypothesis was not rejected. 
The results of the statistical tests are then re-examined 
using this new alpha level. As before, one stops if none 
of the tests are significant, or moves to another stage if 
at least one of the null hypotheses is rejected. The 
procedure ends when one reaches the point at which none of 
the remaining null hypotheses are rejected.
To employ this procedure in the proposed study, the 
twenty tests involving the rS02 data were initially 
examined using an alpha level of .0025, while the tests 
involving the SIT and PSG variables were examined using an 
alpha level of .001.
The tests of the rS02 B-wave amplitude during the SIT 
and PSG involved a total of six pairwise comparisons of 
interest. These included all three possible pairwise 
comparisons of the rS02 B-wave amplitude during the SIT, 
and all three possible pairwise comparisons of the rS02 B- 
wave amplitude during the PSG. These six tests were 
analyzed with planned F-tests, using weights of 1 and -1 
for the two group means. For the directional hypotheses,
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the p level attained was divided by two, since the 
statistical package that was used only gives a p value for 
a two-tailed hypothesis.
The analyses involving the rS02 value at the 
beginning of SIT sensory/motor events and the beginning of 
PLMs during sleep involved a total of five tests. These 
included all three pairwise comparisons for SIT motor 
events (both RLS and PLMS subjects had motor events, they 
were compared to each other and to the control mean), RLS 
versus controls for SIT sensory events (the PLMS and 
control subjects did not have sensory events) , and all 
patients with PLMs versus controls for the sleep data.
It was originally proposed to compare the average 
rS02 values occurring at the beginning of these events in 
patients (SIT sensory and motor events, and PLMs in sleep) 
to the average B-wave trough rS02 values in the normal 
subjects. This was proposed because it was predicted that 
events in the patients would occur at the B-wave troughs. 
This prediction was not confirmed; therefore, in lieu of 
those comparisons, non-directional tests were performed 
comparing the average rS02 values at the event onsets in 
the patients to the mean values for the controls (the 
small number of SIT epochs with movement in the control
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subjects were not used in computing their average rS02 
values) .
There were six additional tests proposed involving 
within subjects analyses. These tests included the 
following: (1) in RLS subjects, the average rS02 at SIT
sensory and motor events were to be compared to the 
average rS02 value at the next B-wave peak (two tests);
(2) in all patients with PLMs (both RLS and PLMS 
subjects), the average rS02 at PLMs were to be compared to 
the average rS02 value at the next B-wave peak (one test);
(3) the percentage of SIT sensory and motor events in RLS 
subjects occurring at each point in the rS02 B-wave cycle 
were to be compared using a within subjects ANOVA (a Chi 
Square goodness of fit test was used instead; two tests); 
and (4) in all patients with PLMs the percentage of PLMs 
occurring at each point in the B-wave cycle were also to 
be compared using a within subjects ANOVA (again, a Chi 
Square goodness of fit test was used; one test) . Because 
the last three tests were so important for testing the PCI 
theory, it was decided to conduct three similar tests with 
the total hemoglobin data. These additional tests 
increased the total number of tests to twenty for the 
oximetry data. As noted above, the prediction that PLMs 
and SIT sensory/motor events would occur at B-wave troughs
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was not confirmed. Therefore, in lieu of those analyses 
(the first three discussed above), non-directional paired- 
sample t-tests were performed comparing the rSO- values at 
the onset of PLMs and SIT sensory/motor events to the 
average rSO; values where no abnormal sensations, 
movement, or PLMs were present.
Table 1 summarizes the 20 tests involving che 
oximetry data, and the predictions made for each of them. 
The last two tests listed in the table actually represent 
a total of six tests (SIT sensory and motor events in both 
the rS02 and total hemoglobin B-wave cycles (for the RLS 
subjects), and PLMs in both B-wave cycles (for the PLMS 
subjects).
The SIT and PSG data involved a total of 33 pairwise 
comparisons, all of which were tested with planned F- 
tests. These 33 tests and the predictions associated with 
them are summarized in Table 2. All of the hypotheses for 
tests involving comparisons between the RLS and normal 
control groups were directional, while six of the eleven 
comparisons between the PLMS group and the normal group, 
and five of the eleven comparisons between the RLS and 
PLMS group, were directional. Two of the comparisons 
between the PLMS and normal controls (those for the SIT 
sensory index and total bed time variables) involved
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Table 1. Summary of Statistical Tests of rS02 Data
Comparison Variable(s ) Prediction
RLS & Normals SIT B-wave amplitude RLS > Normals
PLMS & Normals SIT B-wave amplitude none
RLS & PLMS SIT B-wave amplitude RLS > PLMS
RLS & Normals PSG B-wave amplitude RLS > Normals
PLMS & Normals PSG B-wave amplitude PLMS > Normals
RLS & PLMS PSG B-wave amplitude RLS = PLMS
RLS & Normals SIT sensory/mean rS02 RLS = Normals
RLS & Normals SIT motor/mean rS02 RLS = Normals
PLMS & Normals SIT motor/mean rS02 PLMS = Normals
RLS & PLMS SIT motor event rS02 RLS = PLMS
PLMS & Normals PLM/mean rS02 PLMS = Normals
RLS (Within Ss) SIT sensory rSO; event=no event
RLS (Within Ss) SIT motor rS02 event=no event
PLMS (Within Ss) PLM and no-event rS02 PLM = no PLM
RLS (Within Ss) % of events at various 
points in B-wave cycle
significant
PLMS (Within Ss) % of PLMs at various 
points in B-wave cycle
significant
predictions that there would be no group differences, 
while no prediction was made for the PLMS/normal group 
comparisons on three other dependent variables.
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Table 2. Summary of Statistical Tests of SIT and PSG Data
Variable RLS/Normals PLMS/Normals RLS/PLMS
SIT Sensory RLS > Normals PLMS Normals RLS > PLMS
SIT Motor RLS > Normals none RLS > PLMS
PLM Index RLS > Normals PLMS > Normals none
Bed Time RLS < Normals PLMS = Normals RLS < PLMS
Efficiency RLS < Normals none RLS < PLMS
Latency RLS > Normals none RLS > PLMS
Light Sleep RLS > Normals PLMS > Normals none
Percent SWS RLS < Normals PLMS < Normals none
Arousals RLS > Normals PLMS > Normals none
Stage Changes RLS > Normals PLMS > Normals none
Stg 1 Periods RLS > Normals PLMS > Normals none
Similarly, no prediction was made for the RLS/PLMS 
comparisons on six dependent variables because it was 
unclear from the RLS/PLMS literature whether or not such 
differences should be expected. The eleven tests in which 
either no prediction was made or in which no group 
differences were predicted were tested with two-tailed 
tests.
Finally, one of the experimental hypotheses (number 
2) was descriptive in nature, and did not require the use
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of an inferential statistical test. This was the 
prediction that waking sensory events in RLS subjects 
would be brief and periodic.
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Results 
SIT and PSG Data 
The group means and standard deviations for the SIT 
sensory and motor indices and the nine sleep variables are 
listed in Table 3. An examination of the standard 
deviations shows that the RLS group had relatively high
Table 3. Group means for SIT and PSG data.
Variable1 RLS PLMS Controls
SIT SI 50.3 (60.4) 0 (-) 0.1 (0.3)
SIT MI 86.4 (40.7) 16.5 (12.8) 5.3 (5.7)
PLMi 35.0 (33.5) 22.5 (14.3) 2.3 (2.5)
%TIB 93.3 (15.3) 99.2 (1.2) 98 .7 (1.3)
Latency 89.6 (124.2) 19.2 (13.1) 21.5 (20.5)
Efficiency 67.0 (19.9) 84.4 (13.4) 81.6 (9.8)
Stage 1 % 12.4 (5.7) 9.6 (5.4) 14.5 (7.2)
SWS % 12.4 (13.6) 13. 9 (9.0) 14.7 (7.2)
Arousals 13.5 (4.6) 10.2 (4.4) 13.3 (3.9)
Stg Changes 24.7 (7.2) 23.5 (3.9) 25. 6 (7.2)
SI Periods 6.2 (2.2) 5.6 (2.9) 7.6 (2.9)
1) Abbreviations are as follows: SIT SI = SIT sensory
index, SIT MI = SIT Motor index, PLMi = Periodic Limb 
Movement Index, %TIB = Percent time in bed, Arousals = 
Arousals per hour of sleep, Stg Changes = stage changes 
per hour of sleep, SI Periods = Stage 1 Periods per hour 
of sleep.
202
R eproduced  with perm ission o f the copyright owner. Further reproduction prohibited without perm ission
2 0 3
relatively high standard deviations (relative to their 
group mean) on the first six variables in Table 3. 
Similarly, the control group had high standard deviations 
relative to their means on the four of the first six 
variables (SIT SI, SIT MI, PLMi, and Latency). The SIT 
sensory index was noteworthy in that no PLMS subject had 
any abnormal sensations during the SIT, while only one 
control subject had a single abnormal sensation. Levene 
tests for homogeneity of variance on all eleven variables 
in Table 3 were significant for the first six (SIT SI, SIT 
MI, PLMi, %TIB, Latency, and Efficiency). Shapiro-Wilk 
tests for normality on all eleven variables for all three 
groups showed that only two variables (Arousals and Stage 
Changes) were normally distributed for all three groups. 
Because of these departures from normality and homogeneity 
of variance, non-parametric Mann-Whitney U tests were used 
in lieu of the planned F-tests for all variables except 
Arousals and Stage Changes. The Mann-Whitney test is a 
rank procedure which yields a z-ratio with a p-level 
corrected for ties.
Table 4 shows the z and t values (and the p values 
associated with them), for the pairwise comparisons on the 
eleven SIT and PSG variables. Using the corrected alpha 
level of .001, three of the comparisons in Table 4
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Table 4. Statistical Results for SIT and PSG Data
Variable RLS/Controls RLS/PLMS PLMS/Controls
SIT SI -3.22 ( .0007) -2. 68 (.0037) -0.73 (n.s . )
SIT MI -3. 68 (.0001) -2.95 (.0016) -2.07 .04)
PLMi -2.79 (.0026) -0.24 (n.s. ) -3.34 .0004)
%TIB -0.16 (n.s . ) -0.66 (n.s. ) i o CTl n. s . )
Latency -1.52 (n.s.) -1.18 (n.s. ) -0.20 n. s .)
Efficiency -1.71 (.04) -2.36 (.009) -0.70 n. s . )
Stage 1 % -0.30 (n.s.) -0.83 (n.s.) -1.71 n. s .)
SWS % -1.48 (n.s.) -0.94 (n. s . )
oCMO1 n. s.)
Arousals -0. 13 (n.s . ) 1.43 (n.s.) -1.49 n. s .)
Stg Changes 0.32 (n.s . ) 0.62 (n.s.) -0.33 n. s .)
SI Periods -1.07 (n.s.) -0. 94 (n.s.) -1. 61 n. s.)
would be considered significant: the SIT SI between the
RLS and controls, the SIT MI between the RLS and controls, 
and the PLMi between the PLMS and controls. Four other 
comparisons reached low p values, and would probably have 
been significant if the sample sizes had been larger: the
SIT SI between the RLS and PLMS subjects, the SIT MI 
between the RLS and PLMS subjects, the PLMi between the 
RLS and control subjects, and sleep efficiency between the 
RLS and PLMS subjects. It is also worth pointing out that
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if the corrected alpha level had been set at .0038 (which 
would have held the experiment-wise Type 1 error rate at 
0.2), then the SIT SI and MI comparisons between the RLS 
and PLMS groups, and the PLMi comparison between the RLS 
and control group would have been significant- 
SIT Sensory Events in RLS Subjects 
Individual subject data for the SIT sensory events is 
presented in Table 5. Two of the nine RLS subjects did 
not report any abnormal sensations, although one of these 
did report a very low level nearly continuous awareness of 
her usual sensory discomfort that she could not precisely 
identify as being present at one moment and not the next. 
Table 5 also lists the mean sensory event duration and 
inter-event-interval (IEI) in seconds, and the percent of 
events which occurred in a series of at least four events 
with IEIs of greater than 5 but less than 90 seconds.
Only three subjects (012, 020, 026) had a majority of 
events that met the PLMS criteria of four events in a 
series with IEIs of between 5 and 90 seconds; however, 
when considering the full PLMS criteria (including event 
duration of less than 5 seconds), only subjects 020 and 
026 had a majority of their sensory events conform to the 
full PLMS criteria. If the IEI criteria were changed to 
greater than 20 but less than 90 seconds, then neither of
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Subj1
# of 
Events
Mean
Duration
Mean
IEI
% in series of 4 
with IEI >5, <90s
012 52 9.5 59. 9 71%
017 24 1.1 145.0 0%
020 156 3.9 15.3 78%
034 22 0.5 163.5 0%
026 165 5.0 11.7 59%
030 9 1.2 375.6 0%
057 41 1.2 83.2 0%
1) Abbreviations: Subj = subject, IEI = inter-event-
interval.
these subjects would have had more than seven percent of 
their events conform to the PLMS criteria. Three of the 
subjects had sensory events of relatively long duration 
(012, 020, and 026). Not surprisingly, subjects with 
fewer events had longer IEIs. In general, the sensory 
events observed in these RLS patients did not appear 
similar to PLMS in their temporal characteristics. A good 
description of RLS sensory events based on the present 
data would be that their temporal characteristics are 
highly variable between subjects.
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The movement data in the RLS subjects also deserve 
brief comment. The average MI for both legs ranged from 
21 to 150, with the group mean being 86. Movement was 
much more prominent than abnormal sensations. For 
example, when considering group means, abnormal sensations 
were present for 18% of the five second SIT epochs, while 
movement was present for 44% of the five second SIT 
epochs. Only three subjects had any clear periodicity to 
their movements, including one who appeared to be having 
waking PLMs. A more common finding, particularly near the 
end of the SIT was that the movements were often of long 
duration (i.e. greater than 30 seconds) and were sometimes 
nearly continuous. Similar movement was observed prior to 
sleep onset in several subjects during the PSG recording. 
In addition, when symptoms were severe, the leg movements 
observed were quite agitated in nature, and included 
vigorous shaking and even stamping of the legs. Thus, 
abnormal movement was a more prominent feature in these 
RLS patients than were abnormal sensations.
Qy;uretry.Pa£.3
Group means and standard deviations for the SIT rS02 
B-wave amplitudes were as follows; RLS: 3.1 + 0.9
percent, PLMS: 2.5 ± 0.7 percent, and Controls: 2.6 ±
0.5 percent. These values are the group means of the 
average wave amplitude for each subject expressed as a
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percentage of that subject's mean rS02 level during the 
SIT. None of the three pairwise comparisons for this 
variable reached statistical significance at the .0025 
level (t values: RLS/Controls, -1.72, p = .05; RLS/PLMS, 
-1.64, p = .06; PLMS/Controls, 0.15, p = .88). As noted 
earlier, these amplitudes were substantially lower than 
expected.
Group means and standard deviations for the PSG rS02 
B-wave amplitudes were as follows; RLS: 2.6 + 0.9
percent, PLMS: 2.3 + 0.8 percent, Controls: 2.2 + 0.3
percent. None of the three pairwise comparisons for this 
variable reached statistical significance at the 0.0025 
level (t values: RLS/Controls, -1.08, p = .15; RLS/PLMS,
-0.89, p = .39; PLMS/Controls, -0.06, p = .48).
The mean and standard deviation for the (actual) rSO;, 
value at sensory event onset in the RLS subjects was 64.0 
+ 6.5. This was compared to the average rSO, value (where 
no movement or sensory events were present) during the 
entire SIT for the control subjects (60.2 + 9.5) using a 
non-directional t-test. This test did not reach 
statistical significance (t = -1.02, p = .32).
The means and standard deviations for the rS02 value 
at motor event onset was 63.3 + 6.0 for the RLS subjects, 
and 65.0 ±  3.9 for the PLMS subjects (recall that the PLMS
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subjects had an average SIT MI of 16.5 movements). These 
values were compared to the control subject mean "no­
event" rS02 (60.2 + 9.5) using non-directional t-tests. 
None of the three pairwise comparisons reached statistical 
significance (t values: RLS/Controls, t = -0.93, p = .36;
RLS/PLMS, t = 0.43, p = .67; PLMS/Controls, t = -1.27, p = 
.22) .
The mean and standard deviation for the rS02 level at 
PLM onset in the thirteen subjects who had PLMs was 65.9 + 
4.1. This was compared to the average sleep rS02 value 
for the controls (61.5 ±7.1) using a non-directional t- 
test. The result of this test did not reach statistical 
significance (t = -1.89, p = .07).
For the RLS group, the mean rS02 value at sensory 
event onset (for the seven subjects who had sensory 
events) was 64.0 + 6.5. This was compared to the mean 
rS02 value for these seven subjects when no sensory or 
motor events were present (63.6 + 6.7) using a non- 
directional paired-samples t-test. This test was not 
statistically significant (t = 2.12, p = .08).
For the RLS group, the mean rS02 value at motor event 
onset was 63.3 + 6.0 (all nine RLS subjects had motor 
events) . This was compared to the average rS02 value when 
no sensory or motor events were present (63.0 + 6.1, for
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all nine subjects) using a non-directional paired-samples 
t-test. This test was not statistically significant (t = 
1.41, p = .20) .
For all subjects with PLMs, the mean rS02 value at 
PLM onset was 65.9 + 4.1. This was compared to the 
average rS02 value when no PLMs were present (65.6 + 4.1) 
using a non-directional paired-samples t-test. This test 
was not statistically significant (t = 1.76, p = .10).
Event Occurrence in the B-Wave _Gv.cle 
The percentage of SIT sensory events occurring at 
each point in the rS02 B-wave cycle (trough, ascending 
limb, peak, descending limb, stable) for the seven RLS 
subjects who had sensory events is listed in Table 6. The 
mean percentages and standard deviations for the group are 
also listed. A Chi Square goodness of fit test on the 
group means (entered as frequencies) was performed to 
determine if the percentages were significantly different 
from equal percentages in each category (which would have 
been expected by chance). The Chi Square statistic was 
56.40, a value which was significant beyond the 0.0001 p 
level. Only two subjects (030 and 057) had more than 50 
percent of their events at any one point in the wave 
cycle, both at the rS02 peaks.
The percentage of SIT sensory events in RLS subjects 
occurring at each point in the total hemoglobin B-wave
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Table 6. Percent of SIT Sensory Events in RLS Subjects
Occurring at Various Points in the rS02 B-wave
Cycle.
Subj1 # Trough Ascend Peak Descend Stable
012 51 29.4 5.9 47.1 7.8 9.8
017 23 13 . 0 0 39.1 13.0 34.8
020 106 23. 6 18.9 38 .7 17.0 1.9
034 10 30.0 20. 0 30.0 20. 0 0
026 120 25.0 4.2 42. 5 5.8 22.5
030 9 11.1 0 66.7 0 22.2
057 25 4.0 0 76.0 16.0 4.0
Mean 19.4 7.0 48.6 11.4 13. 6
S.D. 10. 1 8. S 16. 6 7.1 13. 1
1) Abbreviations are as follows: Subj = Subject, # =
Number of events, Ascend = Ascending, Descend = 
Descending, S.D. = Standard deviation
cycle is listed in Table 7. A Chi Square goodness of fit 
test on the means yielded a value of 32.80, which was 
significant beyond the 0.0001 p level. Again, only two 
subjects (017 and 030) had more than 50 percent of their 
of their events at any one point in the hemoglobin wave 
cycle; one at the peaks (017), and one at the troughs 
(030).
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Table 7. Percent of SIT Sensory Events in RLS Subjects
Occurring at Various Points in the Total
Hemoglobin B-wave cycle.
Subj: # Events Trough Ascend Peak Descend
012 51 37. 3 5.9 39.2 17. 6
017 23 21.7 4.3 60. 9 13.0
020 106 47.2 9.4 24 . 5 18. 9
034 10 20.0 20.0 40.0 20.0
026 120 41.7 5.8 45.0 7.5
030 9 55. 6 0 44 . 4 0
057 25 28.0 8.0 40.0 24 . 0
Mean 35. 9 7.6 42. 0 14 . 4
S.D. 13.3 6.2 10. 8 8.3
1) Abbreviations are as follows: Subj = Subject, # =
Number of events, Ascend = Ascending, Descend = 
Descending, S.D. = Standard deviation
The percentages of SIT motor events in the RLS 
subjects occurring at each point in the rS02 B-wave cycle 
for the nine RLS subjects are presented in Table 8. Only 
movements occurring in the leg contralateral to the 
oximetry sensor were used in this analysis. A Chi Square 
goodness of fit test on the group means yielded a value of 
37.70, which was significant beyond the 0.0001 p level. 
Only two subjects (034 and 057) had more than fifty
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Table 8. Percent of 
Occurring 
Cycle.
SIT Motor 
at Various
Events
Points
in RLS Subjects 
in the rSO, B-wave
Subj1 # Trough Ascend Peak Descend Stable
012 92 34 . 8 3.3 42.4 9.8 9.8
017 80 28 . 8 7.5 32.5 3.8 27.5
020 121 28. 9 11.6 36.4 21.5 1.7
034 54 20. 4 5.6 55. 6 18.5 0
026 144 23. 6 2.1 41.0 8.3 25.0
030 27 48.1 11.1 22.2 7.4 11.1
050 94 30. 9 7.4 43.6 12.8 5.3
049 24 37.5 20.8 20.8 12.5 8.3
057 29 20.7 0 55.2 20. 7 3.4
Mean 30.4 7 . 7 38 . S 12.8 10.2
S.D. 8.9 6.3 12. 4 6.2 9.8
1) Abbreviations are as follows: Subj = Subject, # =
Number of events, Ascend = Ascending, Descend = 
Descending, S.D. = Standard deviation
percent of their motor events at any one point in the rS02 
B-wave cycle (both at the peaks).
The percentages of SIT motor events in RLS subjects 
occurring at each point in the total hemoglobin B-wave 
cycle for the nine RLS subjects are presented in Table 9. 
A Chi Square goodness of fit test on the group means
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Table 9. Percent of SIT Motor Events in RLS Subjects
Occurring at Various Points in the Hemoglobin
B-wave Cycle.
Subj ’• # Events Trough Ascend Peak Descend
012 92 50.0 13.0 21.7 15.2
017 80 33.8 13.8 42.5 10.0
020 121 45.5 12.4 22.3 19.8
034 54 35.2 11.1 44 . 4 9.3
026 144 41.0 5.6 39. 6 13. 9
030 27 59. 3 11.1 25. 9 3.7
050 94 29. 8 9.6 47 . 9 12.8
049 24 29.2 20.8 33. 3 16.7
057 29 41.4 3.4 37. 9 17.2
Mean 40. 6 11.2 35. 1 13.2
S.D. 9.9 5.0 9.8 4.9
1) Abbreviations are as follows: Subj = Subject, # =
Number of events, Ascend = Ascending, Descend = 
Descending, S.D. = Standard deviation
yielded a value of 27.84, which was significant beyond the
0.0001 p level. Only two subjects had more than 50 
percent of their events at any one point in the hemoglobin 
wave cycle (012 and 030), both at the troughs.
The percentages of PLMs occurring at each point in 
the rSO, B-wave cycle for the thirteen subjects who had
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Table 10. Percent of Periodic Limb Movements in RLS and
PLMS Subjects Occurring at Various Points in
the rS02 B-wave Cycle.
Subj: # Trough Ascend Peak Descend Stable
012 33 30. 3 3.0 42.4 24 .2 0
020 72 6.9 18 .1 69.4 2.8 2.8
034 344 16.3 27.0 48.8 7.6 0.3
033 44 9.1 6.8 56.8 20. 5 6.8
026 305 13.4 6.9 60.0 7.9 11.8
030 139 24 . 5 16. 5 48.2 3.6 7.2
052 116 28 . 4 15.5 46.6 8.6 0.9
050 24 37. 5 0 25.0 8.3 29.2
049 130 8.5 5.4 61. 5 22. 3 2.3
056 297 14 . 8 3.7 56.6 7.4 17.5
060 35 17. 1 8 . 6 51. 4 8.6 14.3
066 115 24 . 3 2.6 39.1 9.6 24 .3
069 106 14 .2 0 21.7 0 64.2
Mean 18. 9 8.8 48. 3 10.1 14.0
S.D. 9.4 8.1 13. 8 7.5 17.8
1) Abbreviations are as follows : Subj = Subject, # =
Number of events, Ascend = Ascending, Descend = 
Descending, S.D. = Standard deviation
PLMs (this included seven RLS subjects in addition to the 
six PLMS subjects) are presented in Table 10. A Chi
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Square goodness of fit test on the group means yielded a 
value of 52.10, which was significant beyond the 0.0001 p 
level. Seven of the thirteen subjects had more than 50 
percent of their PLMs at one point in the B-wave cycle; 
six of these were at peaks, and one was during stable 
points. For eleven of the thirteen subjects the rS02 peak 
was the wave point with the highest percentage of their 
PLMs.
The percentages of PLMs occurring at each point in 
the total hemoglobin B-wave cycle for the thirteen 
subjects who had PLMs are listed in Table 11. A Chi 
Square goodness of fit rest on the group means yielded a 
value of 23.76, which was significanr beyond the 0.0001 p 
level. Five subjects had more than 50 percent of their 
PLMs at one point in the B-wave cycle; at the peaks for 
three subjects, and at the troughs for two subjects.
Seven of the subjects had the greatest percentage of their 
PLMs at the hemoglobin wave peaks, while six had the 
greatest percentage of their PLMs at the hemoglobin 
troughs.
In summary, none of the events studied (SIT sensory 
events, SIT motor events, and PLMs) occurred at any one 
point in either the rS02 or total hemoglobin B-wave cycle
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Table 11. Percent of Periodic Limb Movements in RLS
and PLMS Subjects Occurring at Various Points
in the Total Hemoglobin B-wave cycle.
Subj 1 # Events Trough Ascend Peak Descend
012 33 42. 4 3.0 36.4 18.2
020 72 9.7 11.1 75.0 4.2
034 344 59. 6 14.5 19.8 6.1
033 44 20.5 15. 9 47.7 15.9
026 305 31.8 16.7 44.6 6.9
030 139 15.8 23.7 55. 4 5.0
052 116 35.7 15.5 33. 0 15.7
050 24 33.3 16.7 37.5 12.5
049 130 36.4 9.3 33. 3 20. 9
056 297 25. 9 6.4 51.5 16.2
060 35 28. 6 17.1 31.4 22.9
066 115 48.7 11. 3 28.7 11.3
069 106 52.8 4.7 30.2 12.3
Mean 33. 9 12.8 40.3 12.9
S.D. 14.5 5.8 14 .4 6.1
1) Abbreviations are as follows: Subj = Subject, # =
Number of events, Ascend = Ascending, Descend = 
Descending, S.D. = Standard deviation
more than 50 percent of the time. In five of the six 
cases however, the events occurred more often at peaks
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than at any other point in the cycle. The most consistent 
findings were that SIT sensory events and PLMs occurred at 
rS02 peaks 49 and 48 percent of the time respectively.
All six of the Chi Square goodness of fit tests were 
highly significant (and well beyond the corrected alpha 
level of 0.0025 used for the oximetry data).
Figure 1 shows a short segment (6.5 minutes) of rS02 
raw data during sleep (with the PLMs marked with 
asterisks) for subject 034. This subject had the largest 
rSO- B-wave amplitude during sleep of any subject with 
PLMs, and had 4 9 percent of his PLMs at rS02 B-wave peaks. 
In the segment shown, there are seventeen B-waves, and one 
PLM per wave. Two of the PLMs occurred at troughs, five 
during the ascending limbs, and ten at the peaks.
Figure 2 shows a short segment (6.5 minutes) of total 
hemoglobin raw data during sleep for subject 020 (with 
PLMs marked with asterisks). This subject had 75 percent 
of his PLMs at the total hemoglobin B-wave peaks. In the 
segment shown, there are fourteen B-waves and eleven PLMs, 
ten of which occurred at peaks, and one which occurred 
during an ascending limb.
Spectral Analysis Results
The spectral analyses revealed that the oximetry data 
(both the rS02 and total hemoglobin signals) were 
characterized by multiple wavelengths in the 11 to 90
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second range for all groups. Wavelengths were determined 
from the spectral analysis periodogram graphs by 
determining the wavelength associated with each 
periodogram peak. In the following discussion, the word 
peak refers to a periodogram peak rather than an 
individual B-wave peak.
For rS02 during the SIT, the RLS group had an average 
of 5.3 peaks per subject, the PLMS group had an average of 
5.2 peaks per subject, and the Control group had an 
average of 4.7 peaks per subject. For total hemoglobin 
during the SIT, the RLS group had an average of 4.6 waves 
per subject, the PLMS group had an average of 4.3 waves 
per subject, and the Control group had an average of 4.2 
waves per subject.
The spectral analyses on the sleep data (for controls 
and subjects with PLMs) were performed with all sleep 
segments for each subject combined into a single data 
file. The mean number of rS02 peaks was 4.5 + 1.6 for the 
PLMS subjects, and 5.2 ± 0.8 for the controls. The mean 
number of total hemoglobin peaks was 4.5 + 1.8 for both 
the PLMS and Control groups.
Table 12 shows the number of periodogram peaks in 
each group (all peaks for every subject in each group were 
counted) in each of the eight 10 second ranges from 11 to
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90 seconds during the SIT. Data are included for both 
rS0: and total hemoglobin, and are presented to provide 
descriptive information only (no statistical tests were 
conducted) . For both rS02 and total hemoglobin, all three 
groups had few (if any) peaks in the 11 to 20 second 
range. For rS02 the RLS group had the largest number of 
peaks in the 31 to 40 second range, and the second largest 
number of peaks in the 51 to 60 second range. For total 
hemoglobin the RLS group had the greatest number of peaks 
in the traditional B-wave wavelength range of 51 to 60 
seconds, and the second largest number of peaks in the 31 
to 40 second range. The PLMS group had the greatest 
number of rS02 peaks in the 31 to 40 second range, and the 
second largest number in each of the three ranges from 51 
to 80 seconds. For total hemoglobin the PLMS group had 
the greatest number of peaks in the 51 to 60 second range, 
and the second largest number of peaks in four ranges (31 
to 50 seconds, and 61 to 80 seconds). The control group 
had the largest number of rS02 peaks in the 41 to 50 
second range, and the second largest number of peaks in 
two ranges (51 to 60 seconds and 71 to 80 seconds). The 
control group had the smallest percentage of rS02 peaks of 
all three groups in the three ranges from 11 to 40 
seconds. For total hemoglobin, the control group had the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
2 2 3
Table 12. Number of Periodogram Peaks in Each Group in 
the Different Wavelength Ranges during the 
Suggested Immobilization Test1
Grp 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90
rSO; Data
RLS 1 7 9 7 8 5 4 7
PLMS 0 3 7 3 5 5 5 3
Con 1 5 4 12 9 8 9 4
Total Hemoglobin Data
RLS 1 4 7 5 10 6 5 3
PLMS 0 3 4 4 5 4 4 2
Con 0 5 7 7 8 9 5 6
1) Abbreviations are as follows: Grp = group, Con =
control. (Wavelength ranges are in seconds).
greatest number of peaks in the 61 to 70 second range, and 
the second greatest number in the adjacent 51 to 60 second 
range.
In summary, the spectral analyses showed that 
subjects in all three groups had multiple rS02 and total 
hemoglobin (wavelength) peaks during the SIT. These 
included wavelengths in the traditional B-wave wavelength 
range of 50 to 70 seconds, and wavelengths in most of the
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224
other ranges from 11 to 90 seconds with the exception of 
the 11 to 20 second range.
Table 13 lists the number of periodogram peaks for 
the thirteen subjects with PLMs (seven RLS subjects and 
six PLMS subjects) and for the Control group in each of 
the eight 10-second wavelength ranges from 11 to 90 
seconds for both oximetry variables during sleep. For 
rSO; the PLMS subjects had the greatest number of peaks in 
the 41 to 50 second range, and the second greatest number 
of peaks in the 71 to 80 second range. The control 
subjects had the greatest number of peaks in the 51 to 60 
second range, and the second greatest number of peaks in 
the 31 to 40 second range. For total hemoglobin, the PLMS 
subjects had the greatest number of peaks in the 21 to 30 
second range, and the second greatest number of peaks in 
the 61 to 7 0 second range. The control subjects had the 
greatest number of peaks in the 21 to 30 second range, and 
the second greatest number of peaks in the 51 to 60 second 
range.
In summary, the distribution of peaks appeared to be 
roughly similar for both groups for total hemoglobin, 
while for rS02 the PLMS subjects appeared to have a 
relatively larger number peaks in the 71 to 90 second 
range than the control subjects. For both groups there
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Table 13. Number of Periodogram Peaks in Control 
Subjects and Subjects with PLMs in the 
Different Wavelength Ranges during Sleep1
Grp 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90
rSO; Data
PLMS 2 7 9 12 8 4 10 7
Con 1 8 11 7 12 9 6 3
Total Hemoglobin Data
PLMS 2 11 7 8 8 10 6 6
Con 1 10 4 8 10 8 7 1
1) Abbreviations are as follows : Grp = Group, PLM =
Periodic Limb Movements in Sleep, Con = Control 
(Wavelength ranges are in seconds!.
were very few peaks in the 11 to 20 second range for both 
variables. As with the SIT data, the spectral analyses 
showed that during sleep both PLMS and control subjects 
tended to have a mixture of different wavelengths in their 
rS02 and total hemoglobin data.
Finally, Figure 3 shows a spectral analysis 
periodogram for a segment of rS02 data during sleep in a 
RLS/PLMS subject. The values on the period axis in this 
figure represent the number of five-second epochs (e.g.
"5" represents a wavelength of 25 seconds). The figure
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shows two large peaks at 34 and 58 seconds, and one very 
small peak at 19 seconds. Figure 4 shows a spectral 
analysis periodogram for a segment of total hemoglobin 
data during sleep for a control subject. The periodogram 
shows two large peaks at 48 and 57 seconds, one medium 
size peak at 34 seconds, and one small peak at 29 seconds.
Wave-to-Wave Change in Wavelength Data 
For the rS02 data, individual wave wavelengths were 
measured for each subject during both the SIT and PSG, and 
the mean change in wavelength from one wave to the next 
wave was computed. Lower values for this wave-to-wave 
change in wavelength number are indicative of more regular 
and uniform waveforms. Such uniformity has been reported 
to be characteristic of B-wave activity; thus, this 
analysis was done in an attempt to determine how many 
subjects were having relatively unambiguous B-wave 
activity. A visual examination of the rS02 graphs 
suggested that when the mean wave-to-wave change in 
wavelength was fifteen seconds or less, there were often 
sections in the rS02 signal that appeared to have the 
regularity characteristic of B-wave activity. Individual 
subject data on this variable are presented in Table 14. 
There were only 14 instances (out of 51) where the mean 
wave-to-wave change in wavelength was 15 seconds or less, 
and only three instances where it was 10 seconds or less.
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Figure 3. Representative Spectral Analysis -enodogram 
of rS02 Data
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'igure 4. Representative Spectral Analysis Periodogram 
of Total Hemoglobin Tata
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Table 14. Wave-to-Wave Change in Wavelength (WWCW) Data1
Subject Group SIT WWCW PSG WWCW
012 RLS 18 .5 13.3
017 RLS 27.5 19.9
020 RLS 13.2 16.4
034 RLS 10.1 8 . 3
033 PLMS 27.0 11. 9
026 RLS 18. 6 18.4
030 RLS 12.2 14.3
052 PLMS 12. 4 12.6
049 RLS 18.9 14.6
050 RLS 14. 6 27.0
051 Control 18 .1 18 .7
054 Control 16.7 21.0
056 PLMS 24.8 17.4
057 RLS 18 .3 18 . 9
055 Control — 24.1
061 Control 23.3 19.4
060 PLMS 11.2 20.5
058 Control 9.2 11. 6
059 Control 17.9 16.4
066 PLMS 27 . 8 27 . 9
/ *_-i ~ ~___ 4- r \(table cont'd)
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Subject Group SIT WWCW PSG WWCW
067 Control 17.6 17.4
068 Control 16. 6 17. 1
073 Control 19.8 21.7
070 Control 18 . 4 19.9
074 Control 21.4 19.9
069 PLMS 18.5 18 .6
1) WWCW values are in seconds
Thus, in general, the "waves" in the rS02 data were not 
uniform and regular from wave to wave for most subjects.
Dual Recording Site Data 
Three bald subjects were recruited into the study in an 
effort to find one or more bald subjects with PLMS. In 
all three subjects, two oximetry recording sites were 
used: one on the forehead, and one the vertex. The
vertex site sensor was placed so that it would be as close 
as possible to the sensory/motor cortex for the legs. 
Although none of the three bald subjects had any 
significant sleep complaints, one of them was found to 
have PLMS (subject 069). There were technical problems 
with his forehead sensor just after the SIT, so the
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polysomnogram was done with only the vertex recording 
site. This subject had a very stable vertex rS02 during 
both the SIT and PSG, and consequently, the majority of 
his PLMs (64%) occurred at stable rS02 points (see Tables 
10 and 11 for this subjects' data on PLM occurrence in the 
rSO: and total hemoglobin wave cycles). For total 
hemoglobin, this subject had the majority of his PLMs at 
troughs (52.8%). Unfortunately, no other bald RLS or PLMS 
subjects could be recruited.
The use of two recording sites in these three 
subjects allowed for direct comparison of the data between 
the two recording sites. In order to determine if the 
rS02 and total hemoglobin readings were changing 
synchronously at the two sites, the number of peaks at 
each recording site were counted, and the number of "peak 
matches" was determined. These data are presented in 
Table 15. In general, the vertex sites had fewer peaks 
and were more stable than the forehead sites. In 
addition, there were relatively few peak matches, 
suggesting that in these three subjects, the rS02 and 
total hemoglobin at the two different sites were changing 
at least partly independently of each other. Correlations 
between the variables at the two different sites were also 
computed. These data are also presented in Table 15. One
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Table 15. Dual Recording Site Data
Subj1 Test Variable Forehead
Peaks
Vertex
Peaks
N o . of 
Matches
r
058 SIT rS02 187 117 65 .34*
058 SIT Hgb 202 197 29 . 17*
058 PSG rS02 158 110 5 -.01
058 PSG Hgb 201 215 23 -.13*
070 SIT rS02 99 35 17 . 16*
070 SIT Hgb 152 91 25 -.55*
070 PSG rS02 87 29 21 .52*
070 PSG Hgb 167 112 41 . 39*
069 SIT rS02 84 49 9 .82*
069 SIT Hgb 135 123 36 . 38*
1) Abbreviations are as follows: Subj = Subject, No. =
Number, Hgb = Hemoglobin.
* p < .0008
subject (070) had two separate segments of PSG/sleep data; 
the correlations in Table 15 are for the first segment.
The correlations for his second segment were -.16 for 
rS02, and -.61 for total hemoglobin. There were a total 
of 12 correlations performed on this data. This increased 
the number of statistical tests in the study to 65; thus, 
these correlations were not regarded as significant unless
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they reached a p level of .0008 (which is .05 divided by 
65). Ten of the twelve correlations reached this p level. 
This included nine of the ten correlations presented in 
Table 15, and the PSG-Hgb correlation from the second 
segment of sleep for subject 070. Although most of the 
correlations were highly significant, the majority of them 
accounted for only proportions of the variance. None-the- 
less, the presence of significant correlations between the 
two recording sites in rS02 and total hemoglobin indicated 
that these blood flow parameters were not completely 
independent of each other at the two recording sites.
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Discussion 
SIT and PSG Data 
The first two hypotheses to be tested in the study 
concerned group differences on the SIT and PSG variables. 
Among the eleven SIT and PSG variables measured, the three 
that were most important were the SIT sensory and motor 
indices, and the PLM index. Differences on these 
variables were expected to occur because these variables 
were used (and are routinely used in clinical practice) to 
define the three groups. Of the nine possible pairwise 
comparisons among the three groups on these three 
variables, there were six directional predictions (see 
Table 2). Only three of these reached significance at the 
modified alpha level of 0.001, although the other three 
comparisons all reached p levels of 0.0037 or lower. The 
finding that one of these comparisons in particular, the 
RLS/PLMS comparison on the SIT sensory index, did not 
reach significance at the 0.001 level is surprising when 
the means of 50.3 (RLS) and 0 (PLMS) are considered. 
Although the low sample sizes of nine and six subjects 
were one obvious reason for the failure of these 
comparisons to reach significance at the specified p 
level, the low power that resulted from the selection of 
such a stringent initial alpha level of 0.001 was also to
234
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blame. That decision could be criticized for lowering 
power to such an extent that it made the probability of 
making a Type II error unacceptably high. In addition, 
these comparisons were confirmatory of known phenomena 
(the nature of sleep in RLS and PLMS), not tests of novel 
hypotheses. That all were highly significant by typical 
standards, but not by the alpha correction based on 
experiment-wise error, indicates that the alpha correction 
procedure was excessively conservative and caused Type II 
error. This problem represents an example of the often 
discussed trade off between Type I and Type II error. 
Keppel (1991, p. 179) noted that "the concern for 
familywise error is usually expressed without regard for 
any increase in Type II error that may result". Keppel 
further suggested that if a researcher choose to limit the 
familywise (experiment-wise) Type I error rate by using an 
alpha correction procedure, then "I strongly urge your 
imaginative use of non-traditional values of FW to avoid 
losing substantial amounts of power" (Keppel, 1991, p. 
180). He suggested cumulative Type I error rates of .10 
and .25 as starting points for consideration. In the case 
of the three non-significant comparisons above, if a 
familywise error rate of .20 had been chosen (as per 
Keppel's recommendation), then the corrected alpha level
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would have been .2 divided by 53 (or 0.0038) , and all 
three comparisons would have been regarded as significant. 
Therefore, those comparisons could be given more weight.
Of the eight remaining PSG variables, there were 
large differences in group means on two others: Sleep
latency, and sleep efficiency (see Table 3). The group 
mean for the RLS group on sleep latency was strongly 
influenced by one subject who had a 6.5 hour sleep 
latency; however, because the Mann-Whitney test that was 
employed uses ranks, this outlier should not have unduly 
influenced the results. Again, the low sample sizes were 
most likely to blame. For sleep efficiency, the two 
comparisons involving the RLS group did achieve p levels 
lower than the traditional 0.05 level used for individual 
comparisons (.04 in the RLS/Control comparison, and .009 
in RLS/PLMS comparison). In these two cases, it seems 
wise to follow another recommendation by Keppel (1991).
In cases where the p level attained falls between the 
corrected alpha level chosen and the traditional 0.05 
level, Keppel recommended that one should not make a 
formal decision regarding the null hypothesis (fail to 
reject H0) , but should instead decide to "suspend 
judgement". In this way, neither a Type I nor a Type II 
error is mad e .
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In reviewing the group means for the other sleep 
variables, two other findings are noteworthy. First, the 
RLS group had a similar amount of slow wave sleep as the 
PLMS and control groups. This occurred despite the lower 
sleep efficiency in this group, and suggests that even 
though the total sleep time of RLS patients may be reduced 
because of their RLS symptoms, their PLMs during sleep 
(like those of the PLMS group) were not sufficiently 
disruptive to reduce slow wave sleep. There was also some 
evidence of a "first night effect" in the Control group, 
as evidenced by the high number of stage changes per hour 
of sleep (Anderson, 1998). The large number of sleep 
stage changes in the RLS and PLMS groups also illustrates 
the primary effect of PLMS, or perhaps a first night 
effect for all three groups.
Sensory and Motor Events in RLS Subjects
The next hypothesis concerned the temporal 
characteristics of the abnormal sensations of the RLS 
subjects during the SIT. It was predicted that the 
sensory events would be similar to PLMs in their temporal 
characteristics, and as such, would represent the waking 
analog of PLMs. The results did not confirm this 
hypothesis. Instead, the sensory events were found to be 
highly variable in their temporal characteristics among
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different RLS subjects; only two of seven subjects had 
sensory events that met the scoring criteria used for 
PLMS.
The motor symptoms that were observed in the RLS 
subjects were also noteworthy. The observation that 
movements could become nearly continuous or be of very 
long duration when symptoms were severe is not consistent 
with the Periodic Cerebral Ischemia theory for at least 
two reasons. First, although RLS symptoms are 
precipitated by prolonged motor inactivity (during which 
B-wave activity should begin according to the PCI theory), 
the subsequent vigorous and long duration movements that 
occur when symptoms are severe should be sufficiently 
activating to both the cortex and brainstem that B-wave 
activity should be eliminated (i.e. the control of 
cerebral blood flow should revert to the waking mechanism 
of local flow-metabolism coupling). Second, if the motor 
symptoms in RLS are caused by cerebral ischemia, then that 
ischemia would have to be of relatively long duration to 
account for the observed motor symptoms, rather than 
periodic as suggested in the PCI theory. This would mean 
that some mechanism other than B-wave activity would have 
to be used to explain the observed motor symptoms in RLS. 
One possibility not previously discussed in this regard is
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endothelin-induced vasospasm. The endothelins are 
peptides that are produced and released by endothelial 
cells; they are potent vasoconstrictors with a relatively 
long duration of action (see Cardell, Uddman, and 
Edvinsson, 1994, for a review). Endothelins are thought 
to play role in several cerebrovascular diseases, 
including migraine headaches and the vasospasm associated 
with subarachnoid hemorrhage. It has been shown that 
hemodynamic shear stress can stimulate the production of 
endothelin (Cardell et al., 1994). The turbulent blood 
flow that occurs near arterial bifurcations might be one 
source of such stress; thus, it is not unreasonable to 
suggest that vasospasm might be involved in RLS. This 
suggestion would represent a post hoc revision of the PCI 
theory.
The absence of PLMS in two of the RLS subjects, and 
the presence of only mild PLMS (PLMi = 15) in another 
subject who had severe waking symptoms, also deserves 
comment. Although this finding is consistent with 
previous work which has shown that only 80% of RLS 
subjects have PLMS when studied with a single night of 
polysomnography (Montplaisir et al., 1994), these previous 
studies have not specifically stated that PLMS could be 
absent when severe waking symptoms were present. Instead,
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they seemed to imply that PLMS symptoms in patients with 
RLS could vary in severity (and even be absent) from night 
to night in much the same way that RLS symptoms vary from 
night to night. In the present study, two subjects who 
clearly had waking RLS symptoms did not have any PLMs 
while asleep. This finding is somewhat inconsistent with 
the PCI theory of RLS and PLMS because it is difficult to 
understand how the proposed B-wave induced periodic 
cerebral ischemia could present during wakefulness, then 
be absent as little as a few minutes later when the 
subject fell asleep. This finding (that PLMS can be 
absent even when severe RLS symptoms are present) brings 
into question the assumption that both RLS and PLMS are 
caused by the same pathogenic mechanism. This doubt is 
further strengthened by the lack of any clear periodicity 
in waking RLS sensory and motor symptoms noted in the 
present study. In addition, as pointed out in the 
introduction, the prevalence of PLMS has been found to be 
higher than normal in a fairly large number of medical 
conditions, including narcolepsy, uremia, organic 
impotence, and congestive heart failure to name a few. In 
one of these conditions in particular (congestive heart 
failure, CHF), a PLMS prevalence rate of 75% has been 
reported (Hanly and Zuberi-Khokhar, 1996). This is very
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similar to the 8 0% value found in RLS subjects 
(Montplaisir et al., 1994). Thus, it is quite possible 
that RLS and PLMS may be caused by different pathologies, 
and that RLS is one of many conditions in which the 
pathology that causes PLMS is more common than normal. 
Future PLMS prevalence studies may help to clarify this 
issue.
Oximetry. Patfl 
There was essentially no support for the primary 
hypotheses of interest in the present study. The most 
important of these were the predictions that PLMs and SIT 
sensory and motor events would occur consistently at rS02 
and total hemoglobin B-wave troughs. In fact, the 
opposite finding (i.e., that events tended to occur more 
frequently at peaks) occurred for all three event types 
(PLMs, SIT sensory events, and SIT motor events) for rS02, 
and for PLMs and SIT sensory events for total hemoglobin. 
For four event types (SIT Motor events in the rS02 cycle, 
and all three event types in the total hemoglobin cycle) a 
relatively large percentage of events also occurred at 
troughs. In order to further explore these results, and 
to determine if the percentages of events at the different 
wave limbs were significantly different from one another, 
a series of additional post hoc tests were performed (see
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Appendix 4). Of the seventeen comparisons that were 
significant (out of a possible 48), twelve of them were 
comparisons in which percentages at peaks were higher than 
at other wave limbs, while five were comparisons in which 
percentages at troughs were higher than at other wave 
limbs. These tests also confirmed that the percentage of 
events at peaks was not significantly different from the 
percentage of events at troughs for five of the six 
comparisons (the peak/trough comparison was significant 
only for PLMs in the rS02 cycle) . In addition, despite 
the fact the Chi Square tests were all highly significant, 
the failure of any event to occur at any one wave point 
(for either rS02 or total hemoglobin) more than 50 percent 
of the time casts additional doubt on whether or not the 
events were related in a causal way to cerebral 
oxyhemoglobin or total hemoglobin levels. One possible 
interpretation of this finding is that separate, but 
interconnected, brainstem centers may be responsible for 
generating RLS/PLMS symptoms and B-waves. If this were 
the case, then one center might be able to occasionally 
entrain the rhythm of the other center. This possibility 
has long been considered to be a potential mechanism by 
which Traube-Hering and Mayer waves might be generated 
(i.e. by influence from the respiratory centers on the
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vasomotor center; see Koepchen, 1984, for a review). If 
this were the case, then the two phenomena of interest in 
the present study (PLMs and B-waves) would be expected to 
occur synchronously at some times, but not at others. The 
data obtained in this study are consistent with this idea. 
However, the idea of a brainstem center being directly 
responsible for the generation of PLMs is inconsistent 
with the idea that PLMs are spontaneous Babinski 
responses, because it has been shown that pyramidal tract 
damage is necessary and sufficient to elicit this reflex 
(van Gijn, 1978) .
Another possibility that should be mentioned in 
regards to the wave cycle data concerns possible lags 
between arterial oxyhemoglobin levels and the variable 
actually measured by the NIRS equipment used in the 
present study. Because the NIRS instrument used in this 
study measures the hemoglobin oxygen saturation of all 
blood (including arterial and venous blood), and because 
about 7 0 percent of the cerebral blood is in the venous 
compartment, any lag between the arterial and venous 
compartments caused by circulation times could potentially 
influence the wave cycle data. Without simultaneous 
measurement of another cerebral blood flow parameter (such 
as blood flow velocity) , it is impossible to know if the
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waves measured by NIRS occur synchronously with waves 
measured by other techniques. Because the Somanetics 
instrument has only been F.D.A. approved in this country 
for just over two years, there are no studies directly 
investigating this issue; such a study would be very 
useful. The sampling rate of the Somanetics instrument 
(one sample per five seconds) was also problematical; this 
rate is inadequate for describing continuous brief 
phenomena such as B-wave peaks and troughs.
Another possibility in regards to the wave cycle data 
is that the critical physiologic parameter involved in the 
generation of PLMs and RLS symptoms might not be 
oxyhemoglobin saturation levels, but rather, C02 levels 
instead. C02 levels cannot be measured with NIRS, and may 
not correlate or vary synchronously with oxyhemoglobin 
levels.
It is worth emphasizing at this point that even if 
cerebral blood flow parameters are not related to PLMs and 
RLS symptoms, it might still be possible that a 
circulatory insufficiency occurring somewhere else within 
the nervous system (e.g. spinal cord, peripheral nerves) 
could be an underlying cause of either RLS symptoms, PLMS 
symptoms, or both. Adding substantial weight to this 
argument are the findings reviewed in the introduction
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that are suggestive of a circulatory insufficiency (and 
resulting ischemia) as the cause of both disorders. These 
include the high prevalence of RLS and PLMS in anemia and 
conditions in which either anemia or circulatory problems 
are common, the transient nature of the symptoms (i.e. 
they are not continuously present throughout the day and 
RLS symptoms can be temporarily relieved by movement), and 
the improvement of RLS by treatment with drugs that either 
correct anemia or improve circulation (e.g. the dextran 
study by Parrow and Werner, 1966; and the sclerotherapy 
study in RLS patients with varicose veins by Ranter,
1995) .
Despite the fact that PLMs and RLS sensory/motor 
events did not occur at any one point in the rS02 and 
total hemoglobin wave cycle with a high frequency (i.e. 
greater than 7 5% of the time), the finding that they 
tended to occur frequently at peaks is not only 
interesting, but is also at least partially consistent 
with the findings of several other recent studies. For 
example, Droste et al. (1996) used transcranial Doppler 
sonography to study B-wave activity in four PLMS patients. 
Although they did not assess where the PLMs occurred in 
the B-wave cycle, they did report that the blood flow 
velocity in the middle cerebral artery was significantly
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higher in all four subjects when PLMs occurred (suggesting 
that they occurred at rS02 and total hemoglobin peaks) 
than at the midway points between PLMs. It would be very 
interesting to replicate their study, and conduct analyses 
similar to those used in the present study, assessing 
whether or not PLMs or RLS sensory/motor events occur 
consistently at any one point in the blood flow velocity 
B-wave cycle. In addition, both Montplaisir, Lapierre, 
and Lavigne (1994) and Parrino et al. (1996) have reported 
that PLMs occur in association with EEG arousal (as 
assessed by spectral analysis in the Montplaisir et al. 
study, and visual scoring of CAP cycles in the Parrino et 
a l . study). It is likely that EEG arousal is associated 
with increased oxyhemoglobin levels (rS02 and total 
hemoglobin peaks), although the issue of whether or not 
the two variables are causally related remains unclear. 
Montplaisir et al. however, reported that waking RLS motor 
events were associated with EEG slowing (rather than 
arousal as was the case for PLMs). This EEG slowing 
during waking RLS movements is not consistent with the 
finding of increased higher oxyhemoglobin levels during 
these events that was found in the present study.
Given the failure to find a very consistent 
relationship between PLMs and RLS sensory/motor events and
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the B-wave cycle in the present study, it is not 
surprising that the within subjects analyses comparing 
rSO: levels at event onset to non-event levels did not 
reach significance. The predictions for those comparisons 
were based on the prediction that the events would occur 
at very high rates at a single point in the B-wave cycle.
Wave Amplitudes, Wavelengths, and Spectral Analyses 
As noted in the Results section, the B-wave 
amplitudes measured in the present study were much lower 
than expected. They were also much lower than the B-wave 
amplitudes found in transcranial Doppler sonography 
studies in normal subjects, which varied between 10 and 30 
percent of the mean flow velocity in normal subjects 
(Diehl et al., 1991). One possible explanation for the 
low amplitudes observed in the present study again 
pertains to the predominately venous nature of the rS02 
index measured by the Somanetics NIRS instrument. Because 
veins are not innervated nearly as much as arteries and 
arterioles, they have a much lower motility than do 
arteries and arterioles. Thus, the overall blood volume 
and oxygen saturations may change relatively little, while 
arterial blood volume and oxygen saturation change to a 
greater extent. The largest individual rS02 B-waves 
observed in any subject in the present study were about
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ten percent of that subjects' mean rS02 level. This is 
one-third of the maximum amplitude of B-waves reported by 
Diehl et al. (1991). Thus, transcranial Doppler 
sonography may be a better tool than NIRS with which to 
measure B-wave activity.
The spectral analyses suggested that the waves 
observed in both the total hemoglobin and rS02 signals 
were characterized by a mixture of many different 
wavelengths. These included wavelengths in the 
traditional B-wave wavelength range of 50 to 7 0 seconds, 
and perhaps more importantly, a sizable number of 
wavelengths that were similar to the inter-movement- 
intervals typically associated with PLMS (i.e., 20 to 40 
seconds). The large number of wavelengths detected by the 
spectral analyses in the present study is in partial 
contrast to the results of several other studies which 
have investigated the periodicity of B-waves. For 
example, in a transcranial Doppler sonography study Droste 
et al. (1993) found that six of ten normal subjects had a 
single B-wave wavelength (periodogram) peak in the 40 to 
70 second range, while two subjects had two wavelength 
peaks in the 25 to 70 second range (one subject had peaks 
at 27 and 44 seconds, while the other had peaks at 29 and 
67 seconds). In another transcranial Doppler study in
with perm ission of the copyright owner. Further reproduction prohibited without perm ission
2 4 9
patients with normal pressure hydocephalus, Droste and 
Krauss (1993) showed a representative spectral analysis 
periodogram from one subject which had one large peak at 
about 50 seconds, and several smaller peaks in the 40 to 
90 second range. In his study of B-waves in intracranial 
pressure tracings from neurological patients, Lundberg 
(1960) did not perform spectral analyses or other 
comprehensive quantitative analysis of B-wave wavelengths; 
however, he did report that the typical wavelength of B- 
waves was approximately one minute, and he also noted that 
waves with wavelengths in between those of the one-per- 
minute B-waves and the six-per-minute C waves did 
occasionally occur.
In the present study, waves in the 20 to 40 second 
wavelength range were generally more common than those in 
40 to 70 second range. In addition, it was common for 
subjects to have four or more peaks in the entire 10 to 90 
second range. These findings suggest that both (brainstem 
generated) B-waves and other waves reflective of regional 
cortical processes were present in the oximetry variables 
measured. Because NIRS measures oxygen saturation and 
blood flow in one small region of the brain, it can detect 
both processes. In addition, although cerebral vasomotor 
responsiveness to C02 is reduced during sleep, there is no
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reason to believe that regional variations in cortical 
metabolic rate (and subsequent changes in regional 
cerebral blood flow and oxygenation) cease to occur during 
sleep. The relatively large number of different 
wavelengths observed in the present study is consistent 
with this dual-process explanation. Another possibility 
that could account for the large number of wavelengths 
observed is that B-wave wavelength may change during the 
course of the night (perhaps in relation to sleep stage). 
Thus, it is possible that a one hour segment of sleep may 
contain B-waves of several different predominant 
wavelengths, all of which would be detected by spectral 
analyses.
Still another possibility that might account for both 
the large number of wavelengths and the low wave 
amplitudes that were observed was suggested by the data on 
the wave-to-wave changes in wavelength. These data 
strongly suggested that the majority of subjects were not 
having (unambiguous) B-wave activity. The low amplitudes 
and variable wavelengths are exactly what would have been 
expected if no B-wave activity was present.
Dual Recording Site Data
The data from the three subjects whose oximetry 
variables were recorded from two sites was also not
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consistent with the proposed PCI theory. In the one 
subject who had PLMs, these events did not tend occur at 
rS02 and/or total hemoglobin troughs. In fact, in this 
subject, the vertex rS02 and total hemoglobin were more 
stable than the forehead rS02 and total hemoglobin. In 
addition, the small percentage of peak matches between the 
two recording sites (and the relatively low correlations 
between them) indicated that B-wave activity was not 
present in these subjects. A high number of peak matches 
and high correlations would have been expected if B-waves 
were present.
Conclusions and Suggestions for Future Research
In summary, no support for the proposed Periodic 
Cerebral Ischemia theory was found in the present study. 
There were no group differences in B-wave amplitude, and 
perhaps more importantly, the RLS sensory/motor events and 
PLMs did not occur with a high frequency at the troughs in 
oxyhemoglobin wave cycle. Although these negative 
findings do not rule out the possibility of circulatory 
insufficiency as an underlying cause of RLS and PLMS, they 
do cast additional doubt on this general idea. Thus, it 
would be useful to replicate the previous studies that 
supported this hypothesis. These would include the 
treatment studies of Parrow and Werner (1966) and Kanter
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(1995), in addition to prevalence studies in a fairly 
large number of patient groups (e.g. those with various 
kinds of circulatory problems) . If treatment studies 
using blood thinners or vasodilators to treat RLS and PLMS 
cannot be justified (based on our current lack of 
knowledge concerning the pathogenesis of RLS and PLMS), 
then perhaps the prevalence of RLS and PLMS can be 
followed before and after treatment in patients who 
receive these drugs for other medical conditions. It 
would also be useful to extend the work of Droste et al.
(1996) which found that B-waves in blood flow velocity 
were related to PLMs. The simultaneous use of 
transcranial Doppler sonography and cerebral oximetry in 
such a study would also be useful. The relationship of B- 
waves and PLMS could also be studied in neurological 
patients undergoing continuous monitoring of intracranial 
pressure as part of an evaluation of neurological 
disorders other than RLS or PLMS (e.g. head injury, 
hydrocephalus). If a relationship between cerebral blood 
flow oscillations and either RLS, PLMS, or both can be 
established, then treatment studies can be considered. 
Conversely, if such a relationship can be ruled out, then 
researchers can focus on other potential causes of, and 
treatments for, both of these disorders.
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Appendix 1 - Questionnaires Used in the Study
Restless Legs Questionnaire
Subject Number_____________________  Date__________
Date of Birth__________________  Age__________  Sex
1) Please describe the problems you have with your legs.
2) Please describe the sensations in your legs in as much detail 
as you can.
3) At what times do you get the symptoms?
4) What do you do when you get the symptoms?
5) Which of the following activities are helpful in relieving 
your symptoms: (please check those that are helpful)
_____  Rubbing or massaging your legs
_____  Moving your legs while in bed
_____  Using a heating pad or taking a warm or not bath
_____  Applying anything cold to the legs
_____  Stretching your legs
_____  Getting up and walking around
_____  Other (please describe below)
289
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6) Which of the above activities are most helpful in relieving 
your symptoms?
7) How old were you when you first began to get the 
symptoms? _________
8) Have there been periods of time when the symptoms got better 
or worse or even went away completely? Please describe.
9) Are there any things which seem to make your symptoms better 
or worse? Please describe below:
10) Are your symptoms worse when you are under stress? (circle 
yes or no) YES NO
11) How often have you had the sensations in your legs over the 
past 6 months? Please check the most correct answer.
  One or two nights a week
  Three or four nights a week
  Five or six nights a week
  Every night of the week
12) Do you also get the sensations in your legs during the day? 
If yes, please note how many days a week you have had them 
over the last 6 months.
13) Please use the list below to indicate where the sensations 
occur. (Check all that apply)
  Feet
  Lower legs (between ankle and knees)
  Thighs
  Groin
  Trunk
  Shoulders or neck
  Upper arms
  Forearms
  Hands or fingers
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14) Please use the list below to indicate what the sensations in 
your legs are most similar to. (Check all that apply)
heat _____  cramps or "Charlie horses"
burning _____  creeping or crawling
cold _____  pulling or stretching
itching _____  like your legs "falling asleep"
aching _____  painful
numbness _____  tingling
15) If the sensations are painful, please describe the pain 
below.
16) Do the sensations occur: _____  on the surface of the skin
  just beneath the skin
  deep within the legs or
muscles
17) Do you find that the sensations are difficult for you to 
describe? (circle yes or no) YES NO
18) Have you ever been told that your legs twitch, kick, or jump 
during the night? (circle yes or no) YES NO
19) Do you ever wake up and find that you have kicked the covers 
off the bed? (circle yes or no) YES NO
20) Do your legs or arms ever "jump" or "twitch" suddenly during 
the day? (circle yes or no). YES NO If yes, please 
describe.
21) Did your mother, father, or grandparents have restless legs 
or leg movements at night? Please circle the correct answer 
below, and indicate in the margin if they restless legs, leg 
movements, or both.
.... YES NO DON'T KNOW
....YES NO DON'T KNOW
Grandmother (mother's side) ___ YES NO DON’T KNOW
Grandmother (father's side) --- YES NO DON'T KNOW
Grandfather (mother's side) --- YES NO DON’T KNOW
Grandfather (father's side).... --- YES NO DON'T KNOW
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22) Did any of your aunts or uncles have restless legs or leg 
movements at night? Please describe below.
23) Do any of your children or grandchildren have restless legs 
or leg movements at night? Please describe below, and be 
sure to indicate if your child or grandchild is a boy or 
girl. If you have no children or grandchildren please note 
that below.
24) Use the rating scale below to indicate how severe your 
restless legs symptoms usually are:
1 2 3 4 5 6 7
Mild Severe
25) Do you have difficulty falling asleep because of your
symptoms? (circle yes or no) YES NO
26a) When you experience symptoms of restless legs, how long does 
it take you to fall asleep (on average)?_____________ minutes
26b) When you do not experience symptoms of restless leg, how
long does it take you to fall asleep (on average)?___________
27) Do you wake up frequently during the night? (circle yes or 
no) YES NO
28a) When you experience symptoms of restless legs, how many
hours do you sleep at night (on average)?_____________ hours
28b) How many hours do you sleep at night when you do not have
symptoms of restless legs?___________ hours.
29) Have you ever become depressed because of your restless legs? 
(circle yes or no) YES NO
If yes, have you been treated for your depression? YES NO
30) Have you ever sought treatment for your symptoms of restless 
legs (or leg movements at night)? (circle yes or no) YES NO
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31) If yes, what treatment or medication did your doctor 
prescribe?
32) Was the treatment(s) effective?
33) Have you ever had a sleep study (polysomnogram) done? YES NO 
If yes, what did your doctor tell you they had found?
34) Please list any other medications which you have taken in the 
past (even if they were not prescribed for you restless legs) 
which helped reduce vour symptoms of restless leas:
3 5) Have you ever had moderately high or high fevers? YES NO 
If yes, how did this affect your symptoms of restless legs?
3 6) Have you ever given blood? YES NO If yes, how did this 
affect your symptoms of restless legs?
37) How does excercise affect your symptoms of restless legs?
38) Do you get headaches? YES NO If YES, does anything in
oarticular seem to cause you to have headaches?
39) If you are a woman, and have had children, how did your 
pregnancy affect your symptoms of restless legs?
40) Please indicate if you have ever had any of the following 
diseases or conditions: (write in a "Y" for yes, or a "N" 
for no)
  anemia _____  stroke or head injury
  kidney disease/uremia _____  high blood pressure
  iron deficiency _____  low blood pressure
  chronic lung disease _____  leg cramps
  rheumatoid arthritis _____  fibromyitis/fibrositis
  gastric (stomach) surgery _____  diabetes
  circulatory problems _____  neurological disease
  heart disease _____  cold hands, legs, feet
  leukemia _____  weakness in legs\arms
  spinal ccrd\back injury _____  headaches
  any other serious illness (list below)
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41) Would you be willing to participate in any future research 
projects that we conduct (circle yes or no) YES MO
42) On the figures below please fill in the areas where your 
restless legs sensations occur.
Thank you for completing this question.-, a ire
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SLEEP OISOROERS INVENTORY
William P. Waters. PH.D.. A8PP. BCSS 
Cooroinator. Sleep Disorders Program 
Ochsner C lin ic o f  Baton Rouge 
and
Department o f  Psychology. Louisiana S ta te  U niversity
INSTRUCTIONS
*** The Sleep D isorders Inventory is  a questionnaire th a t i s  designed to  obtain
information th a t  w i l l  a s s i s t  in the d escrip tion  and d iagnosis o f a p a t ie n t 's  sleep  
d isord er, i t  a ls o  provides information that i s  h elp fu l in determining th e  causes and 
th e  correct treatm ent o f  a p a tie n t's  sleep  d isord er .
*** P lease  answer th e se  q uestions to  th e b est o f  your a b i l i t y .  It is  understood zr.at some 
o f  your answers w i l l  be approximations, not ex a c t . Such estim ates are accep tao le . 
A lso, a few o f  th e  questions may require inform ation from a person who has observed 
your s leep . I f  you have access to  such inform ation, fe e l free  to  use i t .
*** I f  you are asked to  g ive  a YES_NO answer, and you are not certa in  o f  your response,
g iv e  the answer th a t is  c lo s e s t  to  the truth as b e s t  you can determine. I f  ycu are 
asked to  g iv e  a numerical answer, such as the number o f  minutes i t  takes you to  f a l l  
asleep , and you are not ce r ta in , give an approximate answer that is  c lo s e s t  to  the 
tru th  as b e s t  you can determine.
*** P lease answer ALL o f  the questions.___ If  a YES_NO item does not apply to  you. answer
NO. It you encounter an item  that c a l ls  for a numerical response and i t  does rot
apply to  you. or you cannot give an estim ate, th e  number 0 w ill  in d ica te  th a t i t  does 
not apoly or th a t you cannot estim ate.
Before beginning tn e Sleep Disorders Inventory, p lea se  provide tne fo llow in c  
in fc m a t io r :
NAME: ______________________________________________  QA": ________
SOCIAL SECURITY NUMBER: __________________________  CLINIC NUMBER:
AGE: _________________  WEIGHT:_________________  HE:^HT. ______
THE SIZE- DISORDERS INVENTORY BEGINS ON TriE NEXT ?iGE.
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SLEEP OISOROERS INVENTORY Page 1
P le a se  CIRCLE tn e appropriate response for eacn o f  tn e  YES or NO q uestions. P lease  PILL 
IN THE BLANK w ith tn e  correct nuioer for eacn q uestion  that is  f o l lo « d  by a blank.
1. Oc you nave a i f f ’ c u lty  fa llin g  asleep at m gnt ? ..................................................................................NO
I r NO. 50 to  t  2
(a) About how many m ghts does th is  happen each week ? ................................-  • ■ ------------
(b) On n ign ts when you have th is  problem, how many minutes does i t  take you to
f a l l  a s leep  ? .............................................................................................................  ^...............................
(c )  On m gh ts when you nave th is  problem, how many hours do you sleep  ; .................. .................
2. Do you wake uo during the night and have d i f f i c u l t y  fa l l in g  back to  s leep  ?  YES NO
I f  NO. go to  I  3
(a) About how many m ghts does th is  happen each v«ek ? ............. ......................................... .................
(b) On th e  average, how many times do you wake up each n ight ? ............. ........................ .................
(c )  How many m inutes does i t  take you to  f a l l  a sleep  a fte r  awakening ? .................. .................
(d) On n ig h ts  when you have th is  problem, how many hours do you sleep  ? .................. .................
3. Oo you wake up in  th e  morning before your scheduled wake tim e, and cannot
return to  s le ep  ? ......................     'ES NO
i f  NO. SO tO #  A
(a) H o  many n ig h ts  per week do you have th is  problem ? ......................  — .......................................
(b) On m gh ts wnen you have th is  problem, hew many hours do you sleep ? .................. .................
a Oo you wase up during the night frequently , out f a l l  asleep  soon afterwards 7 ...Y E S  NO 
NO. go to  #  5
(a) h o w  many tim es a n ight do you wake up ? ................................................................................................
CDJ Hew many n ig h ts  each week do you have th is  problem ? ................................................... .................
On m g h ts wner. you 00 not have any problem f a l l in g  a sleep  or regaining s le e p ,  
h o  many m inutes does i t  usually take you to  f a l l  a sleep  ? ..........................................
Hew many n igh ts each week do you have sleep  lo ss  o f  any kind ?. 
Hex mary hours cc you sleep  on your o est m gnts ? .............................
Or '•’.a r ts  wrer you to not have any orcolem 'a i l in g  a sleep  or regaining s le ep ,  
new many hours "tc yet usually  sleep ? ......................................................................................
Dees lack  o f  s le ep  often  cause vcu to  fa l l  a sleep  at inappropriate times or m  
tne wrong p lace  during the day ? ....................................................................................................
10. Does lack o f  s le e p  often  cause you to  have tro u b le  fun ction ing  during tn e day
11. Does your Ded partner disturb ycur sleep  at n igh t ? ..........................................................
I * NQ. OC to  4 12 .
; a ; Dees i n s  tau se  k u  sleep  ;ess some or tne tim e 7 ...............
vcu ' : s e  sleep most o f the ra te  2 .........................a . . 1 0  *
Is veur s eep r s t u r e e c  oy erv 'ronrercs: 'a s te r s  sucn as tra f' 
-'ar-^y nemce-s ...............................................................................................
;a, Dees t m s  cause y:u sleep  le ss  some o f  tne tim e ? ................
(p.’ is  t m s  *ry you ose sleep  most o f  the time ? .........................
Is ycur oecrccm dark enough for s 'e e c  at m em  ? ...........................
* -  .• ZZ - r  “ ^  i ' *
C c e s ' f s  cause vcu sleep  ': s s  some z~s tim e '
Is f " .  .-tu ' : s e  s ie e :  t e s t  :* t _e v e
YES NC 
YES NC 
YES NC
c. ne’grpcrs cr
YES
YES
YES
.YES
NC
NC
NC
NC
YES NC 
. VES NC
YES NC 
VE5 NC
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NO14 Is your bedroom temperature comfortable enough for s le ep  at n ight ? ........................... YES
I f  YES. go to  #  15
(a) Does t m s  cause you sleep  loss sane o f  th e  tim e ? ............................................................ YES NO
(b) Is tm s  why you lo se  sleep  most o f  the tim e ? ..................................................................... YES NO
15 Oo you sleep  enough nours but have trouble waking up. fe e lin g  unrefreshed ? ...........YES NC
16. Oo you sleep  enough hours Dut fa ll asleep  in v o lu n ta r ily  during the day. but only
when r e la t iv e ly  unstimulated ( lik e  watching tv )  ?  YES NO
17. Do you s le ep  enough hours but fa ll asleep  in v o lu n ta r ily  during the day. even
when doing something very important ( l ik e  d r iv in g ) ?  YES NO
18. Oo you s le ep  enough hours but s t i l l  have trou b le  function ing during the day 7...YES NO
19. How many n ig h ts  per month do you:
  Snore loudly and p ers isten tly
 Thrash about while asleep (Out are not dreaming)
 Gasp or snort w hile asleep
 Stop breathing w hile asleep
 wake up in the night and feel unable to  breathe
20. How many mornings a month do you awaken w ith a headache ? ................................................ ................
21. Oo you wake up frcm a sound sleep  repeatedly because your legs jerk ? ........................YES NO
I f  YES: Are you r  leg  movements frequent, v igorous and regular ? ..................................... YES NO
If y es- How many nights per month does th is  occur ? ..............................................................................
22. Is your s le e p  ever delayed because your legs f e e l  r e s t le s s  or  odd in bed ? .............YES NO
i L nq. go to  # 23
(a) Do you need to  move your legs in bed. or g e t  up and move to  fa ll  asleep  7 . . . YES NO
(b) How*many n igh ts per month do you legs f e e t  t h is  way 7 .............................................. ................
23. Do ycu have sudden and compelling attacks o f  s ’ e e p in e ss . so bad you must stop
what ycu are doing and sleep  7  YES NO
I f  NO. go to  # 24
(a) how many minutes do you sleep  (nap) when you have such an attack 7 ....................  .......
(b) Do you awaken from you nap fee lin g  refreshed  7 ..................................................................YES NG
Cc) How many tim es eacn month does th is  occur 7 .......................................................................................
24. wher, you are s ta r t le d , emotional, ex c ited , or happy do you often  experience
extreme weakness (for example, in your le g s)  or drop th in gs 7 .........................................YES NO
25. when you are s ta r t le d , emotional, ex c ited , or happy do you co lla p se  ( f a l l )  ? — YES NO
If  vE.v Are you s t i l l  aware o f  your surroundings 7 ................................................................. YES NO
25. As you f a l l  a sleep  or wake up. do you o ften  se e  th in gs that are not there 7  YES NO
If  VES: Is wrat you see very clear ano r e a l i s t i c  7  YES NO
-cw many nights eacn month 7 ............................................................................................... .................
27. As 'Cu fa * I asleep  or wake up. oo you o ften  f e e l  unaole to  move (paralyzed) 7 . . . YES NO
If  VES: h o w  many nights each month 7 ................................................................................................ .................
28. On rex many n ig h ts  nave nightmares awakened you in tn e la s t  month 7 ...........................................
I f  ANY: h o w  in te n se  are they: 1-MilC. 2 -F righ tem n g . 3-T errirying 7 ............................ .................
29. Do you o fte n  move v’o len tly  during ycur s le ep  wfiile_dreanring and sometimes
eve'1 nurt y o u r se lf  or ycur partner by acc id en t, or *a ll out o f  bed 7  YES NC
lY 'E T ; -cw  rnarv times in tne la st month nas t h is  nacoened 7 ................................... ................
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30. Oo you awaken from a deep s le ep  sweating, your heart beating fa st or
sounding, w ith  a fe e lin g  o f  fear but with no memory o f  a dream ? ...................................YES NO
If NO. go to  #  31
(a) how many tim es in the la s t  month has th is  happened ? ...................................................................
(b) new in ten se  is  th is  experience: 1-Mild. 2-Frightem ng. 3 -T ern fy in g  ? ..............
(c) Do you have sim ila r  experiences during the day as w ell ? ........................................... y£$ nO
31. Oo vou walk in your s leep  ? .........................................................................................................  . YES NC
If ftC. go to  # 32
(a) how many tim es a month does th is  happen ? ........................................................................... ................
(b) About how many minutes pass by w hile you are sleetxwalking ? ............................ — _______
32. Do you o ften  ta lk  in  your s le ep  ? ...................................................................................................... YES NO
33. Do you o ften  grind your te e th  in your sleep  ? .............................................................................YES- NO
34. Haw many tim es per n igh t do you wake up s p e c if ic a lly  to  use the bathroom ? ............................
35. how many n ig h ts  per week do you wake up with in d igestion  or heartburn ? .................. ................
36. Do you o ften  e a t your la s t  meal or a large snack w ithin  2 hours o f  bedtime ?  YES NC
37. Do you o ften  g o vigorous e x e r c ise  w ithin  an hour o f  bedtime ? ..........................................YES NO
38. How many g la s s e s  (b o t t le s /c a n s )  o f  a lc o h o lic  drink do you have each day ? ..............................
39. How many n igh ts each month do you use alcohol to  aid sleep  ? .......................................... ................
40. h o w many cups or g la s s e s  o f  ca ffe in a ted  beverages do you drink in a day ? ..............................
41. How many days a week do you drink ca ffe in a ted  beverages a fte r  7 p.m. ? .....................................
42. Hew many c ig a r e tte s  a day do you smoke ? ...................................................................................... ................
43. Do you take any m edications th a t contain  c a ffe in e  or stim ulants, such as a lle r g y
m edications, nasal d econ gestan ts, or oain k i l le r s  ? .............................................................. YES NC
i~ VE5: Hew many minutes b efore try in g  to  s leep  do you take them ? ........................... .................
44. is yz'jr  s 'e e c  problem causec or mace -worse by physical discom fort or oam :
 Never:  Rarely;  Sometimes.  Green;  Most or All o f tn e  Time.
45. Do you ever *cr<  n ight s h i f t s  (Any 3-12 hour s h i f t  sta rtin g  6 pm to  12 am) ?  YES .NC
If '9 5 : How many n ig h ts  per month ? ..................................................................................................................
Hew many tim es a month do your worfc hours change ? ............................................... ................
46. Do you work at ncme a f te r  8:00 p.m. ? ............................................................................................YES NC
how many n ig h ts  per week ? ................................................................................................... •_______
47. Do you i s c r i - i t e  s leep  tim e in order : :  get m  mere 'work or  - 3m ly  time ? . .  YES NC
If *25: -cw ?*ry hours oer n igh t ? ................................................................ " ............................... ................
-Cw - -" y  m g h ts  per week 7 ...................................................................................... ...............
43. On weesencs pr ycur days o f f .  co you often  sleep  mere than an ncur ia t e r' tnan
your usual wase up tim e ? .....................................................................................................................  YES VC
50. when vcu nave s 'e ep  problems, do ycu:
(a) Often go t :  pec e a r l ie r  to  make up for lo s t  or unrefresnm g slaeo 1 ...................YES NC
CD; Often wake up la te r  to  make uo for lo s t  or un-efreshm c s ’eeo 7 .................. YES NC
It , Cat up Put pf P9d and.  water tv: . rea-t:  eat:  ^ work CHECK all ~-at APPL'
' t  "ase niP 3 t .-" r g  ncraa' wak’ rg "Cu'S - . .  YES NC
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I f  NO naps, go to  # 5L 
(T) Hew many tim es per  week do you take naps ? . . .
(2) How many minutes are your naps, on average ?.
(3) Oo you awaken from your naps refreshed 1 .................................................yES nC
51. Is your sleep  problem worse w*ien you are under s t r e s s  ? .......................................................YES NC
Do you s le e o  b e tte r  when you sleep  away frcm home ? ................................................................YES NC
52. Have ycu been under noteworthy stre ss  recently  ? ......................................................................YES nC
53. When you try  to  s le ep , does worrying or problem so lv in g  o fte n  keep you awake ?..YES NO
Oo you o ften  worry about g e tt in g  enough sleep  to  fun ction  th e  next day ? ................... YES NO
Oo you o ften  g et frustrated  and angry about not g e t t in g  to  sleep  ? .............................. YES NO
54. Oo you worry too  much in general ? ....................................................................................................YES NO'
55. Does your s leep  problem a f fe c t  your mood during th e  day ? ................................................. YES NO
56. Are you cu rren tly  diagnosed as having a mood d isord er (depression)..? .....................  YES NC
57. Are you cu rren tly  diagnosed as having an anxiety d isord er ? .............................................YES NO
58. Have you eve" been treated  for m ental/em otional/drug/alcohol problems ? ......................YES NO
I f  YES: Have you ever  been h osp ita lized  for such problems ?  YES NC
59. How long have you had your sleep  problem ?  No. Y e a r s  No. Montns  No. weeks
50. Have you p rev iou sly  received non-drug treatment fo r  s le e o  problems ?  YES NC
51. Have you recen tly  taken any prescription  or over-th e-cou n ter medication for
s leep  problems ? ............................................................................................................................................YES NC
If"no. go to  § 62
(a) How many n igh ts a week do ycu usuallv take th is  m edication ? .................................................
(b) How many months have you oeen taking sleep  m edication ? ........................................... ................
52. P lease  l i s t  winch m edications you are now taking and th e condition  for v*ncn eacn i s  
being taker. Include p rescrip tion  and over-th e-cou nter m edications.
me: : : a' i : n ccnoi' icn meoicaticn ccnoiticn
53. P lease  l i s t  any m edications ycu have recently  stopped taking and the condition  for
Y ..ar r\r\i n/* l rtn an/i nv/Of* _ f h a  fnO/ll f* 2 T 'if' flCwhich eac- *as cem c  
mech.-ticn  *
taken. 
CCNC
rclude p rescr ip tion
" .: n
nd over-the-counter m edications. 
MEDICATION CONDITION
Is th ere m g you would W e  to c la r ify  or acd. tnat .irgnt be he'b 'u! ? You may 
w rite  you' torren ts te'cw  arc ;r  ore reve'se  s i c e  o f  t h i s  cage:
- - an:< "5. i w .-i ' ing ?- i !  :'ivE'r:=v
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DAILY SLEEP DIARY
Subject N u m b e r ______________________________Date_____________________
PLEASE RESPOND TO THESE QUESIONS SOON AFTER YOU WAKE UP FOR THE DAY.
1. About what time did you first try to fall asleep last night?_____
2. Approximately how many minutes did it take you to fall asleep?________
3. If you awoke from sleep last night, please indicate about how long it 
took you to get back to sleep.
_min
min
nun
min
_min
min
_mxn
min
About what time did you awaken for the day this morning?_
About how many hours did you sleep altogether last night?_ 
How difficult was it for you to fall asleep last night?
_min
min
Not very 
difficult
7. How rested do you feel this morning?
1 2  3 4
Very Rested 
3. Rate the quality of last night's sleep.
1 2  3 4
Excellent
Extremely
difficult
Poorly Rested
Very Poor
9. What was your level of physical tension when you went to bed last 
night?
Extremely
Relaxed
Extremely
Tense
10. Rate your level of mental activity when you went to bed last night.
1 2 3 4 5
Very Quiet Very Active
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Daily Sleepiness Scale 
Form D
Data
Instruction*: Plaasa ua««r q wiUoos I - 14 bafora you go to bad tonight. Bafora
answanng thasa quastions, think about bow slaapy you fait today. Than, raad aacb
applias to you. Plaasa answar guaation 15 whan you wala up in tha morning.
1) About how many hours did you slaap last night?
(a) 5 hours or lass (f) 7 u* hours
(b) 5 hours (g> 8 hours
(c) 6 hours (h) 8 hours
(d) 6 h hours (i) 9 hours
(a) 7 hours (3) 9 h hours or mora
2) What was tha ovarall quality of your slaap last night?
1 2 3 4 5
Vary Poor Excallant
3) How difficult was it for you to awaJcan this morning?
1 2 3 4 5
Not at all Vary
difficult difficult
4) How of tan did you axparianca a strong dasira to lay down and slaap today?
1 2  3 4 5
Almost navar Vary Of tan
5) How many tiaas did you -nod off" (or fall aslaap for just a faw saeonds) today 
whila you wara angagad in unimportant tctiwitiaj Cfor axampla. wbila watching TV 
or raading)’
(a) Nona (d) Thraa tins*
(b) Onca (a) Four or aora timas
(c) Twico
S) How many cuas did you "nod off" (or fall aslaap for just a faw saeonds) today 
whila you wara angagad in important aetlvitias (for axanpla, whila driving or 
having a convarsation)?
(a) Nona (d) Thraa tiaas
(b) Onca (a) Four or aora timas
(c) Twica
?) About how many ainutas did you nap today'1
(a) nona (d) 41 to SO ainutas
(b) 1 to 20 ainutas <«) 51 ainutas or mora
(c) 21 to 40 ainutas
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8) Ho* of ton did you do thinff to holp yourself stay awaka today? For oxagplo: move
around or u n r u u ,  . . . waah your face or take a showor, . . . drink coffee or other 
caffainated bovorago, ate..
1 2 3 4 5
Almost navar Vary Ofton
91 How such did sleepiness negatively «ffoct your job performance or normal 
activities today?
Hot at v-rY
All HUeh
10) How of tan did you hava troublo concentrating or paying attontion today?
1 2 3 4 5
Almost navar Vory Oftan
11) How much did you yawn today’
1 2 3 4 5
Almost navar Vory Oftan
12) How oftan did your ayas faal tirwd, hoavy, or droopy today?
1 2 3 4 5
Almost navar Vory Oftan
13) How ofton did you foal physically tirod or fatiguad (but not nocossanly sloapy) 
today’
1 2 3 4 5
Almost navar Vory Oftan
14) Ovorall. how sloapy war* you today?
1 2 3 4 5
Not at all Vary
sloapy iloopy
Please answor this last quostion whan you wako -so m  tha morning.
15) About how long did it taka you to fall aslaap last night?
(a) 0 to 5 minutos (d) 31 to 40 ainutas
(b) 4 to 15 ainutas (a) 41 or mora ainutas
(c) 16 to 30 ainutas
Thank you for completing this questionnaire'
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Appendix 2 - Study Consent Form
LOUISIANA STATE UNIVERSITY-BATON ROUGE CAMPUS 
Consent Form
1. Study Title; Cerebral Hemoglobin Oxygen Saturation in
Patients with Restless Legs Syndrome and 
Periodic Limb Movements in Sleep.
2. Performance Sites: Louisiana State University
3. Investigators: The following investigators are available
for questions at the phone numbers listed 
below.
4. Purpose of Study: To determine if symptoms of Restless
Legs Syndrome and Periodic Limb Movement Disorder are 
associated with abnormalities in blood flow and oxygen 
transport to the brain.
5. Patient Inclusion: The study includes three groups of
subjects aged 19 to 30 years old: patients with Restless
Legs Syndrome, patients with Periodic Limb Movements in 
Sleep, and healthy control subjects. Each group will 
consist of 12 to 15 subjects.
c. Patient Exclusion: Persons younger than 18 or older char. 50
years old, persons with any sleep disorder other than 
Restless Legs Syndrome or Periodic Limb Movements in Sleep, 
persons with any neurological disorder, life-threatening 
medical condition, or mentally disabling medical disorder.
Description of the Study: This study consists of two parts.
Part One is a screening process that begins with a phone 
interview lasting about ten minutes. The purpose of the 
phone interview is to make an initial decision about whether 
or net you meet the inclusion criteria for the study. If 
ycu do, you will be sent a consent form and packet of 
questionnaires to complete. After you have received the 
packet, you will again be contacted by phone so that the 
study and consent form can be explained to you. This should 
take about ten or fifteen minutes. The questionnaires 
include the Sleep Disorders Inventory, which should take 
about 20 minutes to complete. Participants with Restless
Name:
Department: 
Telephone Number:
William Waters, Ph.D.
Psychology
388-4115
Name:
Department: 
Telephone Number:
Mark Hurry, M.A.
Psychology
766-6399
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Legs Syndrome will also fill out a questionnaire called the 
Restless Legs Questionnaire; this should take about 20 
minutes to complete. In addition, each subject will be 
required to complete two short questionnaires, the Daily 
Sleep Diary and the Daily Sleepiness Scale, each day for a 
period of two weeks. Each of these questionnaires takes 
about five minutes to complete each day. After you have 
returned the questionnaires, they will be reviewed, and, 
according to the results, you may or may not qualify for 
Part Two of the study.
Part Two of the study will require you to undergo a one 
hour test during which you will try not to move your legs 
(Suggested Immobilization Test!, and then undergo an 
overnight sleep study on the same night. Both tests will be 
conducted in the L.S.U. Department of Psychology's sleep 
laboratory in Audubon Hall, which is located on L.S.U.'s 
Baton Rouge campus. For some subjects the Suggested 
Immobilization Test will consist of 30 minutes of attempting 
to remain still, followed by 15 minutes of walking in place, 
and Cher, an additional 30 minutes of attempting to remain 
still. During the Suggested Immobilization Test and the 
overnight sleep study, blood flew to the brain will be 
measured by a small sensor placed on the forehead. Brain 
activity, eye movements, muscle tone, heart rate, breathing, 
and leg movements will also be measured during these tests 
using sensors attached to the surface of the skin. It will 
take about one hour and fifteen minutes to attach the 
recording sensors, sc subjects will be required to arrive at 
Che sleep laboratory two and half hours prior to their 
normal bedtime, or at about 8:12 p.m.. Subjects will be 
awakened at 6:00 a.m. in the morning, and should be ready to 
leave about 30 minutes later.
8. Benefits: The study will not benefit all subjects directly, 
though some subjects may choose to have their results sent 
to their physician. The study will benefit subjects by 
helping physicians understand the causes of Restless Legs 
Syndrome and Periodic Limb Movement Disorder, and by 
enabling researchers to target more specific and effective 
treatments for their disorders.
9. Risks: The risks are very small, and include a small
possibility of developing mild skin rashes where recording 
devices are attached to the skin. Patients with Restless 
Legs Syndrome and Periodic Limb Movement Disorder who 
withdraw from medications being used to treat their disorder 
may experience increased difficulty in falling asleep, a 
decrease in the quality of their sleep, and an increase m  
daytime sleepiness. Patients with Restless Legs Syndrome 
and Periodic Limb Movement Disorder who withdraw from
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medical treatment will be required to do this under the 
supervision of their physician.
10. Alternatives: This study does not evaluate any treatment
for Restless Legs Syndrome or Periodic Limb Movement 
Disorder. Alternative methods for measuring blood flow to 
the brain include transcranial Doppler sonography, which is 
technically difficult, and various types of "brain scans", 
which are both costly and invasive.
11. Removal: Subjects who agree to participate will fulfill all
of the study requirements when the overnight sleep study is 
completed, or when they return the questionnaires to us if 
they do not qualify for Part Two of the study.
12. Right to Refuse: Subjects may choose NOT to participate or
withdraw from the study at any time with no penalty.
13. Privacy: The results of the study may be published as group
data in which no subjects' results are presented 
individually. The privacy of participating subjects will be 
protected and the identity of participants will not be 
revealed. The data collected will not be used for any 
purpose not approved by the participants and the L.S.U. 
Institutional Review Board.
14. Release of Information: The questionnaires and recordings
for participants in this study will be reviewed by the 
investigators, but the identity of the participants will not 
be revealed. If any participant wishes to have results from 
their overnight sleep study (or any ether results from the 
study) sent to their physician, they may do so by filling 
cut a written request for information form at their 
physician's office, or by sending a written request to:
William Waters, Ph.D.
Department of Psychology 
236 Audubon Hall 
Louisiana State University 
Baton Rouge, LA 70803
15. Financial Information: There are no costs to participants 
m  the study other than any travel costs that mignt be 
incurred in coming to LSU for the overnight sleep study.
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16. Signatures:
The study has been discussed with me and my questions have 
been answered. I understand that additional questions 
regarding the study should be directed to investigators 
listed above. I understand that if I have questions about 
subject rights, or other concerns, I can contact Charles E. 
Graham, Chairman, Institutional Review Board (504-388-1492). 
I agree with the terms above and acknowledge I have been 
given a copy of the consent form.
Signature of Study Participant______________________  Date___________
Witness_____________________  Date___________
Investigator___________________  Date___________
The study subject has indicated to me that she or he is unable to 
read. I certify that I have read this consent form to the 
subject an explained that by completing the signature line above 
the subject has agreed to participate.
Signature of Reader_______________________   Date_____________
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Appendix 3 - Scoring Rules for B-Wave Cycle Data
1) The waves in the rS02 and total hemoglobin data should 
be thought of as consisting of three equal parts: 
troughs, ascending/descending limbs, and peaks. If the 
trough to peak (ascending part of wave) and peak to trough 
(descending part of wave) are not equal in height, divide 
each segment into equal thirds as described above.
2) To determine wave limb in the rS02 waves, use the 
following guidelines:
a) If the wave height is 1 rS02 point, there are only 
peaks & troughs.
b) If the wave height is 2 rS02 points, the bottom points 
are troughs, the middle ones are either ascending or 
descending, and the top points are peaks.
c) If the wave height is 3 rS02 points, the bottom points 
are troughs, the two middle ones on each limb are either 
ascending or descending, and the top points are peaks.
d) If the wave height is 4 rS02 points, the two bottom 
points are troughs, the one middle point is either 
ascending or descending, and the two top points are peaks.
e) If the wave height is 5 rS02 points, the two bottom 
points are troughs, the two middle points are either 
ascending or descending, and the two top points are peaks.
f) If the wave height is 6 rS02 points, the two bottom 
points are troughs, the three middle points are either 
ascending or descending, and the two top points are peaks.
3) Stable points can occur whenever the rS02 value does 
not change for 5 or more data points. Whenever there are 
five or more data points at the same rS02 level, the first 
two points after the increase or decrease are scored as 
either peaks or troughs (peaks if the previous point was 
lower, and troughs if the previous point was higher). 
Similarly, the last two points before the next increase or 
decrease are scored as either peaks or troughs (peaks if 
the next point is lower, and troughs if the next point is 
higher). All points in the middle are scored as stable 
(this can be as few as one data point).
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Appendix 4 - Additional Statistical Tests on B-Wave Cycle
and Periodogram Peak Data
This appendix contains a number of additional 
statistical tests on the event occurrence in the B-wave 
cycle and spectral analysis periodogram peak data. These 
tests were done on a post hoc basis to help clarify the 
results. There were a total of 68 of these tests (48 
pairwise comparisons on the wave cycle data, 14 Chi Square 
tests on the periodogram peak data, and six ANOVAs on the 
mean number of periodogram peaks among the groups). An 
initial alpha level of .004 was used to assess the 
significance of these tests. This reflects the number of 
tests (68) divided into an overall alpha level of .25).
The .25 overall alpha level was used as per the 
recommendations of Keppel (1991). In addition, the 
multistage Bonferroni correction procedure of Larzelere 
and Mulaik (1977) was used. There were 16 tests that 
reached significance in the first step of this multi-stage 
procedure, and one test that reached significance (at the 
.005 p level) in the second step of this procedure.
The data presented in Tables 6 through 11 in the 
Results section are summarized in Table A4-1, which lists 
the group means for the percentages of events (SIT 
sensory, SIT motor, and PLMs) occurring at each point in
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Table A4-1. Summary of B-Wave Cycle Data (Percent of
Events Occurring at each Point in the Cycle)
Event Trough Ascend Peak Descend Stable
rSO; Data
Sensory 19.4 7.0 48 . 6 11.4 13 . 6
Motor 30 . 4 7.7 38 . 9 12.8 10.2
PLMs 18 . 9 8 . 8 48 . 3 10.1 14 . 0
Total Hemoglobin Data
Sensory 35. 9 7.6 42.0 14 . 4 —
Motor 40. 6 11.2 35.1 13.2 —
PLMs 33. 9 12.8 40.3 12. 9 —
the rS02 and total hemoglobin B-wave cycles. The SIT 
sensory and motor event means are for RLS subjects only, 
while the PLMS means are for the thirteen subjects who had 
PLMs (seven RLS and six PLMS subjects). These data were 
assessed for normality with Shapiro-Wilk tests, and for 
homogeneity of variance (within each row in Table A4-1) 
with Levene tests for homogeneity of variance. The 
Shapiro-Wilk tests were significant, indicating non-normal 
distributions, for three means: the ascending limb for
SIT sensory events in the rS02 cycle, and the descending
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and stable limbs for PLMs in the rS02 cycle. The Levene 
tests for homogeneity of variance were significant for SIT 
motor events in the total hemoglobin cycle and PLMs in the 
total hemoglobin cycle. Differences among the means 
(within each row) in Table A4-1 were assessed with paired- 
sample t-tests whenever both means were normally 
distributed and had homogeneity of variance, and Wilcoxin 
tests whenever the comparison involved any non-normally 
distributed mean or pair of means with unequal variances. 
The t values and Wilcoxin z values, and their associated p 
values, for these pairwise comparisons are listed in Table 
A4-2 (for rS02 data) and Table A4-3 (for total hemoglobin 
data) . For SIT sensory events in the rSO, B-wave cycle, 
the percentage of events occurring at peaks was 
significantly higher than the percentage of events 
occurring at descending or stable limbs. For SIT motor 
events in the rS02 B-wave cycle, the percentages of events 
occurring at peaks was significantly higher than the 
percentages occurring at ascending, descending, and stable 
limbs. The same pattern was seen for the percentage of 
events occurring at the troughs, while the peak/trough 
comparison was not significant. For PLMs in the rS02 B- 
wave cycle, the percentage of PLMs occurring at the peaks 
was significantly higher than the percentages of PLMs
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Reproduced 
with 
perm
ission 
of the 
copyright ow
ner. 
Further reproduction 
prohibited 
without perm
ission.
Table A4-2. Summary of Pairwise Comparisons on rS02 B-Wave Data
Comparison1
Event' P/T P/A P/D P/S T/A T/D T/S A/D A/S D/S
Sens -3.04 -2.37 4.83 4.40 -2.37 1.86 0.82 -1.35 -1.01 -0.32
(n.s.) (n.s.) (.003) (.005) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.)
Mot -1.24 -5.25 7.47 4.68 9.43 4.04 4.75 -1.68 -0.62 0.50
(n.s.) (.001) (.001) (.002) (.001) (.004) (.001) (n.s.) (n.s.) (n.s.)
PLMs -5.01 -11.37 -3.18 -2.62 2.67 -2.13 -1.88 -0.53 -0.47 -0.24
(.001) (.001) (.002) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.) (n.s.)
1) Abbreviations are as follows: T = Trough, A = Ascending, P = Peak,
D = Descending, S = Stable
2) Abbreviations are as follows: Sens = Sensory, Mot = Motor
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Table A4-3. Summary of Pairwise Comparisons on Total
Hemoglobin B-wave Data
Event
Comparison-
P/T P/A P/D T/A T/D A/D
Sensory -0.79 -6. 42 4 . 61 4 .22 2. 90 -2.86
(n.s.) (.001) (.004) (n.s.) (n.s.) (n.s.)
Motor -0. 53 -2. 67 -2. 67 -2.61 -2. 67 -0.71
(n.s.) (n.s.) (n.s.) (n.s.) (n.s.) (n.s. )
PLMs -0. 66 -3.18 -3.18 -2. 90 -3. 18 -0.20
(n.s.) (.002) ( .002) ( .004) ( .002) (n.s.)
1) Abbreviations are as follows: T = Trough , A =
Ascending, P = Peak, D = Descending
occurring at troughs, ascending limbs, and descending 
limbs.
For SIT sensory events in the total hemoglobin B-wave 
cycle, the percentage of events occurring at the peaks was 
significantly greater than the percentages of events 
occurring at the ascending or descending limbs. There 
were no significant pairwise comparisons for the SIT motor 
event occurrence in the B-wave cycle. For the PLM 
occurrence in the total hemoglobin B-wave cycle, the
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percentages of events occurring at both peaks and troughs 
was significantly greater than the percentages of events 
occurring at the ascending and descending limbs.
In summary, of the seventeen comparisons above that 
were significant, twelve were comparisons in which the 
percentage of events occurring at the peak was greater 
than the percentages occurring at other wave limbs, while 
five were comparisons in which the percentage of events 
occurring at the troughs was greater than the percentages 
occurring at the other wave limbs. Only one of the 
peak/trough comparisons was significant (for PLMs in the 
rS02 B-wave cycle) .
In Table 12 (see the Results section), the number of 
periodogram peaks in the different wavelength ranges for 
all three groups during the SIT were presented. A total 
of six Chi-Square tests were done on these data to 
determine if the observed frequencies were significantly 
different from equal frequencies in all ranges. None of 
these tests reached significance at the .004 p level.
In Table 13 (see Results section), the number of 
periodogram peaks in the control subjects and in all 
subjects with PLMs during sleep were presented. A total 
of four Chi Square tests were run on these data to 
determine if the observed frequencies were significantly
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different from equal frequencies in each range. None of 
these four tests reached significance at the .004 p level.
In addition, four Chi-Square tests of homogeneity 
were run to determine if the groups differed significantly 
in their frequencies in the different ranges (one test 
each for rSO; and total hemoglobin data during both the 
SIT and PSG). None of these tests reached significance at 
the .004 p level.
Four ANOVAs were run on the group means for the 
number of periodogram peaks per subject (one each for rS02 
and total hemoglobin during both the SIT and PSG) to 
determine if there were any group differences in the 
number of periodogram peaks. None of these four ANOVAs 
reached significance at the .004 p level.
Finally, two ANOVAs were run on the group means for 
the wave-to-wave change in wavelength data (see Table 14) 
to determine if the groups differed on this variable. 
Neither of these two ANOVAs reached significance at the 
.004 p level.
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